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Magnetosomes are membranous organelles found in magnetotactic bacteria (MTB). The 
organelle consist of ferromagnetic crystals housed within a lipid bilayer chained together 
by an actin-like filament and allows MTB to orient within magnetic fields. The genetic 
information required to produce these organelles has been linked to four different 
operons, encoding for 30 genes. These membranous organelles and the magnetic minerals 
housed within have various biotechnological applications, therefore enhanced 
recombinant production of such structures in a model organism holds significant potential. 
The research described in this thesis is focuses on the production of recombinant 
magnetosomes in the model organism Escherichia coli. 
Cloning the genes involved in the generation of the organelle individually or in various 
combinations resulted in the construction of over 100 different plasmids, compatible with 
the model organism. SDS-PAGE and electron microscopy analysis was used to characterise 
E. coli cells harbouring these constructs. The observation of electron dense particles, 
arranged in a chain structure, show that magnetosome generation in the model organism 
is possible, but is highly dependent on the growth conditions used. The need for specific 
growth conditions is later backed up by the analysis of the maturation of the cytochrome c 
proteins involved in magnetosome biomineralisation, which can only be correctly 
processed under certain conditions. 
Individual production of two different magnetosome proteins, MamQ or MamY, allowed 
the generation of various membranous structures in E. coli observed in 48.9% and 56.2% 
of the whole population of cells respectively. Combinations of these with MamI, MamL or 
MamB in a variety of combinations led to a variation in the phenotype observed. 
Bioinformatics analysis of MamQ led to the discovery of a novel membrane restructuring 
protein family, the LemA protein family, present in a broad range of bacteria. Four different 
LemA proteins from Bacillus megaterium, Clostridium kluyveri, Brucella melitensis or 
Pseudomonas aeruginosa were then produced in E. coli and the analysis of the resulting 
strains revealed the presence of novel intracellular membranous structures which vary in 
size, form and localisation. Furthermore, when attempts were made to target these 
proteins for the modification of the outer membrane, a mechanism for increased outer 
membrane vesicle generation was serendipitously discovered and different effects of these 
proteins were once again observed. 
Together, the results described shows good evidence for recombinant magnetosome 
production in E. coli and opens a new avenue of membrane engineering in this commonly 
used organism. Such membranous structures have various biotechnological applications, 
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For years, one of the defining features of prokaryotic organisms was the lack of any 
membranous organelles. Recently, this view has been changing with the characterisation 
of bacterial organelles such as chromatophores, the photosynthetic organelles found in 
photosynthetic bacteria, nuclear envelopes, present in the Planctomycetes species, outer 
membrane vesicles (OMVs), produced by a range of different gram-negative bacteria and 
magnetosomes, characteristic of a variety of magnetotactic bacteria (Saier and Bogdanov, 
2013). 
Magnetosomes (Figure 1.1) are bacterial organelles that consist of a lipid membrane and a 
crystalline magnetic mineral, which are arranged in a chain within the cytoplasm (Gorby et 
al., 1988). In recent years, these organelles have been extensively studied as they provide 
an excellent model for bacterial compartmentalisation and biomineralisation. 
Furthermore, the magnetic nano-particles and the membranous organelles produced have 
potential use in a variety of biotechnological and medical applications, some of which are 
discussed later (Yan et al., 2012). 
 
 
Figure 1.1. Transmission elecron micrographs of magnetosomes. 
Transmission elecron micrographs of various arrangements of magnetosomes in different 




1.1. Discovery of Magnetotactic Bacteria 
The first observation of magnetotactic bacteria was made by Salvatore Bellini and is 
described in work carried out in 1963, which was distributed in small numbers through a 
variety of Italian universities. While observing drainage water and sediment from a pothole 
using light microscopy methods, Bellini noticed that the majority of microorganisms 
migrated to the same geographical direction. By varying the sample and environmental 
conditions, it was concluded that the organisms migrated towards magnetic north. 
Additional experimentation revealed that the introduction of an artificial magnetic field 
could alter this behaviour and was dependent on the availability of iron. In later work, 
Bellini also discovered that these organisms prefer micro-anaerobic conditions. Due to the 
growing interest in the field, the research carried out was later translated into English 
(Bellini, 2009a; b) thanks to the initiative taken by Richard Frankel (Frankel, 2009). 
As Bellini ?s work was only published recently, the discovery of magnetotactic bacteria is 
usually attributed to Richard Blakemore (Blakemore, 1975). While analysing sediments 
from near Woods Hole, Massachusetts, Blakemore also identified a group of motile 
bacteria that migrated towards magnetic north. This directional movement was not altered 
by the positioning of the microscope or varying environmental conditions, such as the 
direction of light. As with Bellini, Blakemore noticed that the introduction of a magnetic 
field near the sample altered the migration of the cells. Furthermore, using electron 
microscopy and electron excitation analysis, Blakemore was able to show that these cells 
contained electron dense particles, consisting of iron, localised within membranous 
compartments and hypothesised that these crystal-like particles were a permanently 




1.2. Magnetotactic Bacteria 
Magnetotactic bacteria are a group of diverse motile gram-negative bacteria that contain 
magnetosomes and grow in the oxic-anoxic transition zone, anaerobic zone or both in 
diverse aqueous environments (Bazylinski et al., 1995; Simmons et al., 2004; Lefevre and 
Bazylinski, 2013).  
A number of magnetotactic bacteria have been cultured in axenic culture. Most of these 
are from the Magnetospirillum genus and include M. magnetotacticum, the first 
magnetotactic bacteria to be grown in a pure culture (Blakemore et al., 1979; Maratea and 
Blakemore, 1981; Schleifer et al., 1991), M. gryphiswaldense (Schleifer et al., 1991) and M. 
magneticum (Matsanuga et al, 1991). A variety of other magnetotactic bacteria, which to 
date have not been fully characterised, have also been cultured in an axenic culture. These 
organisms include Magnetovibrio blakemorei (Bazylinski et al., 1988; Bazylinski et al., 
2013), marine coccus MC-1 (Meldrum et al., 1993; DeLong et al., 1993), a marine spirillum 
MMS-1 (Meldrum et al., 1993), Desulfovibrio magneticus (Sakaguchi et al, 1993, 2002), 
Candidatus Desulfamplus magnetomortis BW-1 (Lefevre et al., 2011a), Magnetofaba 
australis (Morillo et al., 2014) and a variety of obligately alkaliphilic strains (ML-1, ZZ-1 and 
AV-1) (Lefevre et al., 2011b).  
A number of magnetotactic bacteria have also been characterised without obtaining an 
axenic culture. These include a variety of multi-cellular prokaryotic organisms (Rodgers et 
al., 1990; Keim et al., 2004; Abreu et al., 2006; 2007), incredibly large bacteria (up to 10 µm 
in length and up to 2 µm in diameter) (Jogler et al., 2010) and thermophilic bacteria (Lefevre 
et al., 2010). 
Complete genome sequencing has been performed on some of these organisms including 
M. magneticum AMB-1 (Matsunaga et al., 2005), D. magneticus RS-1 (Nakazawa et al., 
2009), marine coccus MC-1 (Schubbe et al., 2009), M. gryphiswaldense (Wang et al., 2014) 





One of the defining features of magnetotactic bacteria is the presence of magnetosomes, 
intracellular membranous organelles, which contain magnetic iron crystals within their 
lumen (Gorby et al., 1988). The term magnetosome was used due to the magnetic 
properties of the organelles (Balkwill et al., 1980). These membranous organelles are 
further organised by alignment on actin-like filaments (Komeili et al., 2006) via an 
anchoring protein (Scheffel et al., 2006).  
The magnetosome membrane has been extensively studied in the Magnetospirillum 
species and has been observed using regular electron microscopy methods (Gorby et al., 
1988; Komeili et al., 2004) and, more recently, re-constructed using cryo-electron 
tomography methods (Figure 1.2) (Komeili et al., 2006; Scheffel et al., 2006). Due to the 
magnetic crystal present in these compartments, the magnetosome membranes can be 
easily isolated from other bacterial membranous content by density ultracentrifugation 
and magnetic separation (Grunberg et al., 2001; 2004), which allows the analysis of the 
biochemical composition of this membrane. The lipid composition of the magnetosome 
membrane resembles that of the cytoplasmic membrane, although the relative amounts 
of these lipids differ with specific enrichement of C16:1 and C18:1 unsaturated fatty acids 
(Gorby et al., 1988; Grunberg et al., 2004; Tanaka et al., 2006). The membrane-protein 
composition is however very specific for the magnetosome (Grunberg et al., 2001; Tanaka 
et al., 2006). Indeed, the identification of the proteins localised to the magnetosome 
membranes helped inform the identification of the operons involved in organelle 





Figure 1.2. Three-dimensional reconstruction of M. magneticum. 
Three-dimensional reconstruction of wild-type M. magneticum cell (Komeili et al., 2006). 
Magnetosomes are shown in yellow and actin-like filaments are shown in green. 
 
Depending on the organism producing these organelles, the ferromagnetic crystal housed 
within magnetosomes can be either magnetite (Fe3O4) or iron sulphide greigite (Fe3S4) 
(Bazylinski et al., 1993). The size of the crystal is usually between 30 and 120 nm (Schuler, 
2008), although much larger 250 nm crystals have been previously isolated (Lins et al., 
2006). Such crystals show single-domain permanent magnetism both when composed out 
of magnetite (Butler and Banerjee, 1975) or greigite (Diaz-Ricci and Kirschvink, 1992). At 
ambient temperatures smaller crystals would not be permanently magnetic, while larger 
crystals would have multiple magnetic domains with opposing magnetic orientations, 
reducing the total magnetism of the crystal (Schuler, 2008). This suggests the cells 
producing the organelles have evolved methods to control the size of the crystals within 
the narrow optimum range. Variation in the crystal morphology found within 
magnetosomes is also observed between different strains (Figure 1.1). Most of these 
morphologies are different to those obtained by chemical synthesis, suggesting a 
controlled mechanism for crystal growth within the organelles (Schuler, 2008).  
1.4. Genes Involved in the Formation of the Organelle 
The majority of genes involved in magnetosome formation were identified using reverse 
genetics. The initial experiment carried out identified the mam22 gene (equivalent to 
mamA in M. gryphiswaldense) in M. magneticum, and showed that the gene product is 
involved in the formation of the organelle (Okuda et al., 1996). Similar studies have been 
carried out in M. gryphiswaldense resulted in the identification of 22 further genes involved 
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in the process of magnetosome formation (Grunberg et al., 2001; 2004). These genes were 
ƐŚŽǁŶ ƚŽ ůŽĐĂůŝƐĞ ƚŽ Ă ŐĞŶŽŵŝĐ ĐůƵƐƚĞƌ ƌĞĨĞƌƌĞĚ ƚŽ ĂƐ ƚŚĞ  ‘ŵĂŐŶĞƚŽƐŽŵĞ ŝƐůĂŶĚ ?  ?D/ )
(Schubbe et al., 2003; Ullrich et al., 2005), as it shares features common to other genomic 
ĨƌĂŐŵĞŶƚƐĚĞƐĐƌŝďĞĚĂƐ ‘ƉĂƚŚŽŐĞŶŝĐŝƚǇ ?Žƌ ‘ĞŶǀŝƌŽŶŵĞŶƚĂů ?ŝƐůĂŶĚƐ ?Žďrindt et al., 2004). 
Such islands are known to be transferred between organisms via horizontal gene transfer. 
Similar genomic islands were also found in M. magneticum (Fukuda et al., 2006) and, to a 
lesser degree of conservation, in other magnetotactic organisms (Jogler and Schuler, 2009). 
The MAI in M. gryphiswaldense is 130 kb (Figure 1.3) and has been subject to extensive 
genetic studies. One of the first of these studies involved the characterisation of a non-
magnetic mutant strain, which had lost a 40 kb fragment from the MAI (Ullrich and Schuler, 
2010). This fragment included three operons: mamGFDC, mms6 and mamAB, which 
contained multiple genes identified by the reverse genetics approach. A previous study had 
shown that the mamGFDC operon was not necessary for magnetosome formation, but 
played a role in the size control of the magnetic crystal (Scheffel et al., 2008). A study 
carried out in a related organism, M. magneticum, showed similar mineralisation defects 
when parts of mamGFDC and mms6 operons were deleted (Lohbe et al., 2011). 
Furthermore, the research demonstrated that the deletion of the mamAB operon resulted 
in cells with no magnetosomes. Analysis of single deletions from the operon was also 
carried out, identifying four genes crucial for magnetosome membrane formation (mamI, 
mamL, mamQ and mamB) and four genes crucial for biomineralisation (mamE, mamM, 
mamN and mamO). Similar studies have also been carried out in M. gryphiswaldense 
(Lohbe et al., 2011; 2014). In one of these studies, another operon from the MAI, mamXY, 
was also shown to be involved, but was not essential in the formation of the organelle. 
More recently, it has been shown that the recombinant expression of these operons 
(mamGFDC, mms6, mamAB and mamYX) in Rhodospirillum rubrum yields the functional 
production of magnetosomes (Kolinko et al., 2014) and the overproduction of these 
operons in M. gryphiswaldense leads to a greatly increased number of the organelles within 






Figure 1.3. The magnetosome island. 
The four operons depicted have been shown to be involved in magnetosome generation. 
 
 
1.5. Mechanism of Magnetosome Formation 
The magnetosome formation mechanism still remains unclear, although it has been well 
established that the proteins involved differ from those involved in eukaryotic organelle 
formation. There is good evidence to suggest a step-wise mechanism (Figure 1.4) (Murat 
et al., 2010a; Lohbe et al., 2011). These steps include membrane vesicle formation, crystal 




Figure 1.4. A schematic representation of magnetosome formation. 
In red  ? initiatory protein; green  ? membrane restructuring proteins;  blue  ? nucleation protein; 





1.5.1. Vesicle Formation 
Vesicle formation can further be broken down into three steps: membrane budding, vesicle 
formation and vesicle maturation. Recently, it has been shown that in M. gryphiswaldense 
only one protein, MamB, is necessary for magnetosome membrane formation (Raschdorf 
et al., 2016). In a closely related organism, M. magneticum, it was shown that the deletion 
of one of four genes, including mamB (also mamI, mamL and mamQ), completely abolished 
magnetosome membrane formation (Murat et al., 2010a). Interestingly, the deletion of 
mamI in M. gryphiswaldense, had little effect on magnetosome membrane formation, 
while the deletion of mamL or mamQ showed a decrease in organelle size, but did not 
completely abolish it (Raschdorf et al., 2016). Significantly, the same study showed that co-
expression of mamB, mamQ, mamL and mamM is not sufficient to form membranous 
vesicles. From these experiments it is clear that MamB plays a key role in membrane 
budding, but there are other factors involved, which may have homologous functions, 
therefore the deletion of one of these does not necessarily result in a null phenotype. 
Proteins involved in vesicle formation have been defined further, as recombinant 
expression of mamLQBIEMO has been shown to restore magnetosome membrane 
formation, but not mineralisation, in a M. gryphiswaldense strain lacking the mamAB 
operon (Raschdorf et al., 2016). It is worth noting that the expression of mamLQRBM did 
not rescue this phenotype and further constructs, containing different genes, were not 
examined. Recently, it has been shown that upon crystal nucleation the magnetosome 
membrane undergoes a further increase in size, which can be described as vesicle 
maturation (Cornejo et al., 2016). The precise mechanism of this process and the proteins 
involved have still to be identified. Furthermore, all of these experiments were carried out 
in a strain that had functional mamGFDC, mms6 and mamXY operons, so therefore their 
contribution to the process can not be omitted. One such example of a possible 
contributors is MamY, produced from the mamXY ŽƉĞƌŽŶ ?ȴmamY strains produce larger 
magnetosome vesicles and the protein has been shown to induce liposome tubulation in 
vitro (Tanaka et al., 2010). 
1.5.2. Crystal Nucleation 
Crystal nucleation is the moment when the soluble iron becomes an insoluble mineral. 
From knock-out studies in M. magneticum, at least 4 proteins are likely to be involved in 
iron nucleation (MamE, MamM, MamN and MamO) (Murat et al., 2010a), while in M. 
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gryphiswaldense it has been shown that MamE, MamM, MamO, MamB, MamQ and 
possibly MamL are essential for membrane formation and nucleation to take place (Lohbe 
et al., 2014). As the majority of these are involved in the formation of the magnetosome 
membrane (see above), iron nucleation may be dependent on MamE, MamM and MamO, 
which are conserved between the two Magnetospirillum species.  
MamE is a multi-domain protein, containing a protease domain, three magnetochrome 
domains and two structural PDZ domains, which are found in signalling proteins. 
Magnetochrome domains are cytochrome c domains with a unique arrangement, which is 
only found in magnetotactic bacteria (Siponen et al., 2012). The protein has been suggested 
to be involved in protein localisation to the organelle (Murat et al., 2010a). Interestingly, 
cells producing mutated variants of MamE, without a functional protease domain or the 
magnetochrome domains, are still able to mediate crystal nucleation, but the crystals 
observed do not exceed 20 nm (Quinlan et al., 2011). This suggests that the protease 
activity and the haem-binding motifs are necessary for crystal growth, but are not involved 
in nucleation. 
MamM and MamB belong to the cation diffusion facilitator (CDF) family. The members of 
this family are involved in metal ion homeostasis and generally transport divalent transition 
metal cations, including Fe2+ (Paulsen and Saier, 1997). Both of these proteins are 
conserved in various magnetotactic bacteria and are predicted to have multiple roles, 
including crystal nucleation (Uebe et al., 2011). MamM has been shown to be necessary for 
biomineralisation and various mutations in the predicted active site of the transporter 
protein can limit this process. It also stabilises MamB, a protein involved in protein 
targeting to the organelle and iron import. Significantly, any attempted mutation in MamB 
abolished magnetosome formation completely. This further highlights the importance of 
this protein as a protein involved in all stages of organelle formation (Uebe et al., 2011). 
MamO has been recently shown to have a degenerative protease domain and to promote 
magnetosome formation by two non-catalytic activities (Hershey et al., 2016). The first 
activity is the activation of MamE protease, which is not involved in crystal nucleation 
(discussed previously). The second activity involves transition metal binding, although this 
was only shown with Ni2+ due to technical limitations. The active site of the protein is large 
enough to easily accommodate Fe2+, which is the suggested substrate. M. magneticum 
cells, producing MamO with a mutation in the metal binding site, shows no crystal 
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nucleation. This suggests that the metal binding site is necessary for crystal nucleation to 
take place. 
Overall, it is clear that at least four proteins are involved in the nucleation step: MamE and 
MamB, playing a role in protein targeting, MamM, stabilising MamB, and MamO, via its 
metal-binding activity. The metal transport activities of MamB and MamM may also be 
involved, but have not been shown to be necessary for crystal nucleation and possibly only 
influence crystal growth. 
1.5.3. Organelle Alignment 
Magnetosome alignment is, arguably, the best understood stage of the organelle 
formation. This is due to relatively few proteins involved as miss-alignment of the 
organelles, to daƚĞ ?ŚĂƐŽŶůǇďĞĞŶŽďƐĞƌǀĞĚ ŝŶ ƚǁŽŵƵƚĂŶƚƐƚƌĂŝŶƐ PȴmamK ĂŶĚȴmamJ 
(Komeili et al., 2006; Scheffel et al., 2006). MamK, a homolog of the bacterial actin-like 
protein MreB, forms filamentous structures in vivo (Figure 1.2), which bind magnetosomes 
via an acidic protein, MamJ, thereby aligning the organelles throughout the cell. 
Furthermore, MamJ has an additional regulatory effect on MamK (Draper et al., 2011). The 
exact molecular mechanisms behind the interaction of MamJ with the organelle or MamK 
are still unclear. 
1.5.4. Crystal Maturation 
Crystal maturation, which includes crystal growth, is a complex biochemical process and 
involves the largest proportion of the magnetosome proteins. A knockout of almost any 
gene from the four operons, suggested to be involved in magnetosome formation, has an 
effect on this process (Scheffel et al., 2008; Murat et al., 2010a; 2012; Lohbe et al., 2011; 
2014). 
One of these operons, mms6, contains five genes, of which four have been shown to be 
produced during magnetosome synthesis (Grunberg et al., 2001; 2004). Two of these, 
mms6 and mmsF, seem to promote crystal growth, while the other two, mg4070 and 
mg4071, seem to inhibit it (Lohbe et al., 2016). Mms6 is the best studied protein from the 
operon and is suggested to function by displaying a charged surface for specific iron binding 
(Staniland and Rawlings, 2016). This protein has been used for controlled chemical 
synthesis of magnetite, allowing the production cubo-octahedral magnetite crystals with a 
narrow size distribution (Amemiya, 2007). MmsF, a protein with a predicted homologous 
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function in vivo, has been shown to form nanostructures termed proteinosomes and can 
also be used to improve the chemical synthesis of magnetite particles (Rawlings et al., 
2014). Interestingly, a M. magneticum mutant, lacking mms6 and mamGFDC operons, has 
ĂƐŝŵŝůĂƌŵŝŶĞƌĂůŝƐĂƚŝŽŶĚĞĨĞĐƚǁŚĞŶĐŽŵƉĂƌĞĚƚŽĂȴmmsF strain (Murat et al., 2012a). 
Both of these phenotypes can be rescued, partially for the double operon mutant and fully 
for the single mutant, by recombinant expression of mmsF. 
Deletion of the whole mamGFDC operon does not result in a non-magnetic phenotype, 
which is striking as combined the proteins expressed from the operon have been shown to 
make up around 35% of the whole magnetosome proteome (Grunberg et al., 2004; Scheffel 
et al., 2008). The observed phenotype is a decrease in size (about 25%) and number of 
crystals produced. This phenotype could be recovered partially by recombinantly 
expressing any single gene from the operon and further by expressing two genes (Scheffel 
et al., 2008). Practically full recovery could be observed when any three of the genes in any 
combination or the full operon was expressed recombinantly, suggesting interchangeable 
functionality. One of the proteins in the operon, MamF, has high similarity to MmsF (62.6% 
amino acid identity and 88.8% similarity in M. gryphiswaldense) and is also able to form 
proteainosome structures but do not improve chemical magnetite synthesis (Rawlings et 
al ? ?  ? ? ? ? ) ? /ŶƚĞƌĞƐƚŝŶŐůǇ ? ĞǀĞŶ ǁŝƚŚ ƐƵĐŚ ŚŝŐŚ ƐŝŵŝůĂƌŝƚǇ ? ŝƚ ĚŽĞƐ ŶŽƚ ƌĞƐĐƵĞ ƚŚĞ ȴmmsF 
phenotype in M. magneticum (Murat et al., 2012a). 
Multiple genes from the mamAB operon have been shown to be necessary for crystal 
maturation in M. magneticum and M. gryphiswaldense (Murat et al., 2010a; Lohbe et al., 
2014). Slight differences are observed between the proteins involved in the different 
strains and, due to the relevance to this work, the discussion will be focused on the M. 
gryphiswaldense model organism. The proteins from the mamAB operon, suggested to be 
involved only in the maturation process of the organelle, are MamH, MamI, MamN, MamP, 
MamR, MamS and MamT (Raschdorf et al., 2013; Lohbe et al., 2014). 
MamH is a member of the major facilitator superfamily (MFS). This family of proteins are 
known to transport small solutes in response to chemiosmotic ion gradients (Pao et al., 
1998). Deletion of mamH results in a decrease of magnetite particle number and size 
(Raschdorf et al., 2013). Although the function of any closely-related proteins to MamH is 
not known, there are examples of MFS members transporting chelated iron, which is the 
predicted function for MamH to date (Lesuisse et al., 1998; Chatfield et al., 2012). 
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In contrast to M. magneticum, where MamI plays a crucial role in magnetosome membrane 
generation (Murat et al., 2010a), it has been shown that in M. gryphiswaldense this protein 
only plays a role in magnetosome maturation (Lohbe et al.,  ? ? ? ? ) ?ȴmamI cells were found 
to produce smaller (around 40% the size of the wild-type) electron-dense particles with 
highly irregular elongated morphologies and at a reduced frequency. Furthermore, the cells 
producing these particles showed no magnetic response and no magnetite was present in 
these cells, suggesting that MamI plays a crucial role in the generation of the magnetic 
mineral. 
MamN has been suggested to function as an ATP-driven proton pump, regulating the pH 
within the organelle (Schuler, 2008). A knockout strain of mamN produces fewer (about a 
third) and smaller (around half the size of the wild-type) magnetite particles, which results 
in a reduced magnetic response (Lohbe et al., 2014). As precipitation of magnetite 
produces a large amount of protons, leading to a change of pH in the organelle, their export 
may play an important, but not essential, role in the synthesis of the particles as the 
maintanence of the periplasmic pH is part of general cellular metabolism. 
MamP is one of the magnetochrome proteins involved in magnetosome synthesis and the 
only one to have its structure solved (Siponen et al., 2013). The reduced state of the protein 
is able to oxidise Fe2+ to magnetite in vitro ?ȴmamP M. gryphiswaldense cells still produce 
magnetite crystals and retain a magnetic response (Lohbe et al., 2014). These crystals are 
larger, but are often flanked by smaller, poorly crystalline electron dense particles. 
MamR is a protein of unknown function, with a helix-turn-helix DNA binding motif. Strains, 
with the genetic knockout of the corresponding gene, have a very similar magnetic 
response when compared to the wild-type cells (Lohbe et al., 2014). The resulting 
phenotype is a small, compared to other gene knockouts, (about 20%) reduction in the 
average magnetosome size and impairment of the chain assembly in some, but not all, of 
the cells observed by electron microscopy. 
Deletion of mamS results in a reduction of magnetosome particle size, but the magnetic 
response or the frequency at which these particles are produced, is not impaired (Lohbe et 
al., 2014). MamS contains no known putative domains and has no known significant 
homology to any protein outside of magnetotactic bacteria. It has amino acid sequence 
similarities with the magnetosome proteins MamE and MamX, but has no magnetochrome 
domains, a characteristic shared by both of these proteins. 
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As with the deletion of mamS, a ȴmamT strain results in an effect on the morphology of 
the magnetite crystal produced, but not the frequency of the crystals or the magnetic 
response (Lohbe et al., 2014). Some of the crystals were similar to wild-type size and 
ĨŽƌŵĞĚ “ƉƐĞƵĚŽĐŚĂŝŶƐ ? ?ďƵƚĂůĂƌŐĞƌƉƌŽƉŽƌƚŝŽŶǁĞƌĞŵƵĐŚƐŵĂůůĞƌ ?ďƌŝŶŐŝŶŐƚŚĞĂverage 
size down to about 80% of the wild-type. MamT is one of four magnetochrome proteins 
suggested to play a role in magnetosome generation and is thought to play a similar role to 
MamP in redox balance of Fe2+ and Fe3+, which is key for magnetite synthesis (Siponen et 
al., 2012). 
Some of the proteins produced from the mamAB operon, involved in the earlier stages of 
magnetosome synthesis, are likely to be involved in magnetosome maturation. A good 
example of this is MamE. As discussed previously, a mutation in the putative protease 
domain or the magnetochrome motifs of MamE does not impair crystal nucleation, but 
stops crystal growth at around 20 nm (Quinlan et al., 2011). This suggests a requirement of 
a proteolytic activation for some of the maturation factors and a contribution of the MamE 
magnetochrome domains to crystal growth. Contributions made by other proteins involved 
in previous stages are difficult to study as genetic knockouts of these impair the organelle 
formation at earlier stages. 
The final operon involved in magnetosome maturation is the mamXY operon which 
encodes four proteins. The deletion of the whole operon results in a decrease in the cellular 
magnetic response and a decrease in average magnetosome size (to about 50% of the wild-
type) (Lohbe et al., 2011). Furthermore, electron microscopy analysis revealed a variation 
between the magnetosomes observed with some lacking any electron dense particles. 
Single deletion strains for all four proteins have been generated in the Magnetospirillum 
ƐƉĞĐŝĞƐ ? DĂŵy ĐŽŶƚĂŝŶƐ ƚǁŽ W ĚŽŵĂŝŶƐ ĂŶĚ ƚǁŽ ŵĂŐŶĞƚŽĐŚƌŽŵĞ ĚŽŵĂŝŶƐ ? ȴmamX 
strains, or strains producing MamX without functional magnetochrome domains, produce 
small, irregularly shaped particles together with wild-type like particles (Raschdorf et al., 
2013; Yang et al., 2013). These cells show a slight reduction in the magnetic response. 
Deletion of a non-related gene from the operon, mamZ, shows a similar phenotype. MamZ 
has two domains: a MFS domain, which is similar to that of MamH, and a ferric reductase 
domain (Raschdorf et al., 2013). Interestingly, a double deletion of mamZ and mamH shows 
an additive effect on biomineralisation, suggesting an overlapping role for the two proteins. 
A further protein from the operon suggested to be involved in the process is FtsZ-like. It is 
a truncated version of a tubulin-like protein, FtsZ, a protein which forms a cytokinetic ring 
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structure, an essential component of the cell division apparatus (Bramhill and Thompson, 
1994). Deletion of ftsZ-like leads to production of smaller, irregular magnetic particles with 
poor alignment (Ding et al, 2010). Magnetospirillum species produce a full length FtsZ, 
which most likely plays a role in cell division. Comparison of this full length FtsZ and the 
FtsZ-like protein has been previously carried out, showing that the two proteins behave in 
a very similar manner and possibly interact (Muller et al., 2014).  These findings show that 
FtsZ-like is involved in magnetosome formation, but it is unclear if it acts as a scaffolding 
protein or facilitates the correct division of the organelles during cell division. There is no 
evidence that the last protein from the operon, MamY, is involved in crystal maturation 
and is suggested to be involved in vesicle formation, as discussed previously. 
Overall, crystal maturation is the most complex step of magnetosome synthesis, with 
proteins from all four operons, linked to magnetite synthesis, involved. There is also 
evidence that proteins involved in cellular metabolism play an important role. One example 
of this is the Cbb3 terminal oxidase complex. When the corresponding operon is deleted, 
M. gryphiswaldense cells not only have a reduction in growth, but also produce much 
smaller, poorly crystalline magnetosomes (Li et al., 2014). 
1.5.5. Other Factors Involved in Magnetosome Biogenesis 
There are two other proteins, produced from the mamAB operon, MamA and MamU, 
which do not seem to be directly involved in any of the stages of magnetosome synthesis. 
Deletion of mamA has a similar phenotype both in M. magneticum and M. gryphiswaldense 
(Komeili et al., 2004; Lohbe et al., 2014). The observed phenotype is a reduction in the 
number of magnetosomes, but not in the size or the overall magnetic response of the cells. 
MamA has been shown to form homo-oligomers, which could be disrupted by a mutation 
in its putative tetratricopeptide (TPR) repeat motif (Zeytuni et al., 2011). This motif is 
known to mediate protein-protein interactions for protein complexes (Zeytuni and 
Zarivach, 2012). It has been suggested that MamA oligomers localise to the outer-surface 
of magnetosomes, contributing to the stabilization of the organelle (Komeili et al., 2004; 
Yamamoto et al., 2010). MamU is the final protein produced in the mamAB operon. 
Interestingly, mamU knockout strains of both M. magneticum and M. gryphiswaldense 
show no observable phenotype for magnetosome formation (Komeili et al., 2004; Lohbe et 
al., 2014). This suggests that the protein is either not involved in magnetosome synthesis 
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at all or is only necessary under certain growth conditions, which have not been tested 
during the knockout experiments. 
1.6. Magnetosome Production 
Production of magnetite particles by cultivating magnetotactic bacteria is still problematic, 
but large-scale production of magnetosomes using a chemostat culture has been 
demonstrated (Liu et al., 2010). One of the challenges is the slow growth of these organisms 
therefore ways of improving magnetosome productivity have been investigated. The most 
successful of these is the introduction of multiple copies of one or all of the four operons 
involved in magnetosome generation in M. gryphiswaldense genome (Lohbe et al., 2016). 
The study demonstrates that the specific duplication of the mms6 operon results in a size 
increase of the magnetite crystals (~35%), while the duplication of all the operons thought 
to be involved in magnetosome synthesis (mamGFDC, mamAB, mms6 and mamXY) results 
in a 2.2-fold increase of the amount of the crystals produced. A different approach is to 
produce magnetosomes in a more readily cultivable organism. This has been achieved in 
Rhodospirillum rubrum by genetic integration of the four genetic operons from M. 
gryphiswaldense mentioned above (Kolinko et al., 2014). Interestingly, E. coli cells were 
used for conjugative transfer of the operons into R. rubrum, but no discussion is given of 
the effect the genetic information had on the donor cells, suggesting that the presence of 
wild-type magnetosome operons in E. coli does not result in magnetetosome generation. 
1.7. Applications of Magnetosomes 
Due to a number of desirable physical properties, such as ferrimagnetism, narrow size 
distribution, nanoscale size and intramembranous environment, magnetic particles 
produced by magnetotactic bacteria have been investigated for various applications (Yan 
et al., 2012). The first known example of this is the immobilization of glucose oxidase and 
uricase on magnetosome membranes, which resulted in an increased activity for both of 
the enzymes (Matsunaga and Kamiya, 1987). Magnetite particles, produced by 
magnetotactic bacteria, have been used for a variety of applications (Alphandery, 2014). 
Some examples of these include novel methods for detection of mRNAs (Sode et al., 1993), 
single nucleotide polymorphisms (Ota et al., 2003; Tanaka et al., 2003) and biomolecules 
(Amemiya et al., 2005), DNA extraction (Yoza et al., 2003) and an efficient way of gene 
vaccine (Tang et al., 2007) or drug delivery (Sun et al., 2008). Furthermore, proteins, 
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involved in the synthesis of magnetosomes, have been used to improve the chemical 
synthesis of magnetic particles (Staniland and Rawlings, 2016). 
1.8. Aims of the Project 
Escherichia coli is one of the most widely used microorganisms for a variety of 
biotechnological applications (Blount, 2015). Recent work has shown that this host can be 
used for the production of recombinant proteinaceous organelles, the bacterial 
microcompartments (Parsons et al., 2010). These compartments can then be engineered 
to produce other chemicals, such as ethanol (Lawrence et al., 2014). The ability to produce 
recombinant membranous organelles in E. coli could have a number of biotechnological 
applications especially for recombinant membrane protein production, pathway 
engineering or as vesicles for specialised vaccine production. Complete recombinant 
magnetosomes in E. coli would also represent a major advance for enhanced nano-
magnetic bead production and could help facilitate an easier study of the organelle 
formation. Furthermore, an improved understanding of the biomineralisation process 
would have applications in bioremediation, especially for the recovery of precious metals 
or metals from metal-contaminated sites. The overall aim of the project was therefore to 
investigate if the genes involved in magnetosome synthesis could be cloned into E. coli and 
to determine what phenotype this would produce within the host. Within this broad aim, 
specific objectives include the characterisation of the proteins involved in the generation 
of the membranous invagination and biomineralisation. The ambitious nature of the aim 
coupled with the large number of genes involved (30 in total) with the process means that 
this is a technically challenging synthetic biology project involving a broad range of 











5-Bromo-4-chloro-3-indolyl phosphate/Nitro blue  Sigma-Aldrich 
Acetic acid  Fischer Scientific 
Agar (bacteriological) Oxoid 
Agar LV resin Agar Scientific 
Agarose Alpha Laboratories 
Ampicillin Sodium Salt Melford 
B-WZ ? Thermo Fisher Scientific 
Biotin Sigma-Aldrich 
Bromophenol Blue Sigma-Aldrich 
CaCl2 x 2 H2O Sigma-Aldrich 
Cacodylate  Sigma-Aldrich 
Chelating Sepharose Fast Flow  GE Healthcare 
Chloramphenicol Sigma-Aldrich 
Coomassie brilliant blue Sigma-Aldrich 
CoSO4 x 7 H2O Sigma-Aldrich 
CuSO4 x 5 H2O BDH Laboratory Supplies 
D-Ca-pantothenate  Sigma-Aldrich 
Dithionite  Sigma-Aldrich 
Ethanol Fischer Scientific 
Ethidium Bromide Fischer Scientific 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich 
FeCl3 x 6 H2O Sigma-Aldrich 
FeSO4 x 7 H2O  Sigma-Aldrich 
Folic acid Sigma-Aldrich 
Glycerol Fisher Scientific 
Glycine Sigma-Aldrich 
H3BO3 Sigma-Aldrich 
HCl Fisher Scientific 
Imidazole Sigma-Aldrich 
/ƐŽƉƌŽƉǇůɴ-D-1-thiogalactopyranoside Melford 






L(+)-Tartaric acid Sigma-Aldrich 
Lead citrate  Agar Scientific 
Lipoic acid  Sigma-Aldrich 
Methanol Fisher Scientific 
MgSO4 x 7 H2O Sigma-Aldrich 
MnSO4 x H2O Sigma-Aldrich 
Na2HPO4 Sigma-Aldrich 
Na2MoO4 x 2 H2O Sigma-Aldrich 
Na2SeO3 x 5 H2O Sigma-Aldrich 
Na-acetate Sigma-Aldrich 
NaCl Fisher Scientific 
NaNO3 Sigma-Aldrich 
NaOH Sigma-Aldrich 
NiCl2 x 6 H2O Sigma-Aldrich 
Nicotinic acid  Sigma-Aldrich 
NiSO4 Sigma-Aldrich 
Nitrilotriacetic acid Sigma-Aldrich 
p-Aminobenzoic acid  Sigma-Aldrich 
Pyridoxine-HCl  Sigma-Aldrich 
Quinic acid Sigma-Aldrich 
Resazurin Sigma-Aldrich 
Riboflavin  Sigma-Aldrich 
Skimmed milk powder Oxoid 
Sodium dodecyl sulfate Fisher Scientific 
Succinic acid Sigma-Aldrich 
TAE Fisher Scientific 
Thiamine-HCl x 2 H2O  Sigma-Aldrich 
Trichloroacetic acid Sigma-Aldrich 
Tris Fisher Scientific 
Tryptone Fisher Scientific 
Uranyl acetate Agar Scientific 
Vitamin B12  Sigma-Aldrich 
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Yeast Extract Fisher Scientific 
ZnSO4 x 7 H2O Sigma-Aldrich 
 
2.2. Media and Solutions 
2.2.1. Sterilisation 
2.2.1.1. Autoclaving 
Sterilisation for 15 min at 121 °C and 15 psi pressure. 
2.2.1.2. Filter Sterilisation 
Sterilisation achieved by filtration through a 0.2 ʅŵĨŝůƚĞƌŶĞǆƚƚŽĂƵŶƐĞŶburner. 





Ampicillin (Sodium Salt) 100 mg/ml 0.1 mg/ml 1:1 EtOH:ddH2O 
Chloramphenicol 34 mg/ml 0.034 mg/ml EtOH 
Kanamycin 50 mg/ml 0.05 mg/ml ddH2O 
 
Ampicillin and kanamycin were sterilised by filter sterilisation. 
2.2.3. Growth Media 
2.2.3.1. Lysogeny Broth (LB) 
Chemical Concentration in dH2O 
NaCl 5 g/l 
Yeast Extract 5 g/l 
Tryptone 10 g/l 
 
Sterilised by autoclaving. 
2.2.3.2. LB - Agar 
LB media with 15 g/l agar (bacteriological) added prior to sterilisation. 
Sterilised by autoclaving. 
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2.2.3.3. Magnetospirillum Media 
Ingredient Concentration in dH2O 
Vitamin solution 10 ml/l  
Trace elements 5 ml/l 
Fe(III) quinate solution 2 ml/l 
Resazurin 0.50 mg/l 
KH2PO4 0.68 g/l 
NaNO3 0.12 g/l  
L(+)-Tartaric acid 0.37 g/l  
Succinic acid 0.37 g/l  
Na-acetate 0.05 g/l  
 
Ingredients were dissolved in the order provided and the pH was adjusted to 6.75 with 
NaOH. 
For anaerobic conditions, the media was dispensed in anoxic vials (up to 2/3 of the volume), 
sealed with rubber closures and N2 gas was bubbled via a needle for 5min. 
Sterilised by autoclaving. 
Filter sterilised Na-thioglycolate was added prior to inoculation to a final concentration of 
0.05 g/l.  





2.2.3.3.1. Trace Element Solution 
Chemical Concentration in dH2O 
Nitrilotriacetic acid 1.5 g/l 
MgSO4 x 7 H2O 3 g/l 
MnSO4 x H2O 0.5 g/l  
NaCl 1 g/l  
FeSO4 x 7 H2O  0.1 g/l 
CoSO4 x 7 H2O 0.18 g/l 
CaCl2 x 2 H2O 0.1 g/l 
ZnSO4 x 7 H2O 0.18 g/l 
CuSO4 x 5 H2O 0.01 g/l 
KAl(SO4)2 x 12 H2O 0.02 g/l 
H3BO3 0.01 g/l 
Na2MoO4 x 2 H2O 0.01 g/l 
NiCl2 x 6 H2O 0.03 g/l 
Na2SeO3 x 5 H2O 0.3 mg/l 
 
Sterilised by autoclaving. 
2.2.3.3.2. Vitamin Solution 
Chemical Concentration in dH2O 
Biotin 2 mg/l 
Folic acid 2 mg/l 
Pyridoxine-HCl  10 mg/l 
Thiamine-HCl x 2 H2O  5 mg/l 
Riboflavin  5 mg/l 
Nicotinic acid  5 mg/l 
D-Ca-pantothenate  5 mg/l 
Vitamin B12  0.1 mg/l 
p-Aminobenzoic acid  5 mg/l 
Lipoic acid  5 mg/l 
 




2.2.3.3.3. Fe(III) Quinate Solution 
Chemical Concentration in dH2O 
FeCl3 x 6 H2O 0.45 g/l 
Quinic acid 0.19 g/l 
 
Sterilised by autoclaving. 
2.2.4. Media for Protein Work 
2.2.4.1. Protein Purification Solutions 
Buffer 
Concentration of chemicals in dH2O 
NiSO4 Tris-HCl (pH 8.0) NaCl Imidazole EDTA 
Charge 0.1% w/v - - - - 
Binding - 20 mM 100 mM 5 mM - 
Wash I - 20 mM 100 mM 50 mM - 
Wash II - 20 mM 100 mM 100 mM - 
Elution - 20 mM 100 mM 400 mM - 
PD10 - 20 mM 100 mM - - 
Strip - 20 mM 100 mM - 100 mM 
 
2.2.4.2. 2x Laemmli Buffer 
Chemical Concentration in dH2O 
Tris-HCl (pH 6.8) 125 mM 
Glycerol 0.2 ml/ml 
Sodium dodecyl sulfate 0.04 g/l 
2-Mercaptoethanol 0.1 ml/ml 





2.2.4.3. Coomassie Blue Stain 
Chemical Concentration in dH2O 
Trichloroacetic acid 250 ml/l 
Coomassie brilliant blue 0.6 g/l 
Sodium dodecyl sulfate 0.1 g/l 
Tris 0.25 g/l 
Glycine 0.15 g/l 
 
2.2.4.4. Western Blotting solutions 
2.2.4.4.1. Transfer Buffer 
Chemical Concentration in dH2O 
Tris 3.03 g/l 
Glycine 14.41 g/l 
Methanol 200 ml/l 
 
2.2.4.4.2. Phosphate Buffered Saline 
Chemical Concentration in dH2O 
NaCl 8.18 g/l 
KCl 0.22 g/l 
Na2HPO4 1.42 g/l 
KH2PO4 0.27 g/l 
 
2.2.4.4.3. Phosphate-free Solution 
Chemical Concentration in dH2O 
NaCl 8.18 g/l 
Tris 6.06 g/l 
 





2.3.1. Bacterial Strains 
Strain  Description  Function 
E. coli BL21 
(DE3) Star 
F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) Protein 
production 
E. coli JM109  endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ ȴ ?ůĂĐ-
proAB) e14- [F' traD36 proAB+ lacIq ůĂĐȴD ? ? ?
hsdR17(rK0-mK+) 
Cloning 
E. coli , ?ɲ F ? endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR 
ŶƵƉ'ƉƵƌ ? ?ʔ ? ?ĚůĂĐȴD ? ?ȴ ?ůĂĐz-argF)U169 
hsdR17(rK ?mK+ ) ?ʄ ? 
Cloning 
E. coli , ? ?ɴ F ? endA1 deoR+ recA1 galE15 galK16 nupG rpsL 
ȴ ?ůĂĐ )y ? ?ʔ ? ?ůĂĐȴD ? ?ĂƌĂ ? ? ?ȴ ?ĂƌĂ ?ůĞƵ ) ? ? ? ?
ŵĐƌȴ ?ŵƌƌ-hsdRMS-ŵĐƌ )^ƚƌZʄ ? 
Cloning 
 
2.3.2. Bacterial Growth 
2.3.2.1. LB Liquid Media 
Liquid cultures with appropriate antibiotics were inoculated to a starting OD of 0.01 from 
overnight starter cultures and grown at 37 °C with shaking (160 rpm). 
2.3.2.2. LB Agar Plates 
Bacteria were spread out on LB-agar plates with appropriate antibiotics and incubated 
overnight at 37 °C.  
2.3.2.3. Overproduction of Individual Proteins for SDS-PAGE 
E. coli BL21 (DE3) Star competent cells were transformed with a plasmid containing the 
gene of interest. 50 ml of LB with appropriate antibiotics was inoculated with 3 colonies 
from the transformation plate. The culture was grown at 30°C with shaking for 6 hours, 
protein production was induced by the addition of IPTG (1 M stock, filter-sterilised) to a 
final concentration of 100 µM. The cultures were then incubated overnight at 19°C with 
shaking. Cells were harvested by centrifugation at 3320 x g for 20 minutes at 4 °C. Cells 
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were lysed and fractionated to soluble and insoluble fractions using B-WZ ? ƐƚĂŶĚĂƌĚ
protocol. 
2.3.2.4. Overproduction of Cytochrome C Proteins 
E. coli BL21 (DE3) Star competent cells, with or without pEC86, were transformed with a 
plasmid containing the gene of interest. 5 ml of LB with appropriate antibiotics was 
inoculated with three colonies from the transformation plate and grown overnight at 37 °C 
with shaking (160 rpm). 1 L of LB with appropriate antibiotics was then inoculated with 1 
ml of the overnight culture. The culture was grown at 30°C with shaking for 8 hours, protein 
production was induced by the addition of IPTG (1M stock, filter-sterilised) to a final 
concentration of 100 µM. The cultures were then incubated overnight at 19°C with shaking. 
Cells were harvested by centrifugation at 3320 x g for 20 minutes at 4 °C. 
2.3.3. Preparation of Competent Cells 
50 ml of LB in a conical baffled flask was inoculated with 3 colonies from a fresh overnight 
LB-agar plate. Cells were grown at 37°C with shaking to an OD600 of ~ 0.6. Cells were 
incubated on ice for 1 hour, then centrifuged at 2,700 x g for 10 minutes at 4°C. Pelleted 
cells were resuspended in 10ml 0.1M CaCl2 (filter sterilised and pre-cooled) stored on ice 
for 1 hour. Following centrifugation at 2,700 x g for 10 minutes at 4 °C the cells were 
resuspended in 1ml 0.1 M CaCl2 with 10% glycerol (filter sterilised and pre-cooled). Cells 
ǁĞƌĞƚŚĞŶĂůŝƋƵŽƚĞĚŝŶƚŽ ? ? ?ʅůĂůŝƋƵŽƚƐŝŶƐƚĞƌŝůĞ ? ? ŵůĞƉƉĞŶĚŽƌĨƚƵďĞƐ ?ĨůĂƐŚĨƌŽǌĞŶŽŶ
dry-ice and stored at -80 °C. 
2.3.4. Transformation of Competent Cells 
 ? ? ?ʅůŽĨƉůĂƐŵŝĚEǁĂƐĂĚĚĞĚƚŽ ? ?ʅůŽĨĐŽŵƉĞƚĞŶƚĐĞůůƐĨŽƌƐŝŶŐůĞƚƌĂŶƐĨŽƌŵĂƚŝŽŶƐ ?&Žƌ
ůŝŐĂƚŝŽŶƐ ?ʅůŽĨƚŚĞůŝŐĂƚŝŽŶǁĂƐƵƐĞĚǁŝƚŚ ? ?ʅůŽĨĐŽŵƉĞƚĞŶƚĐĞůůƐ ?dŚĞĐĞůůƐǁĞƌĞƚŚĞŶ
incubated on ice for 30 minutes, heat shocked at 42°C for 1 minute and incubated on ice 
ĨŽƌĂĨƵƌƚŚĞƌ ?ŵŝŶƵƚĞƐ ? ? ? ?ʅůŽĨ>ǁĂƐƚŚĞŶĂĚĚĞĚĂŶĚƚŚĞĐĞůůƐǁĞƌĞŝŶĐƵďĂƚĞĚĂƚ ? ? ?
for 1 hour. Cells were subsequently plated on LB agar plates with appropriate antibiotics 




2.4. Molecular Biology 
2.4.1. Primers 
All primers were supplied by EurofinsTM. 
Name Gene Primer 
Restriction 
site 
Mg4070nde2 4070 CTTCATATGCTATTACGCCTGATCGTC 
NdeI 
(CATATG) 
Mg4070spe 4070 GCTACTAGTCATGTACTGCGGAACAG 
SpeI 
(ACTAGT) 
Mg4071nde 4071 CTGCATATGGACATCAACGAAAAGGCAC 
NdeI 
(CATATG) 
Mg4071spe2 4071 GTCACTAGTAATAGCATGGATCACTCGTCTC 
SpeI 
(ACTAGT) 
MgMmsFnde mmsF CTGCATATGAAGAAGTCGAACTGCGCGAC 
NdeI 
(CATATG) 
MgMmsFspe mmsF GTCACTAGTCAGATCCGGTCGGCCAC 
SpeI 
(ACTAGT) 
MgMms6nde mms6 GTACATATGGTTTGCCCCCCTGGGGTTCC 
NdeI 
(CATATG) 
MgMms6spe mms6 CATACTAGTTCAGGACAGCGCGTCGCACAG 
SpeI 
(ACTAGT) 
Mg4074nde  4074 GCTCATATGGGCTTGTGGTTTTGG 
NdeI 
(CATATG) 
Mg4074spe 4074 GTCACTAGTCAATCAAGTAGTGCGGGACTG 
SpeI 
(ACTAGT) 
MgMamGnde2 mamG GCTCATATGATCAAGGGCATCGCGGGAG 
NdeI 
(CATATG) 
MgMamGspe mamG GTCACTAGTTAAGCAGGCTCGGCGGAG 
SpeI 
(ACTAGT) 
MgMamFnde mamF CTGCATATGGCCGAGACTATTTTGATC 
NdeI 
(CATATG) 
MgMamFspe mamF GTCACTAGTCAGATCAGGGCGACTAC 
SpeI 
(ACTAGT) 
MgMamDnde2 mamD GCTCATATGCAGGACCTTTTTCTCGCCAAG 
NdeI 
(CATATG) 





MgMamCnde mamC GCACATATGAGCTTTCAACTTGCGCCGTAC 
NdeI 
(CATATG) 
MgMamCspe2 mamC GCTACTAGTCAGGCCAATTCTTCCCTCAG 
SpeI 
(ACTAGT) 
MgMamHase mamH TGCGATTAATATGGAACCTGGCAGATCAGAAGTTG 
AseI 
(ATTAAT) 
MgMamHspe  mamH CGCTACTAGTGATACAGAACACAAGC 
SpeI 
(ACTAGT) 
MgMamIATGnde  mamI GCAGCATATGCCAAGCGTGATTTTCG  
NdeI 
(CATATG) 
MgMamIspe  mamI CGCTACTAGTCAACCATCGATGTTAGG 
SpeI 
(ACTAGT) 
MgMamEnde2 mamE GCTCATATGACCATGTTCAATGGTGATGTGGAAGACG 
NdeI 
(CATATG) 
MgMamEspe2 mamE GCTACTAGTCAAAGAACAATCCAGAACTCTTGGCCATTGC 
SpeI 
(ACTAGT) 
MgMamEsolSac mamE CATGAGCTCATGGAGCAGATGACAGGCGCACG 
SacI 
(GAGCTC) 





MgMamJase mamJ GCATCATATGGCAAAAAACCGGCGTG 
NdeI 
(CATATG) 
MgMamJspe mamJ GACGACTAGTCCACAGGTCTCTATTTATTC 
SpeI 
(ACTAGT) 
MgMamKnde2 mamK GTGCATATGTGGATTGATCTGTTAGCACG 
NdeI 
(CATATG) 
MgMamKspe mamK GACGACTAGTCACTGACCGGAAACTGC 
SpeI 
(ACTAGT) 
NewMgMamLase mamL GTGATTAATATGGTAAGAGTGATCGGATC 
AseI 
(ATTAAT) 
MgMamLspe mamL GATCACTAGTCCGACGGAGCATGGAATG 
SpeI 
(ACTAGT) 
MgMamMnde  mamM CGACATATGAGGAAGAGCGGTTG 
NdeI 
(CATATG) 





MgMamMxho mamM CAGCTCGAGGTTATCCACCTTGGACAGCATG 
XhoI 
(CTCGAG) 
MgMamNnde  mamN CGTCATATGGTTGGATTTATCACCCTCGCTGTG 
NdeI 
(CATATG) 
MgMamNspe  mamN GCTACTAGTCATCCTGCGAGAACGGCGATGTAC 
SpeI 
(ACTAGT) 
MgMamOase  mamO CGTGATTAATATGATTGAAATTGGCGAGACCATGGGTG 
AseI 
(ATTAAT) 
MgMamOspe  mamO CATACTAGTCACACCGTTGTCAGCATC 
SpeI 
(ACTAGT) 
MgMamPnde  mamP CGACATATGAATAGCAAACTCGTCCTG 
NdeI 
(CATATG) 
MgMamPspe  mamP GTCACTAGTGGCTAATTTATCACGTGG 
SpeI 
(ACTAGT) 
MgMamPsolSac mamP CATGAGCTCGTTGCTCCTCAGTCGATCAG 
SacI 
(GAGCTC) 
MgMamAnde  mamA CGACATATGTCTAGCAAGCCGTC 
NdeI 
(CATATG) 
MgMamAspe  mamA CAGACTAGTACATCGACTGCTTAG 
SpeI 
(ACTAGT) 
MgMamQase  mamQ GCTGATTAATATGGCAGTAAGCGATGC 
AseI 
(ATTAAT) 
MgMamQspe  mamQ GTGCACTAGTCAATTCTTGGATTCCTG 
SpeI 
(ACTAGT) 
MgMamQ-sSac mamQ GTCGAGCTCATTCTTGGATTCCTGCGAATG 
SacI 
(GAGCTC) 
MgMamRnde  mamR GCACATATGACCTTTGTTCAGGGCGCCATG 
NdeI 
(CATATG) 
MgMamRspe  mamR GAGACTAGTCATCGGTTCATGTATTCCAC 
SpeI 
(ACTAGT) 
MgMamBnde  mamB GCCGCATATGAAGTTCGAAAATTGCAG 
NdeI 
(CATATG) 
MgMamBspe  mamB CATTACTAGTGATCAGACCCGGACCGT 
SpeI 
(ACTAGT) 
MgMamBxho mamB GTTCTCGAGGACGAACAGGCGGATATCTC 
XhoI 
(CTCGAG) 





MgMamSspe  mamS CAGACTAGTCACTGCACGGTCATC 
SpeI 
(ACTAGT) 
MgMamTnde  mamT GTTCATATGGGTACGCCAGG 
NdeI 
(CATATG) 
MgMamTspe  mamT GTCACTAGTACCGGCGCTTAC 
SpeI 
(ACTAGT) 
MgMamTsolSac mamT CATGAGCTCTGGGATGAGCTGTCCCTC  
MgMamUnde  mamU GTGCATATGCGGATCGCCGCAATC 
NdeI 
(CATATG) 
MgMamUspe  mamU CTATACTAGTGGCGGCGTTATTTCGGAACCAGTATGG 
SpeI 
(ACTAGT) 
MgMamYnde mamY GCTCATATGTTGATGAACTTTGTCAACAATG 
NdeI 
(CATATG) 
MgMamYspe mamY CACACTAGTCACGCATCGGAGATGG 
SpeI 
(ACTAGT) 
MgMamXnde mamX CAGCATATGAACACCAAAGCCGTTGC 
NdeI 
(CATATG) 
MgMamXspe mamX CAGACTAGTTACCGCTCTTCGGCATCC 
SpeI 
(ACTAGT) 





MgMamZnde mamZ CTACATATGACCGTGGGCTCTCTG 
NdeI 
(CATATG) 















MgMagAnde magA GCTCATATGGAACTGCATCACCCCGAAC 
NdeI 
(CATATG) 
MgMagAspe magA CACACTAGTCAGGCATCGTCGGACCTC 
SpeI 
(ACTAGT) 
3a vector BglII FW - CAAGATCTCGATCCCGCGAAATTAATACG 
BglII 
(AGATCT) 







LemA.153.FW LemA GAGCATATGAAGAAAAGAGGTAGTACATTG 
NdeI 
(CATATG) 












LemA.159.RV LemA GAGACTAGTTAAAATTGAATCTTTACATCGGCCTTTTTC 
SpeI 
(ACTAGT) 
LemA.501.FW LemA GTACATATGACCGCTCAGACGGTTGCCAC 
NdeI 
(CATATG) 
LemA.501.RV LemA GACACTAGTCAGTTGAAGTTGACCTTAG 
SpeI 
(ACTAGT) 
LemA.565.FW LemA GTACATATGAGTCTGACCGCTATCGCTTTC 
NdeI 
(CATATG) 
LemA.565.RV LemA GTAACTAGTCAGCCGAACAGGGCCTTGAG 
SpeI 
(ACTAGT) 
COCO2.KpnI.FW - CATGGTACCAGATCTTCATATTCATG 
KpnI 
(GGTACC) 
COCO2.NcoI.RV - CATCCATGGTCCCAGACTAATAATCAG 
NcoI 
(CCATGG) 
COCO2.Mut.FW - CATCAAGAACAAGTTTAAGCTC - 






2.4.2.1. Plasmids Obtained From Other Sources 
Name Resistance Description 
pET3a Ampicillin pET3a vector plasmid obtained from Dr. Evelyne 
Deery, University of Kent. 
pETlac Ampicillin pETlac vector plasmid obtained from Dr. Evelyne 
Deery, University of Kent. 
pET3a.TBAD Ampicillin pET3a.TBAD vector plasmid obtained from Dr. 
Evelyne Deery, University of Kent. 
pET3a.pRha Ampicillin pET3a.pRha vector plasmid obtained from Dr. 
Evelyne Deery, University of Kent. 
pET14b Ampicillin pET14b vector plasmid obtained from Dr. Evelyne 
Deery, University of Kent. 
pEC86 Chloramphenicol Cytochrome C maturation plasmid containing the 
Ccm operon from E. coli expressed form a 
constitutive promoter. Obtained from Professor 
Stuart Fergusons laboratory, University of Oxford. 
pZS24 Kanamycin pZS24 vector plasmid obtained from Dr. Evelyne 
Deery, University of Kent. 
pETcoco2 Ampicillin pETcoco2 vector plasmid obtained from Dr. Evelyne 
Deery, University of Kent. 
 
2.4.2.2. Plasmids Constructed as Part of This Work 
Name Resistance Description 
pET.cocoR Ampicillin pETcoco2 vector with a removed SpeI site in the 
parB gene. 
pET3a.mamH-N Ampicillin mamHIEJKLMN expressed from a T7 promoter. 
mamH has the ribosome binding site from the pET3a 
vector, while all other genes have native sites. 
pET3a.mamO-U Ampicillin mamOPARQBSTU expressed from a T7 promoter. 
mamO has the ribosome binding site from the pET3a 
vector, while all other genes have native sites. 
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pET3a.mamH-U Ampicillin mamAB operon expressed from a T7 promoter. 
mamH and mamO have ribosome binding sites from 
the pET3a vector, while all other genes have native 
sites. 
pETlac.mamH-U Ampicillin mamAB operon expressed from a lactose promoter. 
mamH and mamO have ribosome binding sites from 




Ampicillin mms6 and mamAB operons expressed from a T7 
promoter in a single transcript. All genes in the 
mms6 operon, mamH and mamO have ribosome 
binding sites from the pET3a vector, while all other 
genes have native sites. 
pET3a.mamG Ampicillin mamG expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamF Ampicillin mamF expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamD Ampicillin mamD expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamC Ampicillin mamC expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.4070 Ampicillin mg4070 expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.4071 Ampicillin mg4071 expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mmsF Ampicillin mmsF expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mms6 Ampicillin mms6 expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.4074 Ampicillin Mg4074 expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamH Ampicillin mamH expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamI Ampicillin mamI expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
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pET3a.mamE Ampicillin mamE expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamJ Ampicillin mamJ expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamK Ampicillin mamK expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamL Ampicillin mamL expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamM Ampicillin mamM expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamN Ampicillin mamN expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamO Ampicillin mamO expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamP Ampicillin mamP expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamA Ampicillin mamA expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamQ Ampicillin mamQ expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamR Ampicillin mamR expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamB Ampicillin mamB expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamS Ampicillin mamS expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamT Ampicillin mamT expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamU Ampicillin mamU expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamY Ampicillin mamY expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamX Ampicillin mamX expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET3a.mamZ Ampicillin mamZ expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
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pET3a.ftsZ-like Ampicillin ftsZ-like expressed from a T7 promoter with the 
ribosome binding site from the pET3a vector. 
pET14b.mamI Ampicillin N-terminus 6xHis tagged MamI produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamE Ampicillin N-terminus 6xHis tagged MamE produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamJ Ampicillin N-terminus 6xHis tagged MamJ produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamL Ampicillin N-terminus 6xHis tagged MamL produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamM Ampicillin N-terminus 6xHis tagged MamM produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamN Ampicillin N-terminus 6xHis tagged MamN produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamO Ampicillin N-terminus 6xHis tagged MamO produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamP Ampicillin N-terminus 6xHis tagged MamP produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamA Ampicillin N-terminus 6xHis tagged MamA produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamQ Ampicillin N-terminus 6xHis tagged MamQ produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamR Ampicillin N-terminus 6xHis tagged MamR produced from a T7 




pET14b.mamB Ampicillin N-terminus 6xHis tagged MamB produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamS Ampicillin N-terminus 6xHis tagged MamS produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamT Ampicillin N-terminus 6xHis tagged MamT produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET14b.mamU Ampicillin N-terminus 6xHis tagged MamU produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET23b.mamM Ampicillin C-terminus 6xHis tagged MamM produced from a T7 
promoter, with the ribosome binding site from the 
pET14b vector. 
pET23b.mamB Ampicillin C-terminus 6xHis tagged MamB produced from a T7 




Ampicillin N-terminus 6xHis tagged soluble domain of MamE 
produced from a T7 promoter, with the ribosome 
binding site from the pET14b vector. 
pET23b.Sec.S Ampicillin Periplasmic targeting sequence from BtuF produced 
from a T7 promoter, with the ribosome binding site 
from the pET14b vector. 
pET23b.Sec.S.mam
E-soluble 
Ampicillin C-terminus 6xHis tagged soluble domain of MamE 
with an N-terminus periplasmic targeting sequence 
from BtuF produced from a T7 promoter, with the 
ribosome binding site from the pET14b vector. 
pET23b.Sec.S.mam
X-soluble 
Ampicillin C-terminus 6xHis tagged soluble domain of MamX 
with an N-terminus periplasmic targeting sequence 
from BtuF produced from a T7 promoter, with the 
ribosome binding site from the pET14b vector. 
pET23b.Sec.S.mam
P-soluble 
Ampicillin C-terminus 6xHis tagged soluble domain of MamP 
with an N-terminus periplasmic targeting sequence 
from BtuF produced from a T7 promoter, with the 





Ampicillin C-terminus 6xHis tagged soluble domain of MamT 
with an N-terminus periplasmic targeting sequence 
from BtuF produced from a T7 promoter, with the 
ribosome binding site from the pET14b vector. 
pET3a.4070.71 Ampicillin mg4070 and mg4071 expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.4070.71.mF Ampicillin mg4070, mg4071 and mmsF expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.m6.4074 Ampicillin mms6 and mg4074 expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.4070-74 Ampicillin mms6 operon expressed from a T7 promoter with 
ribosome binding sites from the pET3a vector. 
pET3a.FD Ampicillin mamF and mamD expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.FDC Ampicillin mamF, mamD and mamC expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.YX Ampicillin mamY and mamX expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.YXZ Ampicillin mamY, mamX and mamZ expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.YXZFtsZ Ampicillin mamYX operon expressed from a T7 promoter with 
ribosome binding sites from the pET3a vector. 
pET3a.HI Ampicillin mamH and mamI expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.EL Ampicillin mamE and mamL expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.EM Ampicillin mamE and mamM expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.MN Ampicillin mamM and mamN expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.NO Ampicillin mamN and mamO expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
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pET3a.OP Ampicillin mamO and mamP expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.PA Ampicillin mamP and mamA expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.QB Ampicillin mamQ and mamB expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.ST Ampicillin mamS and mamT expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.HU Ampicillin mamH and mamU expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.ELM Ampicillin mamE, mamL and mamM expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.HIEL Ampicillin mamH, mamI, mamE and mamL expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.IELM Ampicillin mamI, mamE, mamL and mamM expressed from a 
T7 promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.NOPA Ampicillin mamN, mamO, mamP and mamA expressed from a 
T7 promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.QBST Ampicillin mamQ, mamB, mamS and mamT expressed from a 
T7 promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.RQBST Ampicillin mamR, mamQ, mamB, mamS and mamT expressed 
from a T7 promoter with ribosome binding sites 
from the pET3a vector. 
pET3a.PARQBST Ampicillin mamP, mamA, mamR, mamQ, mamB, mamS and 
mamT expressed from a T7 promoter with ribosome 
binding sites from the pET3a vector. 
pET3a.NOPARQBST Ampicillin mamN, mamO, mamP, mamA, mamR, mamQ, 
mamB, mamS and mamT expressed from a T7 






Ampicillin mamM, mamN, mamO, mamP, mamA, mamR, 
mamQ, mamB, mamS and mamT expressed from a 
T7 promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.TBAD.HI Ampicillin mamH and mamI expressed from an arabinose 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.pRha.HI Ampicillin mamH and mamI expressed from a rhamnose 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.pRha.HIEL Ampicillin mamH, mamI, mamE and mamL expressed from a 
rhamnose promoter with ribosome binding sites 
from the pET3a vector. 
pZS24.U Kanamycin mamU expressed from a T7 promoter with ribosome 
binding sites from the pET3a vector in pZS24. 
pZS24.QBSTU Kanamycin mamQ, mamB, mamS, mamT and mamU expressed 
from a T7 promoter with ribosome binding sites 
from the pET3a vector in pZS24. 
pZS24.MNOPARQB
STU 
Kanamycin mamM, mamN, mamO, mamP, mamA, mamR, 
mamQ, mamB, mamS, mamT and mamU expressed 
from a T7 promoter with ribosome binding sites 
from the pET3a vector in pZS24. 
pET.cocoR.HIEL Ampicillin mamH, mamI, mamE and mamL expressed from a 
T7lac promoter with ribosome binding sites from the 
pETcoco2 vector in pETcocoR. 
pET.cocoR.HIELMN Ampicillin mamH, mamI, mamE, mamL, mamM, and mamN 
expressed from a T7lac promoter with ribosome 
binding sites from the pETcoco2 vector in pETcocoR. 
pET.cocoR.HIELMN
OP 
Ampicillin mamH, mamI, mamE, mamL, mamM, mamN, mamO 
and mamP expressed from a T7lac promoter with 




Ampicillin mamH, mamI, mamE, mamL, mamM, mamN, 
mamO, mamP, mamA, mamR, mamQ, mamB, mamS 
and mamT expressed from a T7lac promoter with 
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Ampicillin The soluble domain of MamQ (amino-acids 73-272) 
produced from a T7 promoter with ribosome a 
binding site from the pET3a vector. 
pET3a.IQ Ampicillin mamI and mamQ expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.LQ Ampicillin mamL and mamQ expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.QB Ampicillin mamQ and mamB expressed from a T7 promoter 
with ribosome binding sites from the pET3a vector. 
pET3a.ILQ Ampicillin mamI, mamL and mamQ expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.LQB Ampicillin mamL, mamQ and mamB expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.IQB Ampicillin mamI, mamQ and mamB expressed from a T7 
promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.ILQB Ampicillin mamI, mamL, mamQ and mamB expressed from a 
T7 promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.IQBY Ampicillin mamI, mamQ, mamB and mamY expressed from a 
T7 promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.LQBY Ampicillin mamL, mamQ, mamB and mamY expressed from a 
T7 promoter with ribosome binding sites from the 
pET3a vector. 
pET3a.ILQBY Ampicillin mamI, mamL, mamQ, mamB and mamY expressed 
from a T7 promoter with ribosome binding sites 
from the pET3a vector. 
pET3a.LemA.153 Ampicillin lemA from Bacillus megaterium expressed from a T7 




pET3a.LemA.159 Ampicillin lemA from Clostridium kluyveri expressed from a T7 
promoter with a ribosome binding site from the 
pET3a vector. 
pET3a.LemA.501 Ampicillin lemA from Brucella melitensis expressed from a T7 
promoter with a ribosome binding site from the 
pET3a vector. 
pET3a.LemA.565 Ampicillin lemA from Pseudomonas aeruginosa expressed from 
a T7 promoter with a ribosome binding site from the 
pET3a vector. 
pET3a.BamE* Ampicillin The first 21 amino-acids of BamE from Escherichia 
coli expressed from a T7 promoter with a ribosome 
binding site from the pET3a vector. 
pET3a.BamE*RFP Ampicillin The first 21 amino-acids of BamE from Escherichia 
coli fused to RFP expressed from a T7 promoter with 
a ribosome binding site from the pET3a vector. 
pET3a.BamE*LemA
.153s 
Ampicillin The first 21 amino-acids of BamE from Escherichia 
coli fused to the soluble domain of LemA from 
Bacillus megaterium expressed from a T7 promoter 
with a ribosome binding site from the pET3a vector. 
pET3a.BamE*LemA
.159s 
Ampicillin The first 21 amino-acids of BamE from Escherichia 
coli fused to the soluble domain of LemA from 
Clostridium kluyveri expressed from a T7 promoter 
with a ribosome binding site from the pET3a vector. 
pET3a.BamE*LemA
.501s 
Ampicillin The first 21 amino-acids of BamE from Escherichia 
coli fused to the soluble domain of LemA from 
Brucella melitensis expressed from a T7 promoter 
with a ribosome binding site from the pET3a vector. 
pET3a.BamE*LemA
.565s 
Ampicillin The first 21 amino-acids of BamE from Escherichia 
coli fused to the soluble domain of LemA from 
Pseudomonas aeruginosa expressed from a T7 




Ampicillin The first 21 amino-acids of BamE from Escherichia 
coli fused to the soluble domain of MamQ from 
Magnetospirillum gryphiswaldense expressed from a 
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T7 promoter with a ribosome binding site from the 
pET3a vector. 
 
2.4.3. Gene Synthesis 
Synthesis of the DNA corresponding to the BamE outer membrane targeting tag was 
ordered from EurofinsTM. 
2.4.4. Fast-start High Fidelity PCR 
Standard protocol for FastStart High Fidelity PCR System from RocheTM was used. All DNA 
used was obtained from DSMZ. Amount of DMSO used was between 0 µl and 3 µl with the 
annealing temperature between 58oC and 65oC for the amplification of all the singe genes 
of interest.  
2.4.5. Overlap Extension Mutagenesis 
Overlap extension mutagenesis was carried out to remove a restriction enzyme site in 
pETcoco2. The targeted region was the KpnI/NcoI site in the vector. Firstly, fast-start high 
fidelity PCR was carried out, using the following primer pairs: COCO2.KpnI.FW together 
with COCO2.NcoI.RV and COCO2.Mut.RV together with COCO2.Mut.FW. The Mut primers 
carry a silent mutation of a thymine to adenine within the desired SpeI site. The second 
PCR was then carried out, using the generated products as template 1 and template 2. 
Reagent Volume  
Fast-start High Fidelity buffer 10x 5 µl 
FW Primer 2 µl 
RV Primer 2 µl 
dNTPs 5 µl 
Template 1 0.5 µl 
Template 2 0.5 µl 
H2O 34 µl 
Enzyme 1 µl 
 
The reaction was carried out in a PCR block with the following settings: 2 minutes at 96oC, 
20 cycles of 30 seconds at 96oC, 30 seconds at 55oC and 120 seconds at 72oC, followed by 
a single cycle of 7 minutes at 72oC. The PCR product was then ran on an agarose gel, gel-
extracted, digested with restrictases (KpnI/NcoI) and ligated into the digested vector 
(KpnI/NcoI site). The correct plasmid was chosen for using restriction enzyme analysis and 
confirmed by sequencing. 
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2.4.6. Expand Long Range PCR 
Standard protocol for Expand Long Range PCR System (now called Expand Long Template 
PCR System) from RocheTM was used to amplify the large genetic fragments (mamH-N and 
mamO-U). Amount of DMSO used was 4 µl with the annealing temperature of 58oC. DNA 
used was obtained from DSMZ 
2.4.7. Plasmid Purification 
QIAprep Spin Miniprep Kit from QIAGENTM was used to purify all plasmids following the 
standard protocol, with the optional PB step. All plasmids were eluted in 30 µl of EB. The 
amount of overnight culture used for pZS24 vectors was increased to 10ml, doubling the 
volumes of reagents used for cell lysis and neutralisation. For pETcoco2 based vectors, 
induction of plasmid production prior to purification was carried using the ŵĂŶƵĨĂĐƚƵƌĞƌƐ ? 
guidelines. 
2.4.8. Restriction Digests 
Restriction enzymes from PromegaTM (BglII; KpnI; NdeI; PstI; ScaI; SacI; SpeI; XbaI; XhoI) and 
NEB (AseI) were used in the experiments digesting in the buffer with highest overall activity 
and at least 50% activity for each of the enzymes. DNA amount used varied form 2 µl for 
test digests, 5 µl for ligations yielding small plasmids (up to 3 genes in a single vector) to 15 
µl for ligations yielding large plasmids (more than 5 genes). Digestions were carried out for 
at least 1 hour in a 37oC water bath. 
2.4.9. Ligations 
DNA fragments wĞƌĞůŝŐĂƚĞĚŝŶ ? ?ʅůƌĞĂĐƚŝŽŶƐĨŽƌĂƚůĞĂƐƚ ?ŚŽƵƌĂƚƌŽŽŵ temperature. 
Reagent Volume  
2x Ligation Buffer 5 µl 
Insert 3.5 µl 
Vector 1 µl 





2.4.10. DNA Electrophoresis 
DNA fragments were separated in a 0.8% agarose-TAE gel run in a TAE buffer. DNA was 
ǀŝƐƵĂůŝƐĞĚǁŝƚŚĞƚŚŝĚŝƵŵďƌŽŵŝĚĞĂƚĂĨŝŶĂůĐŽŶĐĞŶƚƌĂƚŝŽŶŽĨ ? ? ?ʅŐ ?ŵů ?ĞĨŽƌĞůŽĂĚŝŶŐ ?ƚŚĞ
DNA was diluted in 5x DNA loading bufĨĞƌ ?ŝŽůŝŶĞ ) ?,ǇƉĞƌ>ĂĚĚĞƌ ? ?Ŭď ?ŝŽůŝŶĞ )ǁĂƐƵƐĞĚ
to approximate fragment sizes. DNA gels were visualised under UV light. 
2.4.11. Extraction of DNA from DNA Gels 
Bands, corresponding to the correct sizes, were excised using a scalpel. QIAquick Gel 
Extraction Kit from QIAGENTM was used to extract all DNA following the standard protocol, 
with the optional additional wash step. All DNA was eluted in 30 µl of EB. For larger 
constructs (10kb+) the EB was pre-warmed to 50oC. 
2.4.12. Sequencing 
Sanger sequencing, to confirm correct amplification and insertion of DNA fragments, was 
carried out by Beckman-Coulter GenomicsTM (now part of GENEWIZTM). 
2.5. Protein Production and Purification 
2.5.1. Protein Extraction Using Sonication 
Cell pellets resuspended in binding buffer were sonicated for 5 minutes with a 30 second 
on 30 second off cycle at an amplitude of 65%. 
2.5.2. Purification of Cytochrome Proteins Using IMAC 
Following cell lysis using sonication, cell debris was removed by centrifugation at 38,000 g 
for 20 minutes at 4 °C. 5 ml of Chelating Sepharose Fast Flow resin was loaded in a column 
and washed with 20 ml of dH2O. The column was charged with 10 ml of charging buffer and 
equilibrated with 20 ml binding buffer. The supernatant was applied to the column and 
then column was then washed with 20 ml of binding buffer, followed by 10 ml of washing 
buffer I and 10ml of wash buffer II. Proteins of interest were eluted with 15 ml of elution 
buffer and 1 ml elution fractions were collected. Nickel was then removed with 5ml strip 




2.5.3. Buffer Exchange Using a PD10 Column 
Following IMAC 2.5 ml of the elution fractions with the highest protein concentration were 
loaded onto a PD-10 desalting column equilibrated in PD-10 buffer and allowed to flow 
through. The protein of interest was eluted by addition of 3.5 ml of PD-10 buffer. 
2.5.4. SDS-PAGE 
Prior to analysis, the cells were lysed and fractionated into soluble and insoluble fractions 
using B-PERTM Bacterial Protein Extraction Reagent (ThermoFisher ScientificTM). NuPAGETM 
4%-12% Bis-Tris Gels (Thermofisher ScientificTM) were run in NuPage MOPS SDS Running 
buffer (Life TechnologiesTM) using standard procedures. Blue Prestained Protein Standard, 
Broad Range (11-190 kDa) (NEBTM) was used to quantitate the observed protein sizes. The 
proteins were denatured prior to loading by diluting in Laemmli buffer and incubation at 
100oC for 15 minutes in a heat block. The proteins were visualised by staining with 
Coomasie Blue stain for 30 min following de-staining in dH2O overnight.  
2.5.5. Western Blotting 
SDS-PAGE gels were run as described above, using various markers depending on the blot. 
Nitrocellulose membrane was equilibrated in methanol for 10 seconds, washed with dH2O 
and equilibrated in transfer buffer together with the gel. Proteins were blotted onto the 
nitrocellulose membrane in a cooled gel tank for 1 hour at 100 volts, constant voltage. Non-
specific antibody binding sites were blocked by incubation of the membrane in phosphate 
buffered saline containing 5% (w/v) skimmed milk powder at 4oC overnight. The membrane 
was subsequently incubated with the primary antibody (mouse anti-His; Sigma-AldrichTM) 
diluted 1:1000 in PBS for 1 hour under gentle agitation. The membrane was rinsed three 
times with PBS and subsequently equilibrated in phosphate-free solution for 10 minutes. 
The secondary antibody (anti-mouse IgG-AP; PromegaTM) was diluted 1:5000 in phosphate-
free solution containing 5% (w/v) skimmed milk powder, the membrane was incubated in 
this solution for 1 hour under gentle agitation followed by three 10 minute washes in 
phosphate-free solution. A single tablet of the substrate 5-Bromo-4-chloro-3-indolyl 
phosphate/Nitro blue tetrazolium (BCIP/NBT) was dissolved in 10 ml of distilled water. The 
membrane was then equilibrated in water for 10 minutes and incubated in the BCIP/NBT 
solution until sufficient colour has developed. The membrane was then washed in dH2O, 
dried and visualised using a camera. 
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2.5.6. Cytochrome C Spectrometry 
UV spectra was obtained using Cary 60 UV-Vis spectrophotometer (Agilent Technologies), 
using the Cary WinUV Scan Application (version 5.0.0.999) scanning 750 nm to 250 nm at 
medium scan speed. 1ml PLASTIBRAND UV-cuvettes were used and the path length was 1 
cm. 1 mM solution of dithionite in dH2O was used to reduce the cytochromes. 
2.6. Electron Microscopy 
2.6.1. Preparation of Whole Cells 
Cells were grown for 6h at 30oC at 180 rpm in a shaking incubator, from multiple colonies 
in 50 ml of either LB or MTB media and induced with 100 µM IPTG overnight at 19oC at 180 
rpm. Cells were harvested using centrifugation, washed with 10 ml of phosphate buffered 
saline three times and resuspended in 1 ml of phosphate buffered saline. 5 µl was pipetted 
on a carbon-coated copper electron microscopy grid and allowed to settle for 5 min 
followed by the removal of the liquid media by absorption using filter paper and air-drying.   
2.6.2. Fixing and Embedding Bacteria in Resin 
Cells were grown and harvested as above. The cell pellet was resuspended in 2 ml 2.5% 
glutaraldehyde in 100 mM cacodylate pH 7.2 in dH2O and incubated for 2 hours with gentle 
spinning. Cells were pelleted by centrifugation at 8,000 rpm for 2 minutes and were washed 
twice with 100 mM cacodylate pH 7.2 in dH2O. Cells were stained with 1% osmium tetroxide 
in 100 mM cacodylate pH 7.2 in dH2O for 2 hours and subsequently washed twice with 
dH2O. Cells were dehydrated by incubation in an ethanol gradient, 50% ethanol for 10 
minutes, 70% ethanol overnight followed by two 10 minute washes in 100% ethanol. Cells 
were further dehydrated using two wash steps in propylene oxide for 15 minutes. Cell 
pellets were infiltrated by resuspension in 1 ml of a 1:1 mix of propylene oxide and Agar LV 
Resin and incubated for 30 minutes with spinning. Cell pellets were embedded by 
incubation in 100% Agar LV resin for 2 hours twice. The cell pellet was resuspended in fresh 
resin and transferred to a 0.5 ml mould, centrifuged for 5 minutes at 1,000 rpm to 





2.6.3. Ultra-thin Sectioning and Staining of Embedded Samples 
Samples were thin sectioned on a RMC MT-XL ultramicrotome with a diamond knife 
(diatome 45°). Sections were placed on 300 mesh copper grids (Agar ScientificTM).  
Grids were stained by incubation in 4.5% uranyl acetate in 1% acetic acid solution for 45 
minutes followed by 2 washes in dH2O. Grids were then stained with 0.1% lead citrate for 
8 minutes followed by a wash in dH2O.  
2.6.4. Visualisation of Samples 






Cloning and Initial Characterisation of 




The bacterial cell is densely packed with different macromolecules, including DNA, RNA and 
proteins (Spitzer and Poolman, 2013). In order for cells to function efficiently, sub-cellular 
organisation must be achieved and maintained (Harold, 2005). It is thought that the 
simplest way of organisation, which is present in all cells, is based on protein-protein 
interactions within hyperstructures (Norris et al., 2007). These include structures involved 
in such key processes as DNA repair and replication, protein production, cell division and 
motility. Some bacteria have also employed more specialised, protein-bound and lipid-
bound organelles (Murat et al., 2010b), one of which is the magnetosome (Bazylinski and 
Frankel, 2004). 
Magnetosomes are membranous organelles that produce a magnetic mineral within its 
lumen (Gorby et al., 1988; Balkwill et al., 2006). These organelles are aligned via an actin-
like protein (Komeili et al., 2006) and are thought to help the bacteria locate its preferred 
environment (Frankel et al., 1997). The membranous nature of the organelle allows for the 
enhanced incorporation of membranous proteins that are associated with the 
mineralisation process but also acts as a barrier in order to facilitate the accumulation and 
reduction of iron. Magnetosomes have great potential in biotechnology, not only because 
of the production of very specific nanomagnets (Bain and Staniland, 2015), but also 
because there is the potential to exploit the membranous nature of the compartment itself.  
E. coli is a model bacterium that has been extensively studied and is used for a variety of 
biotechnological applications (Blount, 2015). This bacterium does not normally produce 
any specific membranous organelles. The research described in this chapter sets out to 
engineer the membranous magnetosome organelle within this organism. 
This chapter presents the research that was carried out in order to clone the mamAB 
operon in its native organisation and to investigate the growth conditions needed for the 
production of magnetosomes. The cloning strategy is complicated as mamAB is a large 
operon (over 16kb), containing 17 genes: mamH, mamI, mamE, mamJ, mamK, mamL, 
mamM, mamN, mamO, mamP, mamA, mamQ, mamR, mamB, mamS, mamT and mamU, 
of these mamL, mamQ, mamB, mamI, mamE, mamM and mamO have been shown to be 
sufficient for magnetosome membrane formation in M. gryphiswaldense (Raschdorf et al., 
2016), with some other members being essential for biomineralisation and establishing 
magnetism. A plasmid, containing the mamAB operon from M. gryphiswaldense, was 
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constructed and expressed in E. coli and the cells were visualised using electron 
microscopy. The construct was then modified and different variants were produced. A 
variety of growth conditions, which yield magnetosome formation in MTB, were 
investigated for production of magnetosomes using the various constructs in E. coli. 
3.2. Results 
3.2.1. Choosing the Organism 
The first step of the experimental design was choosing the organism to be used as a source 
for the genetic information. Multiple magnetotactic bacteria were considered and M. 
gryphiswaldense was chosen as it is the most extensively studied organism. Moreover, it 
has had its genome completely sequenced and has been subject to a large number of 
genetic studies in order to identify the genes involved in magnetosome formation. Prior to 
cloning, the codon adaptation index (CAI) for expression in E. coli was calculated for the M. 
gryphiswaldense proteins thought to be involved in magnetosome formation 
(Supplementary table 1). This gave an average CAI of 0.66, with the lowest being 0.57 
(mg4074). When compared to the CAI of lacZ from E. coli (0.75), these results suggest 
efficient translation of all the analysed proteins in the organism. 
3.2.2. Cloning of the mamAB Operon 
As discussed in the introduction, the MAI of M. gryphiswaldense contains four operons that 
have been implicated in magnetosome formation with the mamAB operon being the 
largest (over 16kb), containing 17 genes. The mamAB operon has been proposed to be 
sufficient for magnetosome formation, but not crystal maturation (Lohbe et al., 2011). Two 
different approaches were used to clone this large operon: a non-modular and a modular 
approach. The latter is discussed in section 4.2.6. The non-modular approach employed 
the use of the Expand Long Template PCR System (Roche), which allows generation of PCR 
products ranging from 5kb to 20kb with high accuracy. Even though it is well within the 
range of the system, no product was obtained when a PCR of the whole mamAB operon 
was attempted. As an alternative approach, two PCR segments containing mamHIEJKLMN 
and mamOPARQBSTU were amplified and ligated into a pET3a vector yielding 
pET3a.mamH-N and pET3a.mamO-U respectively (Figure 3.1.). These were then combined 
to produce pET3a.mamH-U (Figure 3.1.), reconstructing the whole mamAB operon that is 
expressed from a T7 promoter. Partial sequencing of the plasmid revealed multiple 
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mutations (Table 3.1.), of which the most severe was a frame-shift mutation in mamE as 
mamJ and mamK are not important for organelle formation these could be disregarded, 
while the mutation in mamB is predicted to be in a non-essential region (protein surface 
not involved in interactions). Attempts to obtain clones without the mutation in mamE 




Figure 3.1. Plasmids constructed using long-range PCR. 
(A) Vector maps of constructed plasmids. (B) PstI digest of pET3a.mamH-U showing the correct 
band pattern. Intensity of the lowest band is too low to be seen in the picture. 
 

































3.2.3. Initial Growth and Microscopy 
E. coli BL21 (DE3) Star cells were transformed with pET3a.mamH-U, grown at 37 oC 180 rpm 
for 6 hours, induced with 100 µM IPTG and incubated over-night at 18 oC. The cells were 
then harvested and imaged either as whole cells or as sections of embedded cells (Figure 
3.2). No electron-dense particles, which would suggest biomineralisation, could be seen in 
the whole cell samples but possible membranous invaginations and inclusion bodies were 
observed in the cell sections. The lack of biomineralisation could be due to a variety of 
reasons including the use of the wrong growth conditions, poor protein 
solubility/expression, the absence of certain genes from the construct or mutations present 




pET3a [Whole Cell] pET3a [Section] 
  
  
pET3a.mamH-U [Whole Cell] pET3a.mamH-U [Section] 
  
  
pET3a.mamH-U [Section] pET3a.mamH-U [Section] 
  
Figure 3.2. TEM of E. coli expressing the mamAB operon.  
Transmission elecron micrographs of E. coli BL21 (DE3) cells (whole cells or cell sections) 
harboring either an empty pET3a control plasmid or pET3a.mamH-U. Black arrows  ? 
possible membrane invaginations; red arrow  ? inclusion body. 
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3.2.4. Development of Growth Conditions: Growing Magnetotactic Bacteria 
In order to develop media for magnetite production in E. coli, M. gryphiswaldense and M. 
magneticum, which both naturally produce magnetosomes, were cultured. M. magneticum 
is a closely related strain to M. gryphiswaldense and was chosen to complement the 
experiment due its much faster growth rate. Cells were cultured as described in materials 
and methods. Growth in LB media was also tested, but no cell growth was observed. The 
magnetism of cells was checked by introducing a magnetic field using a neodymium magnet 
at the side of the growth flask. The cells were observed to migrate towards the magnet. 
Whole cells of both strains were imaged (Figure 3.3). Cell sections were obtained of M. 
magneticum (Figure 3.3), but not M. gryphiswaldense due to the failure to obtain enough 




M. gryphiswaldense [Whole Cell] M. magneticum [Whole Cell] 
  
  
 M. magneticum [Section] 
 
 
Figure 3.3. Transmission electron microscopy of Magnetospirillum species. 
Transmission elecron micrographs of either whole cells or cell sections of Magnetospirillum 
species (M. gryphiswaldense and M. magneticum) grown in MTB media. Red arrows  ? 
electron dense particles indicitive of magnetosomes 
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3.2.5. pET3a.4070-74.mamH-U and pETlac.mamH-U 
Additional constructs were made for growth studies (Table 3.2.). The mamAB operon from 
pET3a.mamH-U was transferred into a pETlac vector, where the T7 promoter had been 
exchanged for a weaker lactose promoter, yielding pETlac.mamH-U. A plasmid containing 
two operons from the MAI (pET3a.4070-74.mamH-U) was constructed by inserting the 
mms6 operon from pET3a.4070-74 (Section 4.2.6) into pET3a.mamH-U, yielding 
pET3a.4070-74.mamH-U. 
 
Table 3.2. Plasmids constructed for the adjusted growth experiments. 
Plasmid Promoter Operons Expressed (Chapter reference) 
pET3a.mamH-U T7 mamAB (3.2.2) 
pETlac.mamH-U Lactose mamAB (3.2.2) 
pET3a.4070-74.mamH-U T7 mms6 (4.2.6); mamAB (3.2.2) 
 
 
3.2.6. Adjusted Growth and Microscopy 
E. coli BL21 (DE3) cells expressing either pET3a.mamH-U, pETlac.mamH-U, pET3a.4070-
74.mamH-U or pET3a (empty vector control) were grown in the same media as MTB for 
72h at 30oC under micro-anaerobic conditions.  The cells were then embedded, sectioned 
and imaged as before. Whole cells of pET3a.4070-74.mamH-U were also imaged. The cells 
looked highly stressed and were miss-shapen (Figure 3.4. and Figure 3.5.), which was 
possibly due to the growth conditions used and the prolonged growth required to obtain 
enough cells to carry out the procedure. Some observed cells contained electron dense 
particles that looked similar to those observed in M. magneticum (Figure 3.3), although 
some were also present in the control (Table 3.3.). When a magnetic field was introduced, 












Figure 3.4. TEM of E. coli expressing the mamAB operon from a variety of operons. 
Transmission elecron micrographs of sectioned E. coli BL21 (DE3) cells harboring either an 
empty pET3a control plasmid, pET3a.H-U or pETlac.H-U. Red arrows  ? electron dense 
particles present within cells; black arrows  ? electron dense particles present outside the 









Figure 3.5. TEM of E. coli expressing the mms6 and mamAB operons. 
Transmission elecron micrographs of either whole cells or cell sections of E. coli BL21 (DE3) 
cells cells harboring pET3a.4070-74.mamH-U. Red arrows  ? electron dense particles present 
within cells; black arrows  ? electron dense particles present outside the cells. 
 
 





pET3a 1 in 50 cells 
Up to 2 particles/cell observed 
+ - 
pET3a.mamH-U 1 in 40 cells 
Up to 2 particles/cell observed 
- + 
pETlac.mamH-U 1 in 40 cells 
 Up to 6 particles/cell observed 
- - 
pET3a.4070-74.mamH-U 1 in 20 cells 
 Up to 12 particles/cell observed 
+ - 




In this chapter the cloning and expression of the M. gryphiswaldense mamAB operon in E. 
coli is described. Cloning of the whole mamAB operon was only partially achieved, as a 
probable loss-of-function frame-shift mutation was present in one of the key genes, mamE. 
Murat et al. (Murat et al., 2010a )ŚĂǀĞƐŚŽǁŶƚŚĂƚĂȴmamE strain of M. magneticum is 
still able to form magnetosome membranes, but not mineralise them. Unfortunately, a 
construct without this mutation could not be obtained, which might be due to the toxicity 
of the protein, a point that is discussed briefly in the next chapter.  
E. coli cells expressing the mamAB operon were subject to TEM studies. When grown under 
aerobic conditions in LB media membranous invaginations similar, but not identical, to 
those produced in magnetosomes were observed, although no electron dense particles 
were observed (Figure 3.2). The presence of invaginations, but not particles, could be due 
to a number of reasons, including the presence of a frame-shift mutation in mamE, 
incorrect growth conditions, poor protein solubility/expression or the absence of certain 
genes from the construct. 
Previously, it has been shown that MTB are only able to produce magnetosomes under 
specific growth conditions, with iron starvation leading to the formation of magnetosome 
membranes but not magnetite crystals (Komeili et al., 2004; Lower and Bazylinski, 2013). 
This suggests that the cellular metabolism plays an important role in the production of the 
organelles. In the lab, E. coli is most commonly grown under aerobic conditions in LB media, 
which is not chemically defined. MTB are normally found in microaerobic environments 
(Lower and Bazylinski, 2013), which suggest a preferred anaerobic respiration mechanism. 
M. gryphiswaldense is cultured in media containing a high concentration of nitrate, which 
is used by the organism as the terminal electron acceptor. E. coli is able to use nitrate as a 
terminal electron acceptor via the nitrate reductase, a heterologous complex that contains 
a cytochrome-c protein. Under aerobic growth conditions, E. coli does not produce the 
enzymes required for cytochrome-c maturation. These proteins have a covalently attached 
heme c group and have been shown to be necessary for magnetosome biomineralisation, 
which suggests that E. coli would only be able to produce the minerals under anaerobic 
growth conditions or if the cytochrome-c maturation machinery is expressed artificially. In 
order to test this, E. coli was grown in the media used to grow MTB (M. gryphiswaldense 
and M. magneticum) under microaerobic conditions. Further constructs were made prior 
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to experiments in the MTB media in order to either try to lower the expression level of the 
proteins (using the lactose promoter) or to introduce additional proteins suggested to be 
involved in the process (the mms6 operon). Electron microscopy experiments were carried 
out which showed the presence of electron-dense particles in all samples, including the 
control (Figure 3.4). This can be explained in several ways. (1) During media preparation, 
the metals in the media may have been oxidised or reacted with other salts present in the 
media to form insoluble, electron-dense particles. (2) E. coli might be able to reduce some 
metals during anaerobic growth, producing metal particles. This process would be very 
specific to the growth conditions used. Although small, non-defined particles were present 
in the control, more of these particles were observed in the cells containing the plasmid 
with the mamAB operon. Furthermore, when the construct containing both mamAB and 
mms6 operons was produced, better defined particles were observed and the total amount 
of particles per cell was the highest. The particles observed in this construct were also 
sometimes organised in chain-like structures, which resembled magnetosomes. None of 
the samples exhibited magnetotaxis, which could be explained by the need for further 
proteins in order to produce the mature, magnetic crystals. 
Recombinant magnetosome production has been shown in R. rubrum, an organism that 
does not normally produce these organelles (Kolinko, 2014). The work concludes that 
expression of mamAB operon is not sufficient for magnetite crystallisation, which was only 
achieved when mamAB, mamGFDC and mms6 operons were inserted into the organism, 
although expression of mamAB only with mms6 was not explored. Mature crystals were 
only obtained when all four operons (mamAB, mamGFDC, mms6 and mamYX) were present 
in the organism. 
Overall, the work discussed in this chapter has provided a number of interesting insights 
into the effects of the mamAB operon on the membranous morphology of E. coli. 
Furthermore, the work suggests the possibility of mineral formation when only mamAB 
and mms6 operons are expressed, although identification of these minerals needs to be 
carried out, which is being carred out in future work. Due to the mutation present in the 
operon construct, it was decided to focus on synthetic reconstruction and characterisation 
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Magnetosome formation has been shown to be a complex process which is still not fully 
understood (Komeili, 2012). Up to 30 proteins (Table 4.1) from the MAI are predicted to be 
directly involved in organelle formation and maintenance (Lohbe et al., 2014). 
Furthermore, it is clear that proteins involved in other cellular processes, such as redox 
processes and iron transport, also contribute to the process. For example, the periplasmic 
nitrate reductase has been shown to be involved in magnetite biomineralisation (Li et al., 
2012) and insertion of a ferrous iron transporter into an organism, engineered to produce 
magnetosomes, improves crystal growth (Kolinko et al., 2014). To date, there has been no 
comprehensive analysis on how MAI proteins behave in E. coli.  
E. coli is one of the most commonly used organisms for protein production. A large variety 
of foreign proteins have been successfully produced in this bacterium. Unfortunately, not 
all proteins can be produced correctly in E. coli and the reasons behind this are not fully 
understood but likely reflect the ability of the foreign protein to fold within the internal 
environment. Other possibilities can also include incorrect targeting, lack of suitable 
chaperones, protease cleavage and poor solubility. Extensive studies have been carried out 
to characterise the metabolism of E. coli (Keseler et al., 2013). It is well established that the 
organism can grow both aerobically and anaerobically, using a variety of molecules as 
terminal electron acceptors. Therefore, if the genes, involved in magnetosome formation, 
are correctly produced in this model bacterium, this respiratory flexibility should allow for 
the identification of growth conditions where mineral formation is possible. 
In this chapter, the proteins from the four operons directly involved in magnetosome 
synthesis (mms6, mamGFDC, mamAB and mamXY), are analysed. The analysis includes a 
bioinformatics approach coupled with the cloning and recombinant expression of the genes 
in E. coli. The chapter also includes the reconstruction of all the operons in a modular 





Table 4.1. General information about the MAI proteins. 
Protein Operon Length (bp) Length (aa) Molecular Weight (kDa) pI 
MamG mamGFDC 255 84 7.72 8.61 
MamF mamGFDC 336 111 12.34 9.14 
MamD mamGFDC 945 314 30.26 9.84 
MamC mamGFDC 378 125 12.43 5.07 
4070 mms6 1350 449 48.04 8.17 
4071 mms6 1044 347 36.38 5.94 
MmsF mms6 375 124 13.78 9.26 
Mms6 mms6 411 136 12.76 9.14 
4074 mms6 273 90 9.73 9.68 
MamH mamAB 1289 428 45.67 7.02 
MamI mamAB 234 77 7.16 8.74 
MamE mamAB 2319 772 78.05 8.19 
MamJ mamAB 1401 466 48.52 4.00 
MamK mamAB 1083 360 39.20 5.45 
MamL mamAB 372 123 8.59 12.19 
MamM mamAB 957 318 34.49 5.88 
MamN mamAB 1314 437 46.18 6.66 
MamO mamAB 1899 632 65.39 6.50 
MamP mamAB 813 270 28.36 7.13 
MamA mamAB 654 217 24.01 5.70 
MamQ mamAB 819 272 30.03 6.12 
MamR mamAB 219 72 8.06 8.31 
MamB mamAB 894 297 31.96 5.38 
MamS mamAB 543 180 18.72 6.78 
MamT mamAB 525 174 18.89 9.65 
MamU mamAB 894 297 32.00 9.32 
MamY mamXY 909 302 40.90 4.80 
MamX mamXY 1851 616 28.22 5.88 
MamZ mamXY 810 269 70.55 9.50 





A bioinformatics approach was initially employed to gain some preliminary information 
concerning the potential function of the proteins associated with magnetosome formation. 
These programmes included: TMHMM2 (http://www.cbs.dtu.dk/services/TMHMM/) and 
SignalP 4.1 (http://www.cbs.dtu.dk/services/SignalP/), which were used to investigate 
protein topology and targeting, and I-TASSER (http://zhanglab.ccmb.med.umich.edu/I-
TASSER/), which was used to investigate any predictable structural similarity to proteins of 
known function.  
TMHMM2 is currently the best ranked freely available transmembrane prediction program 
and is able to predict membrane protein topology with very high reliability (Moller et al., 
2001). The newest version of the program has been shown to predict 97%-98% of all tested 
transmembrane helices, although the specificity is lower when signalling peptides are 
present (Krogh et al., 2001). SignalP 4.1 can be used to predict these signalling peptides 
and was designed to distinguish between transmembrane helices and signal peptides 
which share similar properties (Petersen et al., 2011). These methods were used in 
combination to predict the number of transmembrane helices (Table 4.2), protein topology 
(Table 4.2 and Supplementary figure 1) and the presence of any signalling peptides present 
(Table 4.2) for all of the magnetosome proteins. 
I-TASSER (Iterative Threading ASSEmbly Refinement) is currently the best ranked 
(http://www.predictioncenter.org/casp11/) freely available protein structure and function 
prediction software (Yang et al., 2015). The software generates a structural model based 
on the available structures of homologues. It also predicts biological function by analysing 
the enzyme commission (EC) numbers, gene ontology (GO) vocabulary and the ligand-
binding sites of the templates used in the structural prediction and structurally similar 
proteins. The method was used to generate models for all MAI proteins. The most 
informative predictions are outlined in Table 4.3, with the full table available as 






Table 4.2. Transmembrane helix (TMHs), largest protein proportion localisation and signalling 
peptide predictions. 
Protein Operon TMHs Largest protein proportion localisation Signalling peptide 
MamG mamGFDC 2 Transmembrane - 
MamF mamGFDC 3 Transmembrane - 
MamD mamGFDC 1 Periplasm - 
MamC mamGFDC 2 Transmembrane - 
4070 mms6 2 Cytoplasm - 
4071 mms6 1 Periplasm - 
MmsF mms6 3 Transmembrane - 
Mms6 mms6 1 Periplasm - 
4074 mms6 0 Cytoplasm - 
MamH mamAB 12 Transmembrane - 
MamI mamAB 2 Transmembrane - 
MamE mamAB 1 Periplasm - 
MamJ mamAB 0 Cytoplasm - 
MamK mamAB 0 Cytoplasm - 
MamL mamAB 2 Transmembrane - 
MamM mamAB 3 Periplasm - 
MamN mamAB 11 Transmembrane - 
MamO mamAB 8 Periplasm - 
MamP mamAB 1 Periplasm - 
MamA mamAB 0 Cytoplasm - 
MamQ mamAB 1 Cytoplasm - 
MamR mamAB 0 Cytoplasm - 
MamB mamAB 3 Periplasm - 
MamS mamAB 1 Cytoplasm - 
MamT mamAB 1 Cytoplasm - 
MamU mamAB 0 Cytoplasm - 
MamY mamXY 2 Cytoplasm - 
MamX mamXY 1 Periplasm - 
MamZ mamXY 18 Transmembrane - 
FtsZ-like mamXY 0 Cytoplasm - 
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Table 4.3. I-TASSER functional, biological and localisation predictions.  
Accuracy refers to the structural prediction confidence by the software (out of 1). Functional 
prediction confidence (out of 1) is shown in brackets. 
Protein Accuracy Molecular Function Biological Process Cellular Location 







Heme binding (0.15) Cellular physiology 
process (0.51) Structural constituent of 
the cytoskeleton (0.14) 
MamD 0.39±0.13  Regulation of cell 
shape (0.35) 
Cytoplasm (0.35) 












Fatty acid binding (0.41) Mitochondrial 
matrix (0.36) 









Vesicle coat (0.35) 








Mms6 0.39±0.13 Zinc ion binding (0.41)  Periplasm (0.31) 
4074 0.26±0.08 Metalloexopeptidase 
(0.07) 
Proteolysis (0.07) Peripheral 
membrane 
protein (0.07) 
Actin binding (0.07) Extracellular 
(0.07) 







(0.76) Cation:sugar symporter 
(0.51) Macromolecular 
complex (0.54) 













MamE 0.44±0.14 Serine-type 
endopeptidase (0.63) 
Proteolysis 













MamJ 0.51±0.15 Enzyme inhibitor (0.48)  Cytoplasm (0.36) 
Protein binding (0.42) Extracellular 
(0.31) Endopeptidase regulator 
(0.32) 
Ion binding (0.32) 
MamK 0.77±0.10 ATP binding (0.98) Adherens junction 
organization (0.52) 
Cytosol (0.52) 








ADP binding (0.52) Actomyosin, actin 
portion (0.52) ATPase activity (0.52) 
Structural constituent of 
cytoskeleton (0.52) 
















MamN 0.52±0.15 Intramolecular 
oxidoreductase (0.48) 
 Cell periphery 
(0.48) 
Oxidoreductase (0.39) Cytoplasm (0.35) 
Metal cluster binding 
(0.39) 
Ion binding (0.39) 














Protein binding (0.48) Proteolysis (0.55) Periplasm (0.40) 













































repressor activity (0.51) 
Response to redox 
state (0.51) 












Porin (0.37) Cell outer 
membrane (0.67) 
MamS 0.29±0.09 Nucleic acid binding 
transcription factor (0.40) 
Regulation of gene 
expression (0.40) 
Intracellular (0.40) 
ATP binding (0.36) Inorganic anion 
transport (0.40) 
MamT 0.31±0.10 Electron carrier (0.07) Oxidation-
reduction (0.13) 
Cytoplasm (0.09) 
Heme binding (0.07) 





ATP binding (0.95) Phospholipid 
biosynthesis (0.95) 
Metal ion binding (0.95) Lipid 
phosphorylation 
(0.88) 
NAD+ kinase (0.94) 
Lipid kinase (0.88) 
MamX 0.28±0.09 Ion binding (0.60)  Intracellular (0.47) 





Signalling (0.32)  







2 iron, 2 sulphur cluster 
binding (0.41) 
Response to metal 
ion (0.46) 
Peroxisome (0.41) 
Iron ion binding (0.41) Plasma membrane 
(0.41) FAD binding (0.41) 





FtsZ-like 0.64±0.13 GTPase (1.00) GTP hydrolysis 
(1.00) 
Cytoplasm (1.00) 














4.2.2. Cloning of All the Individual MAI Genes 
Primers were designed for all magnetosome island genes to allow for their amplification by 
PCR. The primers contained flanking restriction enzyme sites for NdeI or AseI ĂƚƚŚĞ ? ?ĂŶĚ
SpeI ĂƚƚŚĞ ? ? ?KŶĐĞĂŵƉůŝĨŝĞĚ ?ƚŚĞEǁĂƐĚŝŐĞƐƚĞĚƵƐŝŶŐƚŚĞĐŽƌƌĞƐƉŽŶĚŝŶŐƌĞƐƚƌŝĐƚŝŽŶ
enzymes and ligated into a pET3a vector via the NdeI/SpeI sites. This allows the over-
expression of the gene using the T7 promoter and the over-production of the protein using 
the optimised ribosome binding site present in the vector. Once cloned, the resultant 
plasmid was transformed into E. coli , ?ɲ ƚŽ ĂůůŽǁ ĂŵƉůŝĨŝĐĂƚŝŽŶ ŽĨ ƚŚĞ ƉůĂƐŵŝĚ ? ĂĐŚ
individual plasmid was confirmed by restriction enzyme analysis and sequencing. More 
details on the cloning procedures and construct list can be found in the materials and 
methods section.  
Two different Magnetospirillum gryphiswaldense MSR-1 genomes are available on the 
NCBI data base (http://www.ncbi.nlm.nih.gov/genome) and the sequences of the cloned 
magnetosome island genes were compared to both. Interestingly, a number of genetic 
differences were identified in the amplified genes when the sequences of the cloned genes 
were compared to these two available genomes (Table 4.4). For instance, protein 4070 was 
obtained with two mutations, which are not present in either of the genomes. Multiple 
amplifications yielded the same product so, therefore, it is assumed that this is a variation 
present in the genomic DNA used. 
 
Table 4.4. Magnetosome protein sequence variation between available genomes. 
Comparison of the magnetosome protein differences in two available Magnetospirillum 
gryphiswaldense genomes and the cloned variant, using MSR-1 genome as the reference. 
Protein Operon MSR-1 v2 genome variant Cloned variant 
MamG mamGFDC N/A (frame shift) N/A (frame shift) 
MamD mamGFDC Val227->Ala MSR-1 v2 
MamC mamGFDC Glu81->Gly MSR-1 v2 
4070 mms6 Identical Lys338->Arg; Lys350->Arg 
Mms6 mms6 Duplication of two segments (GKVGA 
and TKVVAAQGAG) 
MSR-1 v2 
4074 mms6 N/A MSR-1 





4.2.3. Production and SDS-PAGE Analysis of Individual MAI Proteins 
In order to investigate the over-expression levels of individual proteins in E. coli all the 
constructs were individually transformed into E. coli BL21 (DE3) Star cells. These were then 
grown, induced and harvested as described in materials and methods. E. coli BL21 (DE3) 
Star cells expressing an empty pET3a vector was used as a control. The resulting whole cell, 
soluble and insoluble fractions for each strain were analysed using SDS-PAGE (Figure 4.1, 
Figure 4.2, Figure 4.3 and Figure 4.4) and their protein profiles were compared to the 
control. Only 7 out of 29 analysed constructs showed observable protein overproduction 
using this method. In order to detect poorly produced proteins, a western blot approach 







Figure 4.1. SDS-PAGE analysis of proteins from the mamGFDC and mms6 operons.  
L is Ladder; 3a(s) is the control sample of cells harbouring a pET3a vector. Arrows indicate 





Figure 4.2. SDS-PAGE analysis of the first 8 proteins (except insoluble fraction of mamJ) from 
the mamAB operon.  
L is Ladder; 3a(L) is the control sample of cells harbouring a pET3a vector. Arrows indicate 








Figure 4.3. SDS-PAGE analysis of the last 9 proteins from the mamAB operon.  
L is Ladder. Arrows indicate predicted protein sizes. Red indicates no observable over-




Figure 4.4. SDS-PAGE analysis of proteins from the mamXY operon.  
L is Ladder; 3a(s) is the control sample of cells harbouring a pET3a vector. Arrows 
indicate predicted protein sizes. Red indicates no observable over-expression. Yellow 




4.2.4. Western Blotting Analysis of Individual MAI Proteins  
In order to use western blotting to analyse the MAI proteins they needed to be tagged with 
a suitable antigen. An N-terminus hexa-histidine tag was chosen due to the ease of sub-
cloning the constructs into an appropriate vector (pET14b) and the availability of a specific 
antibody against the tag. Key mamAB operon proteins (Table 4.5) were chosen for analysis 
due to their roles in the organelle formation process. These were sub-cloned into a pET14b 
vector (NdeI/SpeI site) either from the previously constructed pET3a plasmids (NdeI/SpeI 
segments) or from directly amplified PCR products (AseI/SpeI segments). If PCR was used 
as part of the procedure, the resulting plasmids were sequenced. 
 
Table 4.5. General information about the mamAB operon proteins analysed using 
Western Blotting. 
Protein Vector Insert Modification Molecular Weight (kDa) 
MamE pET14b pET3a.mamE N-term 6xHis 80.21 
MamJ pET14b PCR N-term 6xHis 50.68 
MamL pET14b PCR N-term 6xHis 10.75 
MamM pET14b pET3a.mamM N-term 6xHis 36.65 
MamN pET14b pET3a.mamN N-term 6xHis 48.34 
MamO pET14b PCR N-term 6xHis 67.55 
MamP pET14b pET3a.mamP N-term 6xHis 30.52 
MamA pET14b pET3a.mamA N-term 6xHis 26.17 
MamQ pET14b PCR N-term 6xHis 32.19 
MamR pET14b pET3a.mamR N-term 6xHis 10.22 
MamB pET14b pET3a.mamB N-term 6xHis 34.12 
MamS pET14b pET3a.mamS N-term 6xHis 20.88 
MamT pET14b pET3a.mamT N-term 6xHis 21.05 
MamU pET14b pET3a.mamU N-term 6xHis 34.16 
MamM pET23b PCR C-term 6xHis 34.51 
 






The plasmids that were constructed were individually transformed into E. coli BL21 (DE3) 
Star cells. These were then grown, induced and harvested under the same conditions as 
previously described. A western blot procedure, using an anti-hexa-histidine tag primary 
antibody, was carried out for each of the strains, as described in materials and methods 
section. The blots are shown in Figure 4.5 and Figure 4.6. This procedure was followed for 
all proteins except for MamQ, which, due to a rather unusual membranous phenotype, that 
was observed during electron microscopy experiments (discussed in the following chapter), 





Figure 4.5. Western blot analysis of N-terminus hexa-histidine tagged proteins from the 
mamAB operon.  
Arrows indicate identified bands of interest. Yellow indicates the band is of predicted size. 






Figure 4.6. Western blot analysis of N-terminus hexa-histidine tagged MamQ protein.  
WC  ? whole cells; S  ? soluble fraction; I  ? insoluble fraction. Arrows indicate identified 
bands. Yellow indicates the band is of predicted size.  
 
 
From this study of 14 constructs, 11 of the strains showed bands that were immuno-
reactive with the anti-His antibody. Of these, only 5 of the constructs produced bands of 
the expected molecular mass. Furthermore, the strain overproducing MamE revealed a 
large number of lower sized bands (Figure 4.5.) indicative of protein cleavage or 
degradation. 
The presence of an N-terminus hexa-histidine tag, could have interfered with the insertion 
of membranous proteins into the membrane. To investigate this possibility further, 
additional constructs of the key predicted membrane proteins, MamM and MamB, were 
generated with a C-terminus hexa-histidine tag. This was achieved by cloning the PCR 
products of mamM and mamB (NdeI/XhoI segments) into a pET23b vector (NdeI/XhoI site) 
(Table 4.5.). The same western-blot procedure was used to analyse the resultant strains 
generated by transforming these plasmids into E. coli BL21 (DE3) Star cells. The relevant 







Figure 4.7. Western blot analysis of C-terminus hexa-histidine tagged MamB and MamM proteins. 
Arrows indicate identified bands of interest. Yellow indicates the band is of predicted size. Red 
indicates the band is of different size from predicted.  
 
When a C-terminus hexa-histidine tag was used to detect recombinant MamM and MamB, 
both proteins could be detected by western analysis. The results confirm that an N-
terminus hexa-histidine tag appears to interfere with the correct production of these two 
membranous proteins. 
Overall, it was therefore possible to identify the recombinant production of 12 out of the 
14 analysed constructs using western blotting. The 2 proteins with no-observed expression, 
MamO and MamN, are also both predicted membrane proteins and should also be 
analysed using C-terminal hexa-histidine tag constructs, but due to time constrains the 
analysis was not carried out. This analysis suggest that the majority of MAI proteins can be 
produced recombinantly in E. coli, but many are only found at low concentrations and 




4.2.5. C Type Cytochrome Proteins 
Four cytochrome c proteins have been identified in the MAI, and are characterised by the 
presence of CXXCH motifs within their sequence. All of these have a suggested role in 
biomineralisation of magnetite within magnetosomes. The sequence of the cytochrome c 
domains of these proteins suggests they fall into two different groups (Figure 4.8 (A)). 
Further motif searches were carried out for these proteins and these are outlined in Figure 
4.8 (B). 
In order to investigate if these cytochromes are processed correctly in E. coli it was decided 
to overproduce the soluble domains of the proteins fused to an affinity tag (hexa-histidine) 
to allow for easier purification. 
The DNA corresponding to predicted soluble domain of MamEȴ ?-55 (MamE-soluble), was 
cloned into a pET14b (NdeI/SpeI site) after amplification by PCR with primers containing 
the appropriate restriction enzyme sites (NdeI/SpeI segment). The correct plasmids were 
identified by restriction enzyme analysis and confirmed by sequencing of the relevant 
clones. E. coli BL21 (DE3) Star cells were used to overproduce the protein, which was then 
purified using nickel affinity chromatography. UV-visible spectrum analysis of purified and 
reduced protein, together with SDS-PAGE and western blotting results for N-terminus hexa-
histidine tagged MamE-soluble are shown in Figure 4.9. The protein appeared highly 
smeared on the western blot suggesting either cleavage by a peptidase or poor 
ĚĞŶĂƚƵƌĂƚŝŽŶ ? EŽ ɲ ? ɴ Žƌ ɶ ƉĞĂŬƐ ? ŝŶĚŝĐĂƚŝǀĞ ŽĨ ƚŚĞ ƉƌĞƐĞŶĐĞ ŽĨ Ă ŚĞŵĞ ŐƌŽƵƉ ?a 
characteristic of cytochrome c proteins, were observed. This suggests that no incorporation 
of heme into the cytochrome had taken place in the cytoplasm of E. coli, which is to be 
expected as the maturation machinery for this process is located in the periplasm of the 
organism. 
In order to investigate how the cytochrome c proteins behave in the periplasm, constructs 
for the fusion of an N-terminus periplasmic targeting sequence onto the protein together 
with a C-terminus hexa-histidine tag were made. Briefly, the periplasmic targeting 
sequence of BtuF (first 32 amino-acids) from E. coli was cloned in a pET23b (NdeI/SacI site) 
vector followed by insertion of the soluble domains of the cytochrome c proteins (SacI/XhoI 
site). All constructs were confirmed by restriction enzyme analysis and sequencing. The 
proteins were overproduced and purified section. As observed ƉƌĞǀŝŽƵƐůǇ ? ŶŽ ɲ ? ɴ Žƌ ɶ
peaks associated with heme were observed for the isolated proteins.  
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A literature search revealed that E. coli only produces the cytochrome c machinery (Ccm 
operon) under very specific growth conditions and hence in order to overproduce 
cytochrome c proteins, the machinery needs to be constitutively expressed from a plasmid 
(Arslan et al., 1998). A plasmid containing the Ccm operon, contained within a plasmid 
(pEC86), was obtained from the laboratory of Professor Stuart Ferguson. The periplasmic 
targeted soluble domains of the cytochrome c proteins were produced in E. coli BL21 (DE3) 
Star, harbouring the pEC86 plasmid, and purified. Purified MamP, MamT and MamX gave 
UV spectra showing the presence of heme, which could be reduced by the addition of 
dithionite, suggesting correct heme insertion (Figure 4.10). Unfortunately, MamE did not 
















Figure 4.8. Sequence analysis of c type cytochromes from the MAI. 











Figure 4.9. Analysis of purified MamE-soluble.  
(A) UV spectrum of native and reduced protein. (B) SDS-PAGE. (C) Western blot.  Arrows indicate 






Figure 4.10. UV spectra of 3 different cytochrome c proteins from the MAI.  
ɲ ?ɴĂŶĚɶƉĞĂŬƐ ?ŝŶĚŝĐĂƚŝǀĞŽĨĐǇƚŽĐŚƌŽŵĞĐƉƌŽƚĞŝŶƐ ?ĂƌĞŚŝŐŚůŝŐŚƚĞĚ ? 
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4.2.6. Combining Individual Gene Constructs 
To produce synthetic variants of all the MAI operons (mamGFDC, mms6, mamAB and 
mamXY) a previously developed method, Link and Lock, was employed which relies on 
having all the genes of interest in the pET3a vector (McGoldrick et al., 2005). Briefly, by 
using an upstream XbaI site on the insert and a downstream SpeI site in the vector, together 
with a downstream restriction site in the vector backbone (usually ScaI), it is possible to 
insert a new gene in the synthetic operon (Figure 4.11). During the cloning process the old 
XbaI and SpeI sites are destroyed, ďƵƚŶĞǁŽŶĞƐĂƌĞŝŶƚƌŽĚƵĐĞĚĂƚƚŚĞ ? ?ĂŶĚƚŚĞ ? ?ŽĨƚŚĞ
operon respectively. The process can be repeated to introduce further genes. All genes of 
interest are cloned into the same transcript, expressed from a T7 promoter and have 
individual ribosome binding sites, which come from the vector. Furthermore, inserts can 





Figure 4.11. Cloning strategy used to create synthetic operons.  
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This method was used to create a large library of synthetic operons (Table 4.6). In this 
manner it was possible to reconstruct fully the mms6 and mamXY operons. The mamGFDC 
operon was reconstructed without mamG, as the gene contained a frame-shift mutation 
(Table 4.4).  
Initially, the reconstruction of the mamAB operon without mamH, mamJ, mamK and 
mamU was planned, as these genes had previously been shown not to be necessary for 
organelle formation or biomineralisation (Murat et al., 2010a; Lohbe et al., 2016). 
However, it was not possible to reconstruct the modified operon by employing the method 
discussed above. The largest construct obtained contained 10 out of 13 genes (Table 4.6). 
No transformants were obtained when attempts were made to add additional genes into 
the construct. One possible reason for this could be due to the leakiness of the T7 
promoter, so alternative promoters were employed as outlined below. 
Two different promoters were used, the previously discussed arabinose promoter 
(pET3a.TBAD) and a rhamnose promoter (pET3a.pRha). Surprisingly, it was even more 
difficult to obtain any larger constructs using these promoters (Table 4.7). Only two or four 
genes could be combined using the arabinose or rhamnose promoter respectively. 
Furthermore, transformants containing the pET3a.pRha.HIEL construct had a significant 
growth defect in that they formed microcolonies (<1mm diameter colonies from 16h 






Table 4.7. Constructs made in attempt to reconstruct the mamAB operon. 
Vector Construct Genes (in construct order) 
pET3a.TBAD pET3a.TBAD.HI mamH, mamI 
pET3a.pRha pET3a.pRha.HI mamH, mamI 
pET3a.pRha pET3a.pRha.HIEL mamH, mamI, mamE, mamL 
pZS24 pZS24.U mamU 
pZS24 pZS24.QBSTU mamQ, mamB, mamS, mamT, mamU 
pZS24 pZS24.MNOPARQBSTU mamM, mamN, mamO, mamP, mamA, mamR, 
mamQ, mamB, mamS, mamT, mamU 
pET.cocoR pET.cocoR.HIEL mamH, mamI, mamE, mamL 
pET.cocoR pET.cocoR.HIELMN mamH, mamI, mamE, mamL, mamM, mamN 
pET.cocoR pET.cocoR.HIELMNOP mamH, mamI, mamE, mamL, mamM, mamN, 
mamO, mamP 
pET.cocoR pET.cocoR.HIELMNOPARQBST mamH, mamI, mamE, mamL, mamM, mamN, 
mamO, mamP, mamA, mamR, mamQ, mamB, 
mamS, mamT 
Table 4.6. Multi-gene constructs made in the pET3a vector. 
Operon Construct Genes (in construct order) 
mms6 pET3a.70 mg4070 
mms6 pET3a.70.71 mg4070, mg4071 
mms6 pET3a.70.71.mF mg4070, mg4071, mmsF 
mms6 pET3a.m6.74 mms6, mg4074 
mms6 pET3a.4070-74 mg4070, mg4071, mmsF, mms6, mg4074 
mamGFDC pET3a.FD mamF, mamD 
mamGFDC pET3a.FDC mamF, mamD, mamC 
mamXY pET3a.YX mamY, mamX 
mamXY pET3a.YXZ mamY, mamX, mamZ 
mamXY pET3a.YXZFtsZ mamY, mamX, mamZ, FtsZ-like 
mamAB pET3a.HI mamH, mamI 
mamAB pET3a.EL mamE, mamL 
mamAB pET3a.EM mamE, mamM 
mamAB pET3a.MN mamM, mamN 
mamAB pET3a.NO mamN, mamO 
mamAB pET3a.OP mamO, mamP 
mamAB pET3a.PA mamP, mamA 
mamAB pET3a.QB mamQ, mamB 
mamAB pET3a.ST mamS, mamT 
mamAB pET3a.HU mamH, mamU 
mamAB pET3a.ELM mamE, mamL, mamM 
mamAB pET3a.HIEL mamH, mamI, mamE, mamL 
mamAB pET3a.IELM mamI, mamE, mamL, mamM 
mamAB pET3a.NOPA mamN, mamO, mamP, mamA 
mamAB pET3a.QBST mamQ, mamB, mamS, mamT 
mamAB pET3a.RQBST mamR, mamQ, mamB, mamS, mamT 
mamAB pET3a.PARQBST mamP, mamA, mamR, mamQ, mamB, mamS, mamT 
mamAB pET3a.NOPARQBST mamN, mamO, mamP, mamA, mamR, mamQ, 
mamB, mamS, mamT 
mamAB pET3a.MNOPARQBST mamM, mamN, mamO, mamP, mamA, mamR, 
mamQ, mamB, mamS, mamT 
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As the change in the promoter did not allow larger constructs to be made, a different, low 
copy number vector (pZS24), was used. This vector contains a kanamycin resistance 
cassette and utilises a lactose promoter for gene expression. In order to clone multi-gene 
constructs into this vector, mamU, the final gene of the mamAB operon from a pET3a 
vector (BglII/NheI site), was first cloned into the pZS24 vector (BamHI/AvrII site). In doing 
so, this strategy also replaced the pZS24 lactose promoter with the T7 promoter from 
pET3a. Furthermore, the construct obtained allows insertion of other genes from the 
previously obtained pET3a constructs (AseI/SpeI site) to be inserted upstream of mamU 
(AseI/XbaI site). This method resulted in the generation of pZS24.MNOPARQBSTU, but, as 
before, it was not possible to obtain constructs containing any further genes.  
The use of another vector, pETcoco2 (NovagenTM), was also investigated. In previous work, 
this vector was used successfully to clone 25 genes associated with the biosynthesis of 
cobalamin (Deery et al., 2012). The vector combines the two important properties: a tightly 
regulated promoter (T7lac) and is maintained at a single copy per cell. Furthermore, using 
arabinose induction, the copy number can be increased allowing for easy amplification of 
the plasmid. In order to sub-clone previously constructed plasmids in a modular manner, 
the SpeI site, located in the parB coding region of pETcoco2, had to be removed. Overlap 
extension mutagenesis was used to remove the site (introducing a silent mutation in parB), 
yielding pETcocoR. An operon containing mamH, mamI, mamE and mamL from pET3a.HIEL 
(XbaI/HindIII site) was inserted into this vector (NheI/HindIII site). The newly constructed 
plasmid (pETcocoR.HIEL (Table 4.7)) allows insertion of further genes (from pET3a 
constructs) into the same operon, downstream of the final gene (mamL), using the 
SpeI/BmtI site (XbaI/BmtI site for the insert). Using this method, it was possible to construct 
pET.cocoR.HIELMNOPARQBST in 3 stages. The new construct contains all the genes that 
were initially set out to be cloned together, with an additional gene, mamH. Unfortunately, 
the construct could not be transfored into strains containing a T7 polymerase. Further work 
is going to be carried out in order to attempt to obtain a strain able to express proteins 




In this chapter bioinformatics analysis of the proteins associated with magnetosome 
formation and the ability of E. coli to correctly produce some of these proteins is discussed. 
Furthermore, the generation of large artificial operons containing multiple genes encoding 
for these proteins is shown. 
Bioinformatics analysis showed a large proportion of the proteins associated with 
magnetosome formation are predicted to be either membrane anchored (10 out of 30) or 
transmembrane proteins (11 out of 30). This was expected, as the magnetosome is a 
membranous organelle and the biomineralisation takes place within the membranous 
space separated from the cytoplasm by the membrane. Interestingly, no targeting 
sequences were identified for any of the associated proteins. This points to a novel 
targeting mechanism for some of the associated proteins, independent of the well 
characterised bacterial sec and tat targeting systems (Natale et al., 2008). There has been 
some evidence for this, suggesting MamE to play a key role in the unknown mechanism 
(Quinlan et al., 2011). 
Protein structure prediction is a growing field of interest as with the availability of more 
and more protein structures together with novel approaches on modelling unknown 
structures, it is possible to predict un-solved proteins with better accuracy (Dorn et al., 
2014). When studying uncharacterised proteins or protein systems, using such predictions 
can be highly informative as the protein fold can often point to functions not identified 
using standard protein sequence alignments or reinforce such predictions. These can then 
be used to design experiments. In order to gain such insight into the proteins involved in 
magnetosome synthesis I-TASSER, a freely available protein structure and function 
prediction software was used (Yang et al., 2015). Some of the more interesting 
observations are discussed. 
Protein 4070 was predicted to have a tetratricopeptide (TRP) repeat fold. In eukaryotic 
cells, proteins containing this fold have been shown to have functions which might be 
utilised in magnetosome synthesis. These include vesicle formation, contribution to protein 
complex assemblies and protein import to cellular organelles (Zeytuni and Zarivach, 2012). 
Notably, six different proteins from the MAI (MamC, 4070, MamI, MamA, MamQ and 
MamZ) had predicted structural motifs suggesting targeting to such organelles. 
Furthermore, two of these (MamI and MamZ) and one further protein in the MAI (MamH), 
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were predicted to be part of macromolecular complexes. TPR-containing proteins can bind 
a variety of ligands that mostly do not share sequence or secondary structure similarities. 
Therefore, it is suggested that this protein is either involved in protein targeting to the 
magnetosome either for transport into the organelle or complex assembly on the 
peripheral of the organelle. 
In previous work, MamK has been established as the actin-like protein forming filamentous 
structures used to string magnetosomes together (Komeili et al., 2006) with MamJ acting 
as a cross-linker between the filament and the organelles (Draper et al., 2011). Structural 
predictions analysed in this chapter suggest further proteins might be involved in these 
structures. Protein 4071 has predicted structural similarities to spectrin, a protein which is 
part of the membrane skeleton (Machnicka et al., 2014), and protein 4074 has predicted 
structural similarities with actin-binding proteins and peptidases, while the cross-linking 
protein, MamJ, showed predicted regulatory activity against such peptidases. Furthermore, 
MamF, and its homologue MmsF, were predicted to localise to the cytoskeleton, possibly 
playing a structural role. 
With respect to the biomineralisation process, surprisingly this approach did not identify 
three of the cytochrome c proteins (MamE, MamP and MamX) as involved in electron 
transport, only identifying MamT. Interestingly, the structural approach suggested MamN 
may be ŝŶǀŽůǀĞĚ ŝŶ ƚŚĞ ƉƌŽĐĞƐƐ ? dŚŝƐ ŝƐ ďĂĐŬĞĚ ƵƉ ďǇ Ă ȴmamN phenotype in M. 
gryphiswaldense, which shows magnetosome membrane biogenesis, but not crystal 
nucleation (Murat et al., 2010b). 
Another interesting finding is the high confidence prediction of MamU as a diacylglycerol 
kinase. This fits well with the protein not being necessary for organelle formation (Murat 
et al., 2010b), but still playing a role in its formation. The predicted product of the enzyme, 
phosphatidic acid (PA), has been proposed to play a role in membrane curvature, especially 
in membrane fission (Kooijman et al., 2003). Furthermore, phosphatidic acid is able to bind 
Fe2+ ions, which may assist in biomineralisation and redox control of the metal during the 
biomineralisation process. This is demonstrated by the ability of PA to protect against iron-
dependent oxidation (Dacaranhe and Terao, 2001). 
Overall, the bioinformatics approach provided interesting insights into magnetosome 
synthesis, allowing informed predictions to be made for proteins with unknown functions. 
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These predictions allow the development of further experiments to better understand the 
magnetosome biogenesis process. 
The construction of a plasmid library, containing all the individual genes (except for mamG, 
due to a frame shift mutation present in the template DNA) from the four MAI operons 
(mamGFDC, mms6, mamAB and mamXY), was achieved. Multiple mutations were observed 
in the cloned variants of the genes, when these were compared to the two available 
genomes (Table 4.4.). This can be explained by the observed high rate of mutations in the 
MAI (Kolinko et al., 2011), which may be due to the high metabolic demand for the 
generation of the organelles. This library allows the study of individual genes as well as 
combinatorial studies, since the plasmids can be easily combined into multi-gene 
constructs. 
The individual gene constructs were then analysed for protein production in E. coli BL21 
(DE3) Star cells. The proteins were produced using the T7 promoter, utilising a genome 
integrated T7 RNA polymerase expressed from a lactose promoter, a commonly used 
method for overproduction of proteins in E. coli. Interestingly, SDS-PAGE analysis showed 
only 7 out of 29 analysed proteins had observable overproduction (Table 4.8). In order to 
carry out a more sensitive, western blot analysis, new constructs with an immuno-sensitive 
tag were made as no antibodies are available for these proteins. An N-terminus hexa-
histidine tag was first used, which allowed identification of 10 out of 14 analysed proteins, 
with further 2 identified using a C-terminus hexa-histidine tag. Five proteins (MamJ, MamL, 
MamP, MamB and MamT) identified using this method had sizes which did not directly 
relate to the predicted protein size. For four of these proteins (MamL, MamP, MamB and 
MamT) this may be due to the membranous domains predicted to be part of the proteins. 
It has been reported, that proteins with hydrophobic domains can have abnormal 
migration during SDS-PAGE (Rath et al., 2009). Considering this abnormality for MamJ, it 
could be explained by the high proportion of the protein consisting of proline (10.3% of all 
amino-acids) as proteins rich in this amino-acid have been reported to have an abnormal 
migration (Boze et al., 2010). This may be due to the curvature induced by this amino-acid. 
Overall, these results suggest, that MAI proteins are produced, but at low levels and cannot 
be detected using standard SDS-PAGE procedures. Further analysis should be carried out 





Table 4.8. Overview of MAI protein production studies. 
Protein Operon TMHs Molecular Weight (kDa) 
Observable 
SDS-PAGE Western Blot 
MamG mamGFDC 2 7.72 N/A N/A 
MamF mamGFDC 3 12.34 - N/A 
MamD mamGFDC 1 30.26 - N/A 
MamC mamGFDC 2 12.43 - N/A 
4070 mms6 2 48.04 + N/A 
4071 mms6 1 36.38 + N/A 
MmsF mms6 3 13.78 - N/A 
Mms6 mms6 1 12.76 - N/A 
4074 mms6 0 9.73 - N/A 
MamH mamAB 12 45.67 - N/A 
MamI mamAB 2 7.16 - N/A 
MamE mamAB 1 78.05 - + 
MamJ mamAB 0 48.52 - +* 
MamK mamAB 0 39.20 + N/A 
MamL mamAB 2 8.59 - +* 
MamM mamAB 3 34.49 - + 
MamN mamAB 11 46.18 - - 
MamO mamAB 8 65.39 - - 
MamP mamAB 1 28.36 - +* 
MamA mamAB 0 24.01 + + 
MamQ mamAB 1 30.03 - + 
MamR mamAB 0 8.06 - + 
MamB mamAB 3 31.96 - +* 
MamS mamAB 1 18.72 + + 
MamT mamAB 1 18.89 - +* 
MamU mamAB 0 32.00 + + 
MamY mamXY 2 40.90 - N/A 
MamX mamXY 1 28.22 + N/A 
MamZ mamXY 18 70.55 - N/A 
FtsZ-like mamXY 0 32.33 - N/A 
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Multiple proteins suggested to be involved in the generation of the magnetic mineral within 
the organelle have cytochrome c domains (Figure 4.8). These domains contain a covalently 
attached heme group. It was decided to test if these are processed in E. coli BL21 (DE3) Star 
cells. Since the proteins are produced at low levels, investigation of truncated versions, 
which only contain the soluble domains, was carried in the hope that higher protein 
concentrations would be obtained. These domains contained the cytochrome c motif and 
showed higher levels of expression making them easier to analyse. In order to process the 
domain under aerobic growth, the protein had to be targeted to the periplasm and the 
cytochrome c maturation machinery had to be recombinantly produced. This is due to E. 
coli cells only producing this maturation machinery under anaerobic growth conditions, 
when specific terminal electron acceptors are present (Iobbi-Nivol et al., 1994). Our results 
show E. coli is able to correctly process 3 out of 4 of these cytochrome proteins (MamP, 
MamT and MamX). A functionalised MamE was not obtained, which may be due to high 
degradation of the protein (Figure 4.9). The observed degradation is likely due to a recently 
reported self-cleavage effect of the protein (Hershey et al., 2016b). Overall, these results 
show that growth conditions need to be taken in consideration if biomineralisation in 
recombinantly produced organelles is to be achieved. This could be related to the 
observations from the previous chapter, when the possible biomineralisation could only be 
observed under anaerobic growth, using nitrate as a terminal electron acceptor. 
In an attempt to produce recombinant magnetosomes, combinations of the single gene 
constructs were combined to represent each of the operons predicted to be involved in 
magnetosome generation. This was achieved for mms6 and mamYX operons. mamGFDC 
operon was also successfully reconstructed, but without mamG, as the gene contained a 
frame-shift mutation in the genomic DNA used as the template. This would suggest that 
MamG does not play a key role in the organelle generation process, which has been shown 
previously (Scheffel et al., 2008), and can be omitted for preliminary studies. 
Reconstruction of mamAB operon proved to be difficult, but using a variety of approaches, 
a large construct, representing 14 out of 17 genes encoded in the operon, was obtained. 
The three genes omitted (mamJ, mamK and mamU), have been shown to not be important 
in the membranous organelle formation (Murat et al., 2010a; Lohbe et al., 2016), two of 
which (mamJ and mamK) are involved in organisation of the organelle within the cell and 
one (mamU) has unknown accessory function (discussed previously). Notably, the most 
challenging steps, in reconstructing the mamAB operon, always included the ligation of a 
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construct containing mamE (data not shown), as often no transformants were observed 
when a ligation product for such a construct was transformed and if transformants were 
present, there were less compared to constructs which did not contain mamE. This may be 
due to the protease activity of MamE, which may have toxic effects in the cytoplasm of E. 
coli. Further efforts should be undertaken, to introduce mamU into the construct. Growth 
experiments and electron microscopy analysis should to be carried out on E. coli strains 
expressing the plasmid containing the partially reconstructed mamAB operon. 
Furthermore, expression of all the operons predicted to be involved in magnetosome 
generation needs to be achieved in a single strain of E. coli, either by integrating some of 
these operons into the genome, expressing from multiple plasmids or combining all the 
operons in a large construct as was done for vitamin-B12 synthesis. 
In conclusion, the work discussed in this chapter shows an analysis of a variety of proteins 
involved in magnetosome production focusing on their compatibility with the model 
organism, E. coli. The research suggests that the production of magnetosomes might be 
possible in the organism, but further work needs to be done to achieve this. The effects on 
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Until recently it has been thought that one of the defining features of prokaryotic 
organisms is a lack of cytoplasmic membranous organelles. As multiple membranous 
organelles have been discovered in prokaryotes so this view is changing (Saier and 
Bogdanov, 2013). These organelles include chromatophores, nuclear envelopes, 
magnetosomes, outer membrane vesicles (OMVs) and others. Furthermore, with the 
development of new bacterial culture approaches (Stewart, 2012) and analytical methods, 
such as cryo-electron tomography (Li and Jensen, 2009), more novel membranous 
structures are likely to be discovered. 
Membrane restructuring in eukaryotic cells have been studied extensively and a variety of 
mechanisms employed by these cells have been discovered (Prinz and Hinshaw, 2009). 
Even though no bacterial homologues of specialised membrane bending proteins, such as 
clathrin, have been discovered, most membrane restructuring proteins share similar 
motifs, which may not necessarily relate to sequence identity. One of the most common 
mechanisms for membrane restructuring is direct insertion of a protein into the lipid bilayer 
via an amphipathic domain, thereby increasing the area of one leaflet, causing the bilayer 
to bend. Therefore, proteins with a variety of other functions, that contain this domain, are 
able to have a drastic effect on the membranes. In other cases, simply having a specific 
shape allows membrane restructuring. A good example of this is the bacterial 
chromatophores where the shape of the light harvesting complexes has been shown to 
induce membrane curvature (Chandler et al., 2009). 
As discussed in the introduction, membrane restructuring during magnetosome formation 
is still not very well understood, although genetic studies have suggested the proteins 
involved. Four proteins (MamI, MamL, MamQ and MamB) from the mamAB operon have 
been shown to be necessary for the magnetosome membrane formation in M. magneticum 
(Murat et al., 2010a). A more recent study in M. gryphiswaldense suggests that a further 
three proteins (MamE, MamM and MamO) from the mamAB are also involved (Raschdorf 
et al., 2016). Neither of these studies looked at other proteins produced by the other 
operons (mamGFDC, mms6 and mamXY) involved in magnetosome formation. 
In order to better understand the biogenesis of magnetosome membranes it was decided 





5.2.1. Analysis of Proteins Involved in Magnetosome Membrane Formation 
In order to investigate if the potential magnetosome membrane protein had an effect on 
the E. coli cytoplasmic membrane, five proteins were selected for the study: MamI, MamL, 
MamQ, MamB and MamY. Their effects on the morphology of the bacterial inner 
membrane were analysed using a transmission electron microscopy approach. Briefly, a 
pET3a construct encoding each of the proteins (section 4.2.2) or an empty vector control 
were transformed into E. coli BL21 (DE3) Star cells, the cells were grown, harvested, fixed, 
embedded, sectioned, stained and imaged as described in materials and methods. Electron 
microscopy revealed that cells producing MamI, MamL or MamB showed no significantly 
phenotype compared to the control. Electron tomographs of E. coli BL21 (DE3) Star cells 
producing MamQ, MamY and the empty vector control are shown in Figure 5.1. A large 
proportion of cells producing MamY had electron light areas while MamQ producing cells 
showed a variety of phenotypes, often complex structures, which appeared to be 
membranous. It was decided to quantitate these effects by cell counting, where any 
deviation from a standard membrane structure was counted as a membranous phenotype. 
Overall, the proportion of cells showing such a phenotype were 56.2% for MamY and 48.9% 
for MamQ compared to 8.6% present in the control cells. The phenotype present in the 
control cells can be related to the chemical fixation process and is not comparable to the 
phenotype observed in the experimental strains. 
In order to test if the membranous structures observed were dependent on protein 
expression levels a new construct was made (pET3a.TBAD.MamQ) which utilises an 
arabinose promoter. The arabinose promoter is known to be a weak promoter compared 
to the T7 promoter. The phenotypes of E. coli BL21 (DE3) Star cells producing MamQ at four 
different levels (T7 promoter with no induction, T7 promoter with auto-induction (lower 
strength than IPTG, but over a longer period of time), T7 promoter with IPTG induction 
(positive control) or arabinose promoter with induction) were then compared. An empty 
plasmid vector was used as a negative control. Strains producing MamQ with no induction 
looked comparable to the negative control (Results not shown as identical to Figure 5.1 
 ‘ĐŽŶƚƌŽů ?ĐŽůƵŵŶ ) ?WŽƐŝƚŝǀĞĐŽŶƚƌŽů samples looked similar as before, with a large variety of 
different membranous phenotypes (Results not shown as identical to Figure 5.1  ‘DĂŵY ?
column). When expressed using auto-induction (Figure 5.2) or arabinose induction (Figure 
99 
 
5.3) methods, the cells produced more consistent phenotypes. No complex cellular 
membranous structures were observed, instead membranous invaginations, which were 
more defined when using the arabinose promoter, were present. Furthermore, when using 
the arabinose method, no more than one of these invaginations were present in the cell, 
as opposed to the multiple invaginations observed using the auto or IPTG induction 
approaches. Overall, the proportion of cells showing a membranous phenotype were 63.9% 




   
   
   
Figure 5.1. TEM of E. coli expressing mamQ or mamY. 
Transmission electron micrographs of sectioned E.coli BL21 (DE3) Star cells harbouring an 
empty control vector, or a vector encoding MamQ or MamY. Red arrows  ? points of interest. 





   
Figure 5.2. TEM of E. coli expressing mamQ using the auto-induction method. 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells producing MamQ 




   
Figure 5.3. TEM of E. coli expressing mamQ from an arabinose promoter. 
Transmission electron micrographs of sectioned E.coli BL21 (DE3) Star cells producing MamQ 




Cells producing just the soluble domain of MamQ (amino-acids 73-272) were also analysed. 
These cells had no membranous phenotype although a high proportion of cells contained 




5.2.2. Analysis of MamQ in Combination With Other MAI Proteins 
As cells producing MamQ showed a strong membranous phenotype, its effect in 
combination with other proteins predicted to affect the membrane was investigated. A 
variety of constructs, using the method discussed in section 4.2.6, containing different 
combinations of the predicted membrane restructuring proteins, were made (Table 5.1). 
 
Table 5.1. Multi-gene constructs analysed by electron microscopy. 
Operon Construct Genes (in construct order) 
mamAB pET3a.IQ mamI, mamQ 
mamAB pET3a.LQ mamL, mamQ 
mamAB pET3a.QB mamQ, mamB 
mamAB pET3a.ILQ mamI, mamL, mamQ 
mamAB pET3a.LQB mamL, mamQ, mamB 
mamAB pET3a.IQB mamI, mamQ, mamB 
mamAB pET3a.ILQB mamI, mamL, mamQ, mamB 
mamAB/mamXY pET3a.IQBY mamI, mamQ, mamB, mamY 
mamAB/mamXY pET3a.LQBY mamL, mamQ, mamB, mamY 




The constructs were then analysed by electron microscopy as discussed above. Strains 
expressing constructs containing two (Figure 5.4), three (Figure 5.5), four or five (Figure 
5.6) genes varied in their phenotype. No strong phenotype was observed when pET3a.IQBY 
or pET3a.LQBY were expressed. 
As when MamQ was produced on its own using IPTG induction, so did the MamLQ 
producing cells also showed a variety of membranous phenotypes, including complex 
structures (Figure 5.4). These structures differed when MamIQ was expressed, showing 
more extreme membrane curvature. On the other hand, MamQB expression gave a result 
that was more similar to the auto-induction method although no complex membranous 
structures were observed, but overall the inner membrane of the cells appeared to be 
curved into the cytoplasm in multiple places throughout the cell. The proportion of cells 
showing a membranous phenotype were 39.3% for MamLQ, 48.2% for MamIQ and 44.1% 
for MamQB. 
When the three gene constructs were expressed, increased structure could be observed in 
the membranous invaginations (Figure 5.5). For MamILQ and MamLQB, complex 
102 
 
membranous structures were once again observed, but these appeared more structured, 
showing less variability between the cells. These structures in MamILQ were single-
membrane and separated, as opposed to multi-layer structures observed for MamQ, 
MamLQ or MamLQB. When MamIQB was produced, small vesicular structures could be 
observed within the cells, sometimes containing multiple membranes. Furthermore, small 
inclusions could be observed. The proportion of cells showing a membranous phenotype 
were 51.5% for MamILQ and 39.9% for MamLQB. 
Surprisingly, the four gene constructs, MamIQBY and MamLQBY, did not show any specific 
phenotype, while MamILQB appeared similar to MamIQB, where defined membranous 
vesicles could be observed within the cell (Figure 5.6). Small inclusions could also be 
observed. The proportion of cells showing a membranous phenotype were 34.2%. 
The largest analysed construct, MamILQBY, showed a phenotype similar to MamIQB and 
MamILQB, where membranous vesicles could be observed, although the number of these 
was increased. Furthermore, no inclusions could be observed. The proportion of cells 
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Figure 5.4.  TEM of E. coli expressing double gene constructs. 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells expressing 
pET3a.IQ (MamIQ), pET3a.LQ (MamLQ) or pET3a.QB (MamQB). Red arrows  ? points of 
interest. Scale bars: MamIQ and MamLQ is 0.1µm and MamQB is 0.5µm. 
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Figure 5.5. TEM of E. coli expressing triple gene constructs. 
Transmission electron micrographs of sectioned E.coli BL21 (DE3) Star cells expressing 
pET3a.ILQ (MamILQ), pET3a.LQB (MamLQB) or pET3a.IQB (MamIQB). Red arrows  ? points of 
interest, black arrows  ? inclusion bodies. Scale bars: MamILQ and MamLQB is 0.5µm and 







Figure 5.6. TEM of E. coli expressing constructs containing mamILQB or mamILQBY. 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells expressing pET3a.ILQB 
(MamILQB) or pET3a.LQB (MamILQBY). Red arrows  ? points of interest, black arrows  ? inclusion 




5.2.3.  Proteins Related to MamQ 
MamQ is a member of the LemA family of proteins, which have no characterised function. 
Based on Interpro (http://www.ebi.ac.uk/interpro/) there are currently 6604 proteins, 
including an additional 120 proteins from metagenomes, within the LemA family, the 
majority of which, 6500, are from bacterial genomes (98 archaeal, 5 eukaryotic and 1 viral). 
Furthermore, they are wide-spread and present in both Gram-positive and Gram-negative 
bacteria. 
A LemA protein was first characterised in 1996 (Lenz et al., 1996) as an H2-M3-restricted 
Listeria epitope. Based on sequence, the suggested role at the time was signalling. There is 
one solved structure of the soluble domain of a LemA-family protein, TM1634 from 
Thermatoga maritima MSB8 (PDB entry: 2ETD), showing a coiled-coil structure. There is no 
analysis of the structure available to date. 
Four different LemA proteins were chosen for comparison with MamQ (Table 5.2). These 
were selected from non-related bacteria (Figure 5.7). TMHMM2 and SignalP 4.1 was used 
to predict protein topology/targeting as before. No targeting sequence was identified for 
any of the proteins and all of them contained a single TMH. All the selected proteins were 
cloned into a pET3a vector in the NdeI/SpeI site, as before (Section 4.2.2). 
Table 5.2. LemA proteins chosen for analysis.   
Name Organism NCBI Accession  Molecular 
Weight (kDa) 




ADF40219 21.81 1 Periplasmic 
LemA.159 Clostridium kluyveri WP_012102790 21.08 1 Periplasmic 
LemA.501 Brucella melitensis WP_006264043 23.24 1 Cytoplasmic 
LemA.565 Pseudomonas 
aeruginosa 




Figure 5.7. Phylogeny tree of the chosen organisms. 
Phylogeny tree of organism which LemA proteins were selected for and their relationship to 




5.2.4. Bioinformatic Analysis of LemA Proteins 
Clustal Omega (Sievers et al., 2011) multiple sequence alignment program was used to 
compare 52 different proteins from the LemA family (Figure 5.8). The results identified 4 
distinct groups, which were analysed for common features in their operon structure 
(Supplemental figure 2). The data collected is analysed in the discussion section. 
5.2.5. Expression and SDS-PAGE Analysis of Individual LemA Proteins 
In order to compare the over-expression levels of individual LemA proteins in E. coli to 
MamQ, all the constructs were individually transformed into E. coli BL21 (DE3) Star cells. 
These were then grown, induced and harvested as described in the materials and methods. 
E. coli BL21 (DE3) Star cells harbouring an empty pET3a vector was used as a control. The 
resulting whole cell, soluble and insoluble fractions were analysed using SDS-PAGE (Figure 
5.9). As with MamQ, no clear over-production could be observed for the LemA proteins 
analysed. Analysis of LemA.159 showed a stronger band just above 22kDa both in whole 
cell and the insoluble fraction. This may be the protein of interest, as it was later observed 







Figure 5.8. Clustal Omega analysis of LemA proteins.  indicate studied proteins 







Figure 5.9. SDS-PAGE analysis of E.coli expressing different lemA genes. 
E. coli BL21 (DE3) Star expressing different lemA genes or a control vector. 3a is empty vector 
control; 153 is LemA.153; 159 is LemA.159; 501 is LemA.501; 565 is LemA.565; Q is MamQ. Red 





5.2.6. Electron Microscopy Analysis of LemA Proteins 
The different LemA producing cells were analysed by electron microscopy as described 
previously (Section 5.2.1). Cells harbouring an empty vector were used as a control. A 
variety of membranous phenotypes were observed in the cells expressing the different 
LemA gene variants (Figure 5.10 and Figure 5.11). The effect of the membrane was 
quantified by cell counting in the sections, treating any deviation from standard 
membrane as a membranous phenotype (Table 5.3).  
Depending on the LemA protein produced a range of phenotypes were observed. These 
were defined as: LemA.153 - large (>200 nm) and smaller (<200 nm) membranous 
vesicles, membranous ruffles and small inclusions (Figure 5.10); LemA.159 - small (<100 
nm) membranous vesicles and large inclusions (Figure 5.10); LemA.501 - membranous 





Table 5.3. Quantification of LemA phenotype. 
Quantitative electron microscopy analysis of thin-sectioned E. coli expressing 
different lemA variants.  
Sample Total Count Cells with a Membranous Phenotype Percentage 
Control 175 15 8.6 % 
mamQ 468 229 48.9 % 
lemA.153 568 303 53.3 % 
lemA.159 400 266 66.5 % 
lemA.501 670 488 72.8 % 










Figure 5.10. TEM of E. coli expressing constructs containing lemA.153 or lemA.159. 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells expressing 
pET3a.LemA.153 (LemA.153) or pET3a.LemA.159 (LemA.159). Red arrows  ? points of interest, 








Figure 5.11. TEM of E. coli expressing constructs containing lemA.501 or lemA.565. 
Electron micrographs of sectioned E.coli BL21 (DE3) Star cells expressing pET3a.LemA.501 
(LemA.501) or pET3a.LemA.565 (LemA.565). Red arrows  ? points of interest, black arrows  ? 




5.2.7. Targeting LemA Proteins to the Outer Membrane 
As LemA proteins had such a strong effect on the inner-membrane it was of interest to 
know what would happen if these proteins were targeted to the outer-membrane. Outer-
membrane proteins are either beta-barrel transmembrane proteins or attached via a lipid 
modification. To achieve this, the soluble domain of different LemA proteins were fused to 
an outer-membrane targeting sequence from BamE (the first 21 amino-acids), an outer-
membrane lipoprotein, which is part of the outer membrane protein assembly complex 
(Table 5.4). A construct containing an outer-membrane targeted red fluorescent protein 
(RFP) was also made to be used as a control. 
 
The construction of the outer membrane targeting peptide was achieved by first cloning a 
fragment of synthesised DNA, corresponding to the BamE tag (AseI/SpeI segment), into a 
pET3a vector (NdeI/SpeI site). The tag was designed to have an in-frame NdeI ƐŝƚĞĂƚƚŚĞ ? ?
end of the coding sequence. This site together with the SpeI site (NdeI/SpeI site) was used 
to clone the soluble domains of LemA proteins (including MamQ) and the RFP control from 
PCR products (NdeI/SpeI segments). 
Cells expressing the different constructs were then analysed by electron microscopy as 
discussed previously (Section 5.2.1). Controls for the experiment included cells expressing 
an empty vector, the outer-membrane tag on its own (pET3a.BamE*) and an outer-
membrane targeted RFP (pET3a.BamE*RFP). Apart from pET3a.BamE*LemA.159s, which 
showed high aggregation, an increase in outer membrane vesicle (OMV) formation was 
observed for all constructs expressing an outer-membrane tagged protein (Figure 5.12, 
Figure 5.13 and Figure 5.14). Cells expressing pET3a.BamE*LemA.153s appeared to have 
vesicles originating from the inner membrane into the periplasm, as they had similar 
electron density and structure to the cytoplasm. Furthermore, based on the construct, 
Table 5.4. Constructs used for outer-membrane targeting experiments. 
Protein Domain (amino acids) Construct 
Predicted size (kDa) 
Expressed Cleaved 
- - pET3a.BamE* 4.87 2.95 
RFP N/A pET3a.BamE*RFP 27.67 25.75 
LemA.153 36-161 pET3a.BamE*LemA.153s 20.43 18.51 
LemA.159 30-187 pET3a.BamE*LemA.159s 20.12 18.20 
LemA.501 38-207 pET3a.BamE*LemA.501s 21.70 19.78 
LemA.565 28-190 pET3a.BamE*LemA.565s 20.53 18.61 
MamQ 73-272 pET3a.BamE*MamQs 24.39 22.48 
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these vesicles seemed to differ in size. A large proportion of cells, expressing 
pET3a.BamE*LemA.501s and pET3a.BamE*LemA.565s, appeared lysed, with a variety of 
intact membranous structures present within the section (Figure 5.15). All tested strains, 
apart from the empty vector control, showed different levels of protein aggregation. 
Quantification of outer membrane vesicles undergoing formation (membranous 
invagination that are visibly still attached to the outer membrane) and aggregation is 
shown in Figure 5.16 and protein production analysis is shown in Figure 5.17. Interestingly, 
cells producing BamE*RFP showed the highest levels of inclusion formation and OMV 
production. No protein overproduction could be observed using the SDS-PAGE method, 
which may be due to the OMVs not being pelleted with the cells during the centrifugation 
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Figure 5.12. TEM of E. coli producing outer membrane targeted proteins (1 of 4). 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells expressing 
pET3a.BamE* (BamE*), pET3a.BamE*RFP (BamE*RFP) or pET3a.BamE*MamQs 










Figure 5.13. TEM of E. coli producing outer membrane targeted proteins (2 of 4). 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells expressing 
pET3a.BamE*LemA.153s (BamE*LemA.153s) or pET3a.BamE*LemA.159s (BamE*LemA.159s). 









Figure 5.14. TEM of E. coli producing outer membrane targeted proteins (3 of 4). 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells expressing 
pET3a.BamE*LemA.501s (BamE*LemA.501s) or pET3a.BamE*LemA.565s (BamE*LemA.565s). 








Figure 5.15. TEM of E. coli producing outer membrane targeted proteins (4 of 4). 
Transmission electron micrographs of sectioned E. coli BL21 (DE3) Star cells expressing 
pET3a.BamE*LemA.565s (BamE*LemA.565s) or pET3a.BamE*MamQs (BamE*MamQs). Red 





Figure 5.16. Quantification of the phenotypes produced by outer membrane targeted 
proteins. 
Quantification of phenotypes observed in strains producing proteins targetted to the periplasm 


































Figure 5.17. SDS-PAGE analysis of E.coli producing different outer membrane targeted 
proteins. 
SDS-PAGE analysis of E. coli BL21 (DE3) Star cells expressing different proteins tagged with the 
BamE outer-membrane targeting sequence. 3a is empty vector control; E is BamE*; ER is 
BamE*RFP; E153 is BamE*LemA.153s; E159 is BamE*LemA.159s; E501 is BamE*LemA.501s; 





In this chapter, the effects on the morphology of E. coli membrane by different 
magnetosome proteins and their combinations are shown. The information collected 
allowed identification of the LemA protein family as a potential membrane restructuring 
group of proteins, which was confirmed for the four tested members from different 
organisms. Finally, when an outer-membrane targeting sequence was attached to the 
soluble domains of these membrane restructuring proteins enhanced OMV formation was 
observed, although this was also observed when a RFP was targeted using the same tag. A 
large proportion of cells producing these tagged variants of the proteins also contained 
inclusion bodies. 
Initially, the aim of the research was to characterise the effects of the predicted membrane 
restructuring proteins from the MAI (MamI, MamL, MamQ, MamB and MamY), that had 
been previously shown to be necessary or involved in magnetosome membrane formation 
(Murat et al., 2010a; Tanaka et al., 2010; Lohbe et al., 2016). Furthermore, from the four 
operons involved in magnetosome biosynthesis in the MAI, only the mamAB operon was 
shown to be necessary for magnetosome membrane formation (Lohbe et al., 2011; 
Raschdorf et al., 2016). These results suggest that the four proteins from the mamAB 
operon (MamI, MamL, MamQ and MamB) are, at least to some extent, involved in 
magnetosome membrane biogenesis. Furthermore, a protein from the mamXY operon, 
MamY, was shown to induce liposome tubulation (Tanaka et al., 2010). Because of a more 
general interest in generating membranous compartments in E. coli, it was decided to first 
study the individual effects of these proteins on the cells. Two of these proteins, MamQ 
and MamY, had observable phenotypic effects on the cellular membrane. Interestingly, no 
membrane tubulation was observed when MamY was overproduced, but small vesicular 
structures were visible. When MamQ was overproduced a variety of membranous 
phenotypes were observed, ranging from membranous invaginations to a variety of poly-
membranous structures. By producing this protein at lower levels, the cells showed a more 
conserved phenotype, which was a singular membranous invagination of the inner 
membrane. Since the only analysed protein from the mamAB operon, which is the only 
operon necessary for magnetosome formation, that showed a strong effect on the inner 
membrane was MamQ, the protein is suggested to play an important role in the initiation 
of the organelle formation. 
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When MamQ was co-produced with the other proteins suggested to be necessary for 
magnetosome membrane formation, different membranous structures were observed. As 
more of these proteins were produced together, more defined, vesicular, structures were 
seen. These results provide evidence that all of these proteins are involved in 
magnetosome membrane formation, as the phenotype observed changes when different 
combinations of these proteins are produced. Further experiments need to be carried out, 
such as incorporating MamE, MamM and MamO in the combinatorial experiments, as 
these proteins have been recently shown to be required for magnetosome membrane 
formation (Raschdorf et al., 2016). 
As MamQ had a strong effect on the membrane of E. coli it was logical to look for related 
proteins in an attempt to identify other membrane restructuring proteins. Protein 
sequence analysis revealed that MamQ is part of a large family of proteins called the LemA 
family. The first analysis of a LemA protein was carried out by Lenz et al. (Lenz et al., 1996) 
and at the time it was suggested to be involved in a signalling pathway. Four different LemA 
family proteins were chosen from a variety of organisms. 
A bioinformatics analysis was carried out in order to try to understand the function of the 
proteins better. A total of 52 different LemA family proteins were compared not only for 
their amino-acid sequence, but also for similarities in their operon structures. Four distinct 
groups were identified based on their amino acid sequence (Figure 5.8). Group 1, which 
contained MamQ (  mamQ) and LemA.159 (  CKL_2444), had no similarity in their operon 
structure. Group 2, which was the biggest group, contained LemA.153 (  BMEA_A1872) 
and LemA.501 (  BcellWH2_04127). Members of this group were always found in one 
operon with one or two members of the TPM_Phosphatase family proteins and is discussed 
further below. Group 3, which contained LemA.565 (  PA1S_23740), were often (4 
members out of 9) found in an operon with a peptidase. This group was specific to gram-
negative organisms. Members of group 4, which contained none of the proteins reported 
in this study, were always found in one operon with a member of the Peptidase_M48 or 
Peptidase_M56 family. Furthermore, group 4 proteins were only found in Gram-positive 
organisms. 
Group 2 proteins appeared always to be co-expressed with a TPM_Phosphatase family 
protein. The first TPM_Phosphatase (TLP18.3) was initially characterised in the thylakoids 
of Arabidopsis thaliana (Sirpiö et al., 2007) with further structural and biochemical 
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experiments carried out by Wu et al. (Wu et al., 2011). These studies showed that the 
protein localises to the thylakoid membrane with no further specific localisation and that 
the protein is up-regulated during high-light stress and is a phosphatase with a variety of 
substrates. A similar protein was discovered in Synechocystis 6803 and was suggested to 
be conserved in all thylakoid-containing cyanobacteria (Wegener et al., 2011). The studies 
conclude, that the protein is likely to be involved in the repair of photosystem II in the 
thylakoids. Our bioinformatics analysis showed that not all organisms containing this family 
member express a photosynthetic system, which suggests a different function either in the 
organisms, or altogether. Regarding the proteins co-expression with LemA proteins, the 
TPM_Phosphatases localise to the highly-curved membrane structures of thylakoids and 
are over-expressed during high-light stress. Recently, it has been discovered that thylakoid 
membranes undergo morphological changes during such stress (Fristedt et al., 2009 and 
Herbastova et al., 2012) and it would be un-wise to rule out the involvement of the 
TPM_Phosphatase in this change, as the phosphatase could act on the phospholipid bilayer 
itself. It is also worth noting that at least one of the TPM_Phosphatases co-expressed with 
group 2 LemA family proteins contain a hydrophobic glycine-rich C-terminus domain, which 
is not predicted to form a transmembrane helix (in the cases of 2 copies of 
TPM_Phosphatases co-expressed with LemA, only one of them contained this motif). Such 
domains have been showed to be involved in RNA binding (Burd and Dreyfuss, 1994), but 
the highly hydrophobic domain might be interacting with the phospholipid bi-layer in an as 
of yet uncharacterised manner, possibly inducing curvature. 
Group 3 and group 4 members are often co-expressed with peptidases. These identified 
peptidases were from the Peptidase_M48 and/or Peptidase_M56 families, which have high 
similarity, and are often identified as HtpX (11/13 from the identified peptidases). This 
peptidase has been showed to be involved in cellular-stress response (Sakoh et al., 2005) 
while other members from these families have been shown to be involved in cellular-stress 
signalling (Zhang et al., 2001). HtpX has been shown to work in conjunction with FtsH in the 
maintenance of membranous proteins in E. coli (Sakoh et al., 2005). Five of the analysed 
LemA proteins, localised in these groups, had a periplasmic N-terminus belonging to the 
FtsH_ext (N-terminus) family. This domain has been shown to be involved in protein-
protein interactions, both with itself and with other proteins (Akiyama, 1998), suggesting 




Overall, the operon analysis suggests LemA proteins to be involved in cell-signalling or 
membrane protein maintenance. Nevertheless, the lack of consistency in the operons and 
the missing knowledge about the co-expressed proteins leaves the functions of LemA 
proteins up for debate. 
Production of different LemA proteins in E. coli BL21 (DE3) Star cells yielded similar results 
to the production of MamQ (Figure 5.9). No protein overproduction could be observed by 
SDS-PAGE analysis, but when electron microscopy analysis of the cells producing the 
different proteins was carried out, a variety of membranous phenotypes could be 
observed, which varied based on the family member produced. This suggest that the 
proteins are likely to play different biological roles, as they would localise to different 
membrane curvature. 
As the observed effects were all on the inner-membrane of E. coli, it was of interest to 
investigate how the cells would behave if these proteins were targeted to the outer-
membrane. To achieve this, the outer-membrane targeting sequence (the first 21 amino-
acids) of an outer-membrane lipoprotein, BamE, was fused to the soluble domains of the 
LemA proteins and an RFP, as a negative control. As with MamQ and wild-type LemA 
proteins, no overproduction could be observed by SDS-PAGE analysis. All the hybrids, apart 
from the BamE*LemA.159s, showed significantly increased OMV formation. Interestingly, 
the BamE*RFP hybrid showed the largest amount of OMV formation, suggesting that the 
overproduction of any protein targeted to the outer membrane can enhance this process. 
A large proportion of lysed cells as well as cells with large OMVs were also observed when 
BamE*LemA.565s or BamE*MamQs was produced. The increase in size of the vesicles may 
be the effect of the membrane restructuring by these proteins and the cell lysis can be 
explained by the decrease in outer-membrane rigidity due to vesiculation, leading to 
compromised cellular integrity. Questions still remain on how the production of these 
proteins impact the cellular growth. Furthermore, a detailed characterisation of the 
produced vesicles needs to be carried out. 
Overall, the production of the magnetosome proteins, MamQ and MamY, seems to have 
an effect on the E. coli inner membrane. When combined with other magnetosome 
proteins this effect can be varied. Furthermore, MamQ belongs to a large family of proteins, 
which are able to restructure the bacterial membrane in a variety of ways. It was discovered 
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The results presented in this thesis reveal a variety of engineered membranous structures 
in the model organism Escherichia coli. These include a reconstructed recombinant 
magnetosome, a magnetosome membrane only and other inner or outer membranous 
structures. 
Firstly, in order to produce a recombinant magnetosome, a construct containing the wild-
type mamAB operon, was made. The initial approach of amplifying the whole operon using 
a long range DNA polymerase system from RocheTM yielded no product. This was surprising 
as the size of the operon is well within the amplification range of the system, but even after 
incorporating a number of troubleshooting approaches, no product was ever obtained. An 
alternative approach was then designed, which relies on amplifying the operon in two large 
segments. Interestingly, it was quite difficult to obtain any product even when the amplicon 
size was reduced to about 9 kilobases for each of the fragments. A large amount of time 
was spent on optimisation and even then the product yield was inconsistent, which may be 
due to the poor quality of the template DNA. Alternatively, the manufacturers of the kit 
may have over-stated the ability of the polymerase. Once the two fragments were 
combined, DNA sequencing revealed a frame-shift mutation in one of the key genes, mamE. 
It is known that frequent mutations occur in the genomic region where the mamAB operon 
is localised (Kolinko et al., 2011). It was decided to try to fix this mutation using a small PCR 
fragment containing this region. Unfortunately, no colonies were observed after multiple 
attempts to transform the ligation (data not shown). 
At the time of this research little information was available on MamE, therefore it was 
decided to conduct growth experiments using the construct with the frame-shift mutation. 
Interestingly, small electron dense particles, which often appeared to be intracellular, could 
be observed when strains harbouring this construct were grown under conditions used to 
culture two different Magnetospirillum species, which naturally produce magnetosomes. 
Similar structures were present in the control, but at a lower frequency. When an additional 
operon, mms6, was introduced into the construct a small proportion of cells produced 
particles which had the appearance of magnetosomes, although no magnetic response was 
observed. Significantly, such structures were not present in the control, although small 
electron dense particles were observed. The presence of non-magnetic electron dense 
particles similar to magnetosomes could be explained by the phenotype observed in M. 
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magneticum cells, expressing different mutated versions of MamE (Quinlan et al., 2011). 
The work showed that the MamE protease and magnetochrome domains are not necessary 
for biomineralisation to take place, but the produced minerals were smaller and showed 
no magnetic response. It is possible that the electron dense particles observed in the cells 
expressing the mms6 operon and the mamAB operon, with the mutated mamE, are non-
magnetic iron crystals within pseudo-magnetosomes. If that is the case, the N-terminal 
domain of MamE might act as a hub for protein complex assembly, allowing localisation of 
other factors involved in magnetosome assembly. 
In order to see if individual magnetosome proteins are produced in E. coli, constructs 
corresponding to each of these, apart for MamG, were made. In the case of MamG the 
genomic DNA used as the template had a frame-shift mutation in the sequence of mamG 
confirmed by sequencing. Further analysis of this protein was not carried out as it has been 
shown not to be required for magnetosome synthesis and the production of other proteins 
from the mamGFDC operon can rescue ƚŚĞ ƉŚĞŶŽƚǇƉĞ ƉƌŽĚƵĐĞĚ ďǇ ȴmamG strains 
(Scheffel et al., 2008). When the constructs were expressed in E. coli BL21 (DE3) Star cells, 
over-production was only observable for 7 out of the 29 gene products when analysed by 
SDS-PAGE. This suggests low or no production of these proteins. This is not surprising as 
most of these proteins are membrane proteins, which usually require extensive 
optimisation in order to obtain detectable overproduction (Freigassner et al, 2009). When 
some of these proteins were analysed by western blotting, identification of 12 out of 14 
proteins was achieved. Two of the proteins which were not identified, MamN and MamO, 
both have an N-terminus transmembrane helix. This helix may have been compromised by 
the recombinant addition of the N-terminus hexa-histidine tag, which was used as the 
antigen for western blotting. Interestingly, multiple analysed proteins showed a variation 
in the molecular weight observed by SDS-PAGE when compared to their predicted weight. 
This may be due to protein degradation or the binding of detergent molecules via the 
hydrophobic domains, thereby obscuring their migration in the gel, as observed previously 
(Rath et al., 2009). It is suggested that these bands are analysed using a peptide mass 
fingerprinting approach to identify any degradation. Furthermore, some of the proteins are 
relatively small (under 10 kDa) and migrate close to the dye front of the gels. In order to 
resolve these proteins a different SDS-PAGE approach should be employed. 
Cytochrome c proteins have been shown to be involved in the production of 
magnetosomes (Siponen et al., 2013; Lohbe et al., 2016). In this work, the production of 
129 
 
three cytochrome c proteins, involved in magnetosomes formation, and their maturation 
in the periplasm of E. coli is shown. The experiments identify the importance of specific 
growth conditions required for magnetosome production in this model organism, as the 
correct processing of these domains can only be achieved under specific growth conditions 
or when accessory proteins are co-expressed recombinantly. This represents the special 
requirements to encourage the formation of a covalent bond between a cysteine residue 
and the vinyl side chain of the porphyrin molecule. 
When generating synthetic multi-gene operons, it was found that constructs containing 
mamE had very poor transformation efficiencies. When a pET3a vector was used, the 
largest combination of genes from the mamAB operon that could be combined into a single 
construct was 10, which was reduced to only 4 when mamE was present. This might explain 
why it was not possible to correct the mutation in mamE present in the mamAB construct 
(Chapter 2). These limitations could be partially overcome by a switch to the pETcoco2 
cloning system, which has a significantly lower copy number and a more tightly regulated 
promoter. Constructs containing mamE still had lower transformation efficiencies, but 
transformants could be obtained. It was possible to reconstruct the desired modified 
mamAB operon, containing all the genes, except for mamJ, mamK and mamU. 
Unfortunately, due to time limitations and difficulties transforming this plasmid into a 
strain with a T7 polymerase, growth experiments of cells producing the construct have not 
been carried out. 
Production of one of two individual magnetosome proteins (MamY or MamQ), suggested 
to be involved in membrane vesicle generation, showed an effect on the inner membrane 
of E. coli. Cells producing MamY appeared to have small vesicular structures, while cells 
producing MamQ, had a variety of phenotypes, which varied based on the production level. 
It is important to note that the analysed cells had undergone chemical fixation. Such 
fixation may introduced various artefacts. Therefore, a control sample and quantification 
of the phenotype was critical during these experiments. The results show that the effect 
on the membrane is based on the protein production and not the fixation method. 
Furthermore, when additional proteins implemented in magnetosome membrane 
formation were introduced, more defined structures were observed. It is suggested that 
other electron microscopy sample preparation methods, such as cryofixation, should be 
used to observe these structures in a more native state. It would also be informative to 
carry out electron tomography experiments to better define the observed structures. 
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Interestingly, when SDS-PAGE analysis was carried out for strains producing MamQ or 
MamY, no clear overproduction was observed. Similar membranous structures to those 
observed when MamQ was produced, have been reported when the b subunit of F1Fo ATP 
synthase was produced, although in this research clear overproduction of the protein is 
observed by SDS-PAGE analysis (Arechaga et al., 2000). This suggests that comparatively 
small amounts of MamQ are required to illicit the drastic changes in membrane structure 
observed, which points to a membrane bending mechanism not dependent on scaffolding 
or direct bending dependant on the shape of the membrane protein (McMahon and Gallop, 
2005). During the bioinformatics analysis, MamQ was predicted to carry out fatty acid 
oxidation. It is known that phospholipids, containing oxidised fatty acid side-chains, induce 
membrane curvature (McMahon and Gallop, 2005). A large amount of such fatty acid side-
chains incorporated into the phospholipid bilayer would explain the phenotypes observed 
when MamQ is produced. It is therefore suggested that the analysis of the lipid content of 
these cells is carried out and compared to that of wild-type cells. 
When other proteins, belonging to the same protein family as MamQ, were produced in E. 
coli, a variety of membranous phenotypes were also observed. Interestingly, these varied 
quite drastically, suggesting different functions for these proteins in their native 
environments. As suggested above, it would be informative to carry out lipid analysis of the 
strains producing these proteins as well as use a variety of alternative electron microscopy 
approaches to analyse the structures produced by these proteins. 
While attempting to target membrane restructuring proteins to the outer membrane, it 
was discovered that the overproduction of any of the tested targeted proteins (including 
RFP) induced OMV production in E. coli. Purification of these vesicles should be carried out 
to investigate if the targeted proteins are incorporated into the vesicles. Furthermore, the 
vesicle production enhancement should be tested for a variety of other proteins with 
different targeting sequences, as only six different proteins with one targeting sequence 
were used in the experiments reported herein. 
Production of various membranous structures in bacteria, as shown in this work, could have 
a number of biotechnological applications (Figure 6.1). Cytoplasmic membranous 
compartments could be used as a basis for synthetic organelles for mammalian-like protein 
modifications, as nanobioreactors, in order to enhance synthetic pathway flux or to protect 
the cell from toxic intermediates, or to improve the energy generation potential of the 
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bacteria by employing these as synthetic mitochondria-like organelles. Poly-membrane 
bodies, which are observed when MamQ is produced, could be used to enhance the 
membrane surface area. This might result in greater production of membranous proteins 
and enhanced phospholipid production. OMVs have been used as vaccines for over 20 
years (Acevedo et al., 2014). Such vesicles are highly immunogenic and are excellent 
carriers for vaccines. Engineering an in vivo system, able to produce high amount of such 
vesicles with specific protein incorporation, might allow for the generation of efficient, low 
price vaccines. The work discussed, shows a potential for such a system in E. coli, whereby 
overproduction of a protein, targeted to the outer membrane via a specific tag, can induce 
the formation of such vesicles. These could then be purified and used as potent vaccines, 
due to their native immunogenicity and the ability to carry a specialised cargo. Other 
potential applications of OMVs could be the incorporation of biotechnologically relevant 
pathways. This could potentially increase the flux of the pathways due to close proximity 
within the OMV, protect the cell from any toxic intermediates produced as well as 
sequester the product and any intermediates from potential degradation within the cell 
and increase the substrate availability, as only transport through a single membrane would 
be required. Furthermore, as it is possible to modify the outside of the outer membrane 
(Rice et al., 2006), such vesicles could be functionalised on the outside to be used for 
targeted drug delivery or protein purification. However, an important question still remains 
regarding the efficiency of incorporation of the targeted proteins into these vesicles and 
could be a basis for future work. 
 
 
Figure 6.1. Possible application for various membranous structures. 





The work discussed contributes to the growing field of synthetic biology exploring a new 
avenue of membrane engineering in bacteria. A full genetic library of the genes, involved 
in magnetosome formation, was constructed for analysis in E. coli. These were then 
combined in a modular manner to produce synthetic operons involved in the synthesis of 
the organelle. This approach allows for easy modification of the genes contained in the 
constructs for further research into and engineering of the membranous organelle. Analysis 
of the individual genes led to the identification of a suggested membrane restructuring 
protein family. Attempts to utilise this protein family for modifying the outer membrane 
resulted in the discovery of a novel method for increased OMV production. Membranous 
structures produced by these approaches expand the capabilities for cellular engineering, 
allowing for new pathways, which may depend on membranous proteins, to be produced 
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Supplementary Table 1. CAI of MAI genes from M. gryphiswaldense in E. coli. 
Gene Length (bp) CAI 
4070 1350 0.599 
4071 1044 0.605 
mmsF 375 0.634 
mms6 411 0.600 
4074 396 0.570 
mamG 255 0.576 
mamF 336 0.762 
mamD 945 0.648 
mamC 378 0.662 
mamH 1287 0.633 
mamI 264 0.672 
mamE 2319 0.663 
mamJ 1281 0.646 
mamK 1044 0.706 
mamL 372 0.656 
mamM 957 0.707 
mamN 1170 0.680 
mamO 1899 0.653 
mamP 813 0.664 
mamA 654 0.700 
mamQ 819 0.683 
mamR 219 0.669 
mamB 894 0.725 
mamS 543 0.631 
mamT 525 0.613 
mamU 894 0.601 
mamY 1116 0.682 
mamX 765 0.688 
mamZ 1932 0.702 
ftsZ-like 936 0.680 




Supplementary Table 2. I-TASSER functional, biological and localisation predictions. 
Protein Accuracy Molecular Function Biological Process Cellular Location 
MamG 0.30±0.10 
Oxidoreductase (0.43) Carboxylic acid 
biosynthesis (0.43) 
Membrane (0.08) 
Fatty acid synthase (0.43) Oxidation-
reduction (0.33) 
Binding (0.33) Fatty acid 
metabolism (0.32) 







Heme binding (0.15) Cellular physiology 
process (0.51) Structural constituent of 
the cytoskeleton (0.14) 
Transmembrane 
signalling receptor (0.12) 
 
MamD 0.39±0.13 Magnesium ion binding 
(0.35) 
Regulation of cell 
shape (0.35) 
Cytoplasm (0.35) 
N-acetyltransferase (0.35) Peptidoglycan 
biosynthesis (0.35) 
Diphosphorylase (0.35) Cell wall 
organisation (0.35) 
 Lipopolysaccharide 
biosynthesis (0.35)  
















































 Vesicle coat (0.35) 
4071 0.36±0.12 Protein binding (0.53) Actin bundling 
(0.12) 



















Mms6 0.39±0.13 Beta-lactamase (0.50) Response to 
antibiotic (0.50) 
Periplasm (0.31) 
Zinc ion binding (0.41) Antibiotic 
catabolism (0.41) 






















Proteolysis (0.07)  
Transferase (0.07)   
Dipeptidase (0.07)   

































































MamE 0.44±0.14 Serine-type 
endopeptidase (0.63) 
Proteolysis 










 Response to 
chemical (0.51) 
 
MamJ 0.51±0.15 Enzyme inhibitor (0.48) Oxidation-
reduction (0.10) 
Cytoplasm (0.36) 











 Proteolysis (0.09) 
 Pathogenesis 
(0.09) 
MamK 0.77±0.10 ATP binding (0.98) Adherens junction 
organization (0.52) 
I band (0.52) 






































Structural constituent of 
cytoskeleton (0.52) 
Response to 




Kinesin binding (0.52) Chaperone 
mediated protein 
folding (0.52) 
Stress fiber (0.52) 





MamL 0.28±0.09 Sphingomyelin 
phosphodiesterase (0.07) 
Cytolysis (0.07) Extracellular 
(0.07) 





Hemolysis in other 
organism (0.07) 
Cytoplasm (0.06) 
























Zinc efflux active 
transmembrane 
transporter (0.44) 































































Protein binding (0.48) Proteolysis (0.55) Plasma membrane 
(0.60) 
 Periplasm (0.40) 





























 Periplasm (0.47) 











transporter activity (0.39) 
MamQ 0.35±0.12 acyl-CoA dehydrogenase 
(0.37) 























repressor activity (0.51) 







GTP binding (0.46)  







membrane (0.92) Zinc(II) ion 
transport (0.50) 























Porin (0.37) Enterobactin 
transport (0.37) 
MamS 0.29±0.09 Nucleic acid binding 
transcription factor (0.40) 
Regulation of gene 
expression (0.40) 
Intracellular (0.40) 
ATP binding (0.36) Inorganic anion 
transport (0.40) 














Regulation of RNA 
metabolism (0.40) 




Cyanate hydratase (0.09) Cyanate catabolism 
(0.09) Electron carrier (0.07) 
Heme binding (0.07) DNA repair (0.07) 
Lactaldehyde 
dehydrogenase (0.07) 












Metal ion binding (0.95) Lipid 
phosphorylation 
(0.88) 
NAD+ kinase (0.94)  
Lipid kinase (0.88)  




















MamY 0.97±0.05 Nucleic acid binding 
transcription factor (0.35) 
Regulation of gene 
expression (0.35) 














to stimulus (0.32) 
Integral 
component of 
membrane (0.32) Signalling (0.32) 
Hemolysis in other 
organism (0.32) 
Cytolysis (0.32) 




















































FtsZ-like 0.64±0.13 GTPase (1.00) GTP hydrolysis 
(1.00) 
Cytoplasm (1.00) 
GTP binding (1.00) Protein 
polymerization 
(1.00) 






Magnesium ion binding 
(0.77) 
Cell cycle (1.00) 







Supplementary Figure 1. TMHMM2 predictions for all studied MAI proteins. 
# mamG Length: 84 
# mamG Number of predicted TMHs:  2 
# mamG Exp number of AAs in TMHs: 45.19829 
# mamG Exp number, first 60 AAs:  39.56139 
# mamG Total prob of N-in:        0.97876 
# mamG POSSIBLE N-term signal sequence 
mamG TMHMM2.0 inside      1     6 
mamG TMHMM2.0 TMhelix      7    29 
mamG TMHMM2.0 outside     30    43 
mamG TMHMM2.0 TMhelix     44    66 
mamG TMHMM2.0 inside     67    84 
 




# mamF Length: 111 
# mamF Number of predicted TMHs:  3 
# mamF Exp number of AAs in TMHs: 59.55496 
# mamF Exp number, first 60 AAs:  28.7993 
# mamF Total prob of N-in:        0.55862 
# mamF POSSIBLE N-term signal sequence 
mamF TMHMM2.0 outside      1    19 
mamF TMHMM2.0 TMhelix     20    38 
mamF TMHMM2.0 inside     39    50 
mamF TMHMM2.0 TMhelix     51    68 
mamF TMHMM2.0 outside     69    72 
mamF TMHMM2.0 TMhelix     73    95 
mamF TMHMM2.0 inside     96   111 
 




# mamD Length: 314 
# mamD Number of predicted TMHs:  1 
# mamD Exp number of AAs in TMHs: 61.6504 
# mamD Exp number, first 60 AAs:  0.31266 
# mamD Total prob of N-in:        0.31374 
mamD TMHMM2.0 outside      1   269 
mamD TMHMM2.0 TMhelix    270   292 
mamD TMHMM2.0 inside    293   314 
 




# mamC Length: 125 
# mamC Number of predicted TMHs:  2 
# mamC Exp number of AAs in TMHs: 44.10464 
# mamC Exp number, first 60 AAs:  21.57353 
# mamC Total prob of N-in:        0.64356 
# mamC POSSIBLE N-term signal sequence 
mamC TMHMM2.0 inside      1     6 
mamC TMHMM2.0 TMhelix      7    29 
mamC TMHMM2.0 outside     30    64 
mamC TMHMM2.0 TMhelix     65    87 
mamC TMHMM2.0 inside     88   125 
 




# 4070 Length: 449 
# 4070 Number of predicted TMHs:  2 
# 4070 Exp number of AAs in TMHs: 41.6469899999999999 
# 4070 Exp number, first 60 AAs:  37.64613 
# 4070 Total prob of N-in:        0.80623 
# 4070 POSSIBLE N-term signal sequence 
4070 TMHMM2.0 inside      1     4 
4070 TMHMM2.0 TMhelix      5    23 
4070 TMHMM2.0 outside     24    42 
4070 TMHMM2.0 TMhelix     43    65 
4070 TMHMM2.0 inside     66   449 
 




# 4071 Length: 347 
# 4071 Number of predicted TMHs:  1 
# 4071 Exp number of AAs in TMHs: 22.55247 
# 4071 Exp number, first 60 AAs:  22.52011 
# 4071 Total prob of N-in:        0.99950 
# 4071 POSSIBLE N-term signal sequence 
4071 TMHMM2.0 inside      1    20 
4071 TMHMM2.0 TMhelix     21    43 
4071 TMHMM2.0 outside     44   347 
 




# mmsF Length: 124 
# mmsF Number of predicted TMHs:  3 
# mmsF Exp number of AAs in TMHs: 62.88052 
# mmsF Exp number, first 60 AAs:  21.20792 
# mmsF Total prob of N-in:        0.97207 
# mmsF POSSIBLE N-term signal sequence 
mmsF TMHMM2.0 inside      1    26 
mmsF TMHMM2.0 TMhelix     27    49 
mmsF TMHMM2.0 outside     50    63 
mmsF TMHMM2.0 TMhelix     64    83 
mmsF TMHMM2.0 inside     84    89 
mmsF TMHMM2.0 TMhelix     90   112 
mmsF TMHMM2.0 outside    113   124 
 




# mms6 Length: 136 
# mms6 Number of predicted TMHs:  1 
# mms6 Exp number of AAs in TMHs: 22.68297 
# mms6 Exp number, first 60 AAs:  0.08179 
# mms6 Total prob of N-in:        0.03311 
mms6 TMHMM2.0 outside      1    91 
mms6 TMHMM2.0 TMhelix     92   114 
mms6 TMHMM2.0 inside    115   136 
 




# 4074 Length: 90 
# 4074 Number of predicted TMHs:  0 
# 4074 Exp number of AAs in TMHs: 18.92606 
# 4074 Exp number, first 60 AAs:  5.31624 
# 4074 Total prob of N-in:        0.55049 
4074 TMHMM2.0 outside      1    90 
 




# mamH Length: 428 
# mamH Number of predicted TMHs:  12 
# mamH Exp number of AAs in TMHs: 259.68139 
# mamH Exp number, first 60 AAs:  29.99955 
# mamH Total prob of N-in:        0.91057 
# mamH POSSIBLE N-term signal sequence 
mamH TMHMM2.0 inside      1    15 
mamH TMHMM2.0 TMhelix     16    38 
mamH TMHMM2.0 outside     39    47 
mamH TMHMM2.0 TMhelix     48    70 
mamH TMHMM2.0 inside     71    82 
mamH TMHMM2.0 TMhelix     83   105 
mamH TMHMM2.0 outside    106   114 
mamH TMHMM2.0 TMhelix    115   137 
mamH TMHMM2.0 inside    138   148 
mamH TMHMM2.0 TMhelix    149   171 
mamH TMHMM2.0 outside    172   175 
mamH TMHMM2.0 TMhelix    176   195 
mamH TMHMM2.0 inside    196   232 
mamH TMHMM2.0 TMhelix    233   255 
mamH TMHMM2.0 outside    256   264 
mamH TMHMM2.0 TMhelix    265   287 
mamH TMHMM2.0 inside    288   298 
mamH TMHMM2.0 TMhelix    299   321 
mamH TMHMM2.0 outside    322   325 
mamH TMHMM2.0 TMhelix    326   348 
mamH TMHMM2.0 inside    349   354 
mamH TMHMM2.0 TMhelix    355   377 
mamH TMHMM2.0 outside    378   386 
mamH TMHMM2.0 TMhelix    387   409 
mamH TMHMM2.0 inside    410   428 
 




# mamI Length: 69 
# mamI Number of predicted TMHs:  2 
# mamI Exp number of AAs in TMHs: 42.73344 
# mamI Exp number, first 60 AAs:  42.73344 
# mamI Total prob of N-in:        0.34850 
# mamI POSSIBLE N-term signal sequence 
mamI TMHMM2.0 outside      1     3 
mamI TMHMM2.0 TMhelix      4    25 
mamI TMHMM2.0 inside     26    31 
mamI TMHMM2.0 TMhelix     32    54 
mamI TMHMM2.0 outside     55    69 
 




# mamE Length: 772 
# mamE Number of predicted TMHs:  1 
# mamE Exp number of AAs in TMHs: 21.10387 
# mamE Exp number, first 60 AAs:  20.58206 
# mamE Total prob of N-in:        0.97866 
# mamE POSSIBLE N-term signal sequence 
mamE TMHMM2.0 inside      1    24 
mamE TMHMM2.0 TMhelix     25    47 
mamE TMHMM2.0 outside     48   772 
 




# mamJ Length: 466 
# mamJ Number of predicted TMHs:  0 
# mamJ Exp number of AAs in TMHs: 0.60206 
# mamJ Exp number, first 60 AAs:  0.00022 
# mamJ Total prob of N-in:        0.05618 
mamJ TMHMM2.0 outside      1   466 
 




# mamK Length: 360 
# mamK Number of predicted TMHs:  0 
# mamK Exp number of AAs in TMHs: 0.05418 
# mamK Exp number, first 60 AAs:  0.02043 
# mamK Total prob of N-in:        0.01331 
mamK TMHMM2.0 outside      1   360 
 




# mamL Length: 78 
# mamL Number of predicted TMHs:  2 
# mamL Exp number of AAs in TMHs: 43.06534 
# mamL Exp number, first 60 AAs:  42.32445 
# mamL Total prob of N-in:        0.99081 
# mamL POSSIBLE N-term signal sequence 
mamL TMHMM2.0 inside      1     4 
mamL TMHMM2.0 TMhelix      5    24 
mamL TMHMM2.0 outside     25    38 
mamL TMHMM2.0 TMhelix     39    61 
mamL TMHMM2.0 inside     62    78 
 




# mamM Length: 318 
# mamM Number of predicted TMHs:  3 
# mamM Exp number of AAs in TMHs: 92.33744 
# mamM Exp number, first 60 AAs:  29.70697 
# mamM Total prob of N-in:        0.96067 
# mamM POSSIBLE N-term signal sequence 
mamM TMHMM2.0 inside      1    12 
mamM TMHMM2.0 TMhelix     13    35 
mamM TMHMM2.0 outside     36    80 
mamM TMHMM2.0 TMhelix     81   103 
mamM TMHMM2.0 inside    104   114 
mamM TMHMM2.0 TMhelix    115   137 
mamM TMHMM2.0 outside    138   318 
 




# mamN Length: 437 
# mamN Number of predicted TMHs:  11 
# mamN Exp number of AAs in TMHs: 246.35642 
# mamN Exp number, first 60 AAs:  44.44556 
# mamN Total prob of N-in:        0.89903 
# mamN POSSIBLE N-term signal sequence 
mamN TMHMM2.0 inside      1     1 
mamN TMHMM2.0 TMhelix      2    21 
mamN TMHMM2.0 outside     22    24 
mamN TMHMM2.0 TMhelix     25    47 
mamN TMHMM2.0 inside     48    58 
mamN TMHMM2.0 TMhelix     59    81 
mamN TMHMM2.0 outside     82   100 
mamN TMHMM2.0 TMhelix    101   123 
mamN TMHMM2.0 inside    124   135 
mamN TMHMM2.0 TMhelix    136   158 
mamN TMHMM2.0 outside    159   172 
mamN TMHMM2.0 TMhelix    173   195 
mamN TMHMM2.0 inside    196   225 
mamN TMHMM2.0 TMhelix    226   245 
mamN TMHMM2.0 outside    246   281 
mamN TMHMM2.0 TMhelix    282   301 
mamN TMHMM2.0 inside    302   320 
mamN TMHMM2.0 TMhelix    321   343 
mamN TMHMM2.0 outside    344   357 
mamN TMHMM2.0 TMhelix    358   380 
mamN TMHMM2.0 inside    381   412 
mamN TMHMM2.0 TMhelix    413   435 
mamN TMHMM2.0 outside    436   437 
 




# mamO Length: 632 
# mamO Number of predicted TMHs:  8 
# mamO Exp number of AAs in TMHs: 201.56296 
# mamO Exp number, first 60 AAs:  20.92075 
# mamO Total prob of N-in:        0.90200 
# mamO POSSIBLE N-term signal sequence 
mamO TMHMM2.0 inside      1    24 
mamO TMHMM2.0 TMhelix     25    44 
mamO TMHMM2.0 outside     45   349 
mamO TMHMM2.0 TMhelix    350   372 
mamO TMHMM2.0 inside    373   378 
mamO TMHMM2.0 TMhelix    379   401 
mamO TMHMM2.0 outside    402   420 
mamO TMHMM2.0 TMhelix    421   440 
mamO TMHMM2.0 inside    441   441 
mamO TMHMM2.0 TMhelix    442   464 
mamO TMHMM2.0 outside    465   514 
mamO TMHMM2.0 TMhelix    515   537 
mamO TMHMM2.0 inside    538   549 
mamO TMHMM2.0 TMhelix    550   572 
mamO TMHMM2.0 outside    573   581 
mamO TMHMM2.0 TMhelix    582   604 
mamO TMHMM2.0 inside    605   632 
 




# mamP Length: 270 
# mamP Number of predicted TMHs:  1 
# mamP Exp number of AAs in TMHs: 22.13825 
# mamP Exp number, first 60 AAs:  21.45319 
# mamP Total prob of N-in:        0.96791 
# mamP POSSIBLE N-term signal sequence 
mamP TMHMM2.0 inside      1     4 
mamP TMHMM2.0 TMhelix      5    27 
mamP TMHMM2.0 outside     28   270 
 




# mamA Length: 217 
# mamA Number of predicted TMHs:  0 
# mamA Exp number of AAs in TMHs: 0.00587999999999999999 
# mamA Exp number, first 60 AAs:  0.00393 
# mamA Total prob of N-in:        0.04844 
mamA TMHMM2.0 outside      1   217 
 




# mamQ Length: 272 
# mamQ Number of predicted TMHs:  1 
# mamQ Exp number of AAs in TMHs: 21.97228 
# mamQ Exp number, first 60 AAs:  12.2057 
# mamQ Total prob of N-in:        0.31720 
# mamQ POSSIBLE N-term signal sequence 
mamQ TMHMM2.0 outside      1    49 
mamQ TMHMM2.0 TMhelix     50    72 
mamQ TMHMM2.0 inside     73   272 
 




# mamR Length: 72 
# mamR Number of predicted TMHs:  0 
# mamR Exp number of AAs in TMHs: 0.00055 
# mamR Exp number, first 60 AAs:  0.00055 
# mamR Total prob of N-in:        0.22089 
mamR TMHMM2.0 outside      1    72 
 




# mamB Length: 297 
# mamB Number of predicted TMHs:  3 
# mamB Exp number of AAs in TMHs: 81.65791 
# mamB Exp number, first 60 AAs:  20.96747 
# mamB Total prob of N-in:        0.98953 
# mamB POSSIBLE N-term signal sequence 
mamB TMHMM2.0 inside      1    12 
mamB TMHMM2.0 TMhelix     13    35 
mamB TMHMM2.0 outside     36    81 
mamB TMHMM2.0 TMhelix     82   104 
mamB TMHMM2.0 inside    105   164 
mamB TMHMM2.0 TMhelix    165   187 
mamB TMHMM2.0 outside    188   297 
 




# mamS Length: 180 
# mamS Number of predicted TMHs:  1 
# mamS Exp number of AAs in TMHs: 23.54119 
# mamS Exp number, first 60 AAs:  22.98948 
# mamS Total prob of N-in:        0.33044 
# mamS POSSIBLE N-term signal sequence 
mamS TMHMM2.0 outside      1    19 
mamS TMHMM2.0 TMhelix     20    42 
mamS TMHMM2.0 inside     43   180 
 




# mamT Length: 174 
# mamT Number of predicted TMHs:  1 
# mamT Exp number of AAs in TMHs: 18.38954 
# mamT Exp number, first 60 AAs:  18.37315 
# mamT Total prob of N-in:        0.43583 
# mamT POSSIBLE N-term signal sequence 
mamT TMHMM2.0 outside      1     9 
mamT TMHMM2.0 TMhelix     10    28 
mamT TMHMM2.0 inside     29   174 
 




# mamU Length: 297 
# mamU Number of predicted TMHs:  0 
# mamU Exp number of AAs in TMHs: 0.47406 
# mamU Exp number, first 60 AAs:  0.19727 
# mamU Total prob of N-in:        0.10933 
mamU TMHMM2.0 outside      1   297 
 




# mamY Length: 371 
# mamY Number of predicted TMHs:  2 
# mamY Exp number of AAs in TMHs: 44.45026 
# mamY Exp number, first 60 AAs:  31.50419 
# mamY Total prob of N-in:        0.83605 
# mamY POSSIBLE N-term signal sequence 
mamY TMHMM2.0 inside      1    18 
mamY TMHMM2.0 TMhelix     19    41 
mamY TMHMM2.0 outside     42    50 
mamY TMHMM2.0 TMhelix     51    73 
mamY TMHMM2.0 inside     74   371 
 




# mamX Length: 269 
# mamX Number of predicted TMHs:  1 
# mamX Exp number of AAs in TMHs: 22.41271 
# mamX Exp number, first 60 AAs:  22.16809 
# mamX Total prob of N-in:        0.65981 
# mamX POSSIBLE N-term signal sequence 
mamX TMHMM2.0 inside      1    11 
mamX TMHMM2.0 TMhelix     12    34 
mamX TMHMM2.0 outside     35   269 
 




# mamZ Length: 648 
# mamZ Number of predicted TMHs:  18 
# mamZ Exp number of AAs in TMHs: 373.22384 
# mamZ Exp number, first 60 AAs:  22.6034 
# mamZ Total prob of N-in:        0.95598 
# mamZ POSSIBLE N-term signal sequence 
mamZ TMHMM2.0 inside      1    27 
mamZ TMHMM2.0 TMhelix     28    50 
mamZ TMHMM2.0 outside     51    64 
mamZ TMHMM2.0 TMhelix     65    87 
mamZ TMHMM2.0 inside     88    93 
mamZ TMHMM2.0 TMhelix     94   113 
mamZ TMHMM2.0 outside    114   116 
mamZ TMHMM2.0 TMhelix    117   139 
mamZ TMHMM2.0 inside    140   162 
mamZ TMHMM2.0 TMhelix    163   185 
mamZ TMHMM2.0 outside    186   189 
mamZ TMHMM2.0 TMhelix    190   207 
mamZ TMHMM2.0 inside    208   257 
mamZ TMHMM2.0 TMhelix    258   277 
mamZ TMHMM2.0 outside    278   286 
mamZ TMHMM2.0 TMhelix    287   309 
mamZ TMHMM2.0 inside    310   315 
mamZ TMHMM2.0 TMhelix    316   333 
mamZ TMHMM2.0 outside    334   342 
mamZ TMHMM2.0 TMhelix    343   365 
mamZ TMHMM2.0 inside    366   371 
mamZ TMHMM2.0 TMhelix    372   394 
mamZ TMHMM2.0 outside    395   408 
mamZ TMHMM2.0 TMhelix    409   428 
mamZ TMHMM2.0 inside    429   448 
mamZ TMHMM2.0 TMhelix    449   468 
mamZ TMHMM2.0 outside    469   482 
mamZ TMHMM2.0 TMhelix    483   502 
mamZ TMHMM2.0 inside    503   521 
mamZ TMHMM2.0 TMhelix    522   544 
mamZ TMHMM2.0 outside    545   556 
mamZ TMHMM2.0 TMhelix    557   579 
mamZ TMHMM2.0 inside    580   591 
mamZ TMHMM2.0 TMhelix    592   609 
mamZ TMHMM2.0 outside    610   618 
mamZ TMHMM2.0 TMhelix    619   636 








# FtsZ-like Length: 311 
# FtsZ-like Number of predicted TMHs:  0 
# FtsZ-like Exp number of AAs in TMHs: 3.94874 
# FtsZ-like Exp number, first 60 AAs:  1.49878 
# FtsZ-like Total prob of N-in:        0.19916 
FtsZ-like TMHMM2.0 outside      1   311 
 





Supplementary Figure 2. Operon analysis of various LemA proteins. 
No. Organism Pfam LemA 
group 
TMD* 
TPM_P [GR-C] DUF2207 P_M48/56 P_S DeH 
1 Acidovorax avenae 2 1     2 0 
2 Acidovorax citrulli       1 1 
3 Acinetobacter 
baumannii AB0057 
2 1     2 0* 
4 Acholeplasma oculi       1 1 
5 Agrobacterium 
tumefaciens 
  1  1  3 1 
6 Bacillus clausii    1   4 1 
7 Bacillus lehensis    1   4 1 
8 Bacillus 
megaterium 
1 1     2 1 
9 Bacillus 
endophyticus 
1 1     2 1 
10 Bacteroides 
cellulosilyticus 
1 1   1 1 2 1 
11 Berkelbacteria 
bacterium 
    1  4 1 
12 Blattabacterium 
BPLAN 
1 -     2 1 
13 Bradyrhizobium 
diazoefficiens 
2 1     2 0 
14 Brucella abortus 2 1 1    1 2 1 
15 Brucella melitensis 2 1 1    1 2 1 
16 Clostridium 
kluyveri 
      1 1 
17 Desulfarculus 
baarsii 
1 1     2 1 
18 Francisella cf. 
novicida 
   1   1 1 
19 Lactobacillus 
johnsonii 
   1   4 1 
20 Lactobacillus 
rhamnosus 
1 1     2 1 
21 Lactobacillus 
acetotolerans 
   1   4 1 
22 Leptospira biflexa      1 2 0 
23 Marinobacter 
salaries 




   1   3 1 
25 Mycobacterium 
smegmatis 
  1    1 1 
26 Nitrosomonas sp. 
AL212 
2 1     2 0* 
27 Nitrosomonas sp. 
Is79A3 
2 1     2/3 0*/1 
28 Owenweeksia 
hongkongensis 
2 1     2 1 
29 Parachlamydia 
acanthamoebae 
   1   3 1 
30 Pasteurella 
multocida 
2 1     2 1 
31 Pectobacterium 
wasabiae 
  1   1 3 1 
32 Pelosinus 
fermentans 
1 1     2 1 





      3 1 
35 Rhodococcus 
aetherivorans 
  1    1 1 
36 Rickettsiales 
bacterium  
      2 1 
37 Rufibacter sp. 
DG31D 
2 1     2 0 
38 Shewanella baltica        1 1 
39 Sorangium 
cellulosum  
1 1     2 0 
40 Spirosoma 
radiotolerans 
2 1    1 2 1 
41 Sphaerochaeta 
coccoides 
  1    3 1 
42 Sphingomonas sp. 
MM-1 
2 1    1 2 0* 
43 Streptococcus 
parauberis 
   1   4 1 
44 Streptococcus 
pneumoniae 
   1   4 1 
45 Streptococcus 
agalactiae 
   1   4 1 
46 Sulfuricella 
denitrificans 
2 1    1 2 0* 
47 Syntrophus 
aciditrophicus 
1 1     2 1 
48 Tannerella 
forsythia 
   1   3 1 
49 Thermoanaerobact
er wiegelii 
      2 1 
50 Vulgatibacter 
incomptus 
1 1   1  2 0 
51 Yersinia pestis       3 1 
52 Zunongwangia 
profunda 
2 1     2 0 
 
TPM_P  ? TPM_Phosphatase 
GR-C  ? TPM_Phosphatases with glycine-rich C-terminus motif 
P_M48/56  ? Peptidase_M48/56 
P_S  ? Peptidase_S7/9/15/41/46/49 
DeH  ? Dehydrogenase  
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1. Acidovorax avenae 
 
Acav_0452 ʹ LemA (Pfam: LemA; LPAM_2[Prokaryotic lipoprotein-attachment site]) 
Acav_0451  ? protein of unknown function DUF477 (Pfam: TPM_phosphatase; MOLO1) 
Acav_0450  ? protein of unknown function DUF477 (Pfam: TPM_phosphatase; DUF5130) 
Acav_0449  ? hypothetical protein (Pfam: NEL[ubiquitin ligase]; TENA_THI-4) 
Acav_0448  ? hypothetical protein (Pfam: NEL[ubiquitin ligase]) 
2. Acidovorax citrulli 
 
Aave_4529 ʹ LemA (Pfam: LemA; TPR_14) 
Aave_4528  ? sun protein (Pfam: Methyltr_RsmB-F; NusB; Methyltr_RsmF_N; Methyltransf_25; Methyltransf_24; FtsJ) 
Aave_4527  ? putative proline rich signal peptide protein (Pfam: DUF4390; Bac_luciferase) 
Aave_4526  ? multi-sensor signal transduction histidine kinase (Pfam: Response_reg; HTH_8; FleQ; Phage_AlpA; HTH_1) 
Aave_4525  ? tRNA-Phe 
3. Acinetobacter baumannii AB0057 
 
AB57_3638  ? hypothetical protein (Pfam: Metal_hydrol; AurF) 
AB57_3637 ʹ LemA (Pfam: LemA; DUF1869; Dynein_heavy; HRXXH) 
AB57_3636  ? conserved hypothetical protein (Pfam: TPM_phosphatase; BCD; DUF5130; SRTM1; Shisa) 
AB57_3635  ? conserved hypothetical protein (Pfam: TPM_phosphatase; DUF4019) 
AB57_3634  ? type IV pilin structural subunit (Pfam: Pilin; N_methyl_3; N_methyl_2; N_methyl) 
AB57_3633  ? O-antigen polymerase family (Pfam: Wzy_C; Wzy_C_2; PglL_A) 




Aocu_08080  ? DAK1/DegV-like protein (Pfam: DegV; Cupin_8; DUF1108) 
Aocu_08090  ? hypothetical protein (Pfam: Adeno_E3_CR1; Sod_Fe_N; DUF1430; IncA) 
Aocu_08100 ʹ LemA (Pfam: LemA; Pmp3; DUF948; ALIX_LYPXL_bnd; DUF4358) 
5. Agrobacterium tumefaciens 
 
Ach5_05530  ? hypothetical protein (Pfam: DUF2007) 
Ach5_05540  ? methyltransferase (Pfam: MTS; Methyltransf_31; Methyltransf_25; Methyltransf_16; Cons_hypoth95; 
GidB; Methyltransf_12; NAD_binding_8; Methyltransf_11; Methyltransf_32) 
Ach5_05550  ? protease sohB [sohB] (Pfam: Peptidase_S49; SDH_sah; CLP_protease; Pribosyltran) 
Ach5_05560  ? membrane protein (Pfam: HAMP; ParE-like_toxin) 
Ach5_05570  ? glycyl-tRNA synthetase alpha chain [glyQ] (Pfam: tRNA-synt_2e; N-glycanase_C) 
Ach5_05580 ʹ LemA (Pfam: LemA) 
Ach5_05590  ? 3-phosphoshikimate 1-carboxyvinyltransferase [aroA] (Pfam: EPSP_synthase) 
Ach5_05600  ? membrane protein (Pfam: DUF2207)  
Ach5_05610  ? glycyl-tRNA synthetase beta chain [glyS] (Pfam: tRNA_synt_2f; DALR_1; MnmE_helical; AARP2CN) 
Ach5_05620  ? addiction module protein (Pfam: Gp49) 
Ach5_05630  ? transcriptional regulator 
Ach5_05640  ? hypothetical protein (Pfam: DUF523) 
 
6. Bacillus clausii 
 
ABC1504  ? heat shock protein HtpX (Pfam: Peptidase_M48; Peptidase_M56; SprT-like; BSP) 
ABC1505  ? LemA (Pfam: LemA; DUF3584; DASH_Spc34; Vps39_1) 
7. Bacillus lehensis G1 
 
BleG1_1318  ? heat shock protein HtpX (Pfam: Peptidase_M48; Peptidase_M56; SprT-like; Borrelia_P13; BSP; Arteri_Gl) 




8. Bacillus megaterium DSM 319 
 
 
BMD_3382  ? conserved hypothetical protein (Pfam: gerPA[germination]) 
BMD_3381  ? glycosyl transferase, family 2 (Pfam: Glycos_transf_2; Glyco_tranf_2_2; Glyco_transf_7C; 
Glyco_tranf_2_3; Glyco_transf_21; Glyco_tranf_2_4; Glyco_trans_2_3) 
BMD_3380  ? polysaccharide deacetylase (Pfam: Polysacc_deac_1; Glyco_hydro_57; SpoVS[sporulation]; DUF2209) 
BMD_3379 ʹ LemA (Pfam: LemA; DUF327; DUF948; FadA; DivIC) 
BMD_3378  ? pomain of unknown function (Pfam: TPM_phosphatase) 
BMD_3377  ? conserved hypothetical protein (Pfam: DUF2254) 
9. Bacillus endophyticus 
 
BEH_06455 ʹ LemA (Pfam: LemA; FtsH_ext; FadA; 4HB_MCP_1; DUF4455; Ribosomal_L36e; ABC2_membrane_3) 
BEH_06460  ? hypothetical protein (Pfam: TPM_phosphatase; Asp4; Amnionless) 
BEH_06465  ? diacylglycerol kinase (Pfam: DAGK_cat; NAD_kinase) 
BEH_06470  ? pseudogene 
BEH_06475  ? hypothetical protein (Pfam: zf-dskA_traR; DUF5133) 
BEH_06480  ? RpiR family transcriptional regulator (Pfam: SIS; HTH_6; SIS_2; HTH_17) 
BEH_06485  ? N-acetylmuramic acid-6-phosphate etherase (Pfam: SIS; SIS_2; ANTAR; DUF2682; UBA_4) 
BEH_06490  ? PTS sugar transporter subunit IIC (Pfam: PTS_EIIC; PTS_EIIB) 
10. Bacteroides cellulosilyticus 
 
BcellWH2_04139  ? hypothetical protein (Pfam: DUF1593; Glyco_hydro_129; REJ) 
BcellWH2_04138  ? GTPase Obg [obg] (Pfam: GTP1_OBG; MMR_HSR1; FeoB_N; MMR_HSR1_Xtn; DNA_pol_phi) 
BcellWH2_04137  ? Laccase domain protein (Pfam: Cu-oxidase_4; DUF4649) 
BcellWH2_04136  ? lipoprotein signal peptidase (Pfam: Peptidase_A8; DUF2569) 
BcellWH2_04135  ? B3/4 domain protein (Pfam: B3_4) 
BcellWH2_04134  ? Murein hydrolase activator NlpD precursor [nlpD_2] (Pfam: Peptidase_M23; PTS_EIIA_1; 
Biotin_lipoyl_2) 
BcellWH2_04133  ? PhoH-like protein [ybeZ_1] (Pfam: PhoH; AAA_30; UvrD-helicase; DEAD; IstB_IS21; AAA_19; 
AAA_22; ResIII; Ribosomal_L4; AAA_25; DUF2075; AAA; Microtub_bd; Sigma54_activ_2; Methyltr_RsmB-F; Kinesin) 
BcellWH2_04132  ? Phosphoribosylaminoimidazole-succinocarboxamide synthase [purC] (Pfam: SAICAR_synt) 
BcellWH2_04131  ? C-methyltransferase UbiE [ubiE] (Pfam: Ubie_methyltran; Methyltransf_25; Methyltransf_11; 
Methyltransf_31; Methyltransf_12; Methyltransf_23; Methyltransf_20; Methyltransf_18; Rsm22; TrmK; UPF0020; 
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PrmA; MetJ; MTS; Methyltransf_8; PCMT; Methyltransf_3; FtsJ) 
BcellWH2_04130  ? Shikimate dehydrogenase [aroE] (Pfam: Shikimate_dh_N; 2-Hacid_dh_C) 
BcellWH2_04129  ? Alpha/beta hydrolase family protein (Pfam: Peptidase_S9; Hydrolase_4; Peptidase_S15; FSH1; DLH; 
Abhydrolase_2) 
BcellWH2_04128  ? hypothetical protein (Pfam: TPM_phosphatase; MOLO1; Zn-ribbon_8; zf-ribbon_3; NOB1_Zn_bind; 
DUF3268; DZR; Ogr_Delta; TF_Zn_Ribbon; zinc_ribbon_15; DNA_RNApol_7kD; Ribosomal_L32p; zinc_ribbon_10) 
BcellWH2_04127 ʹ LemA (Pfam: LemA; DivIC; 4HB_MCP_1) 
11. Berkelbacteria bacterium 
 
UT28_C0001G0235  ? hypothetical protein 
UT28_C0001G0234  ? hypothetical protein (Pfam: DUF4307; DUF2850; DUF2140) 
UT28_C0001G0233  ? hypothetical protein (Pfam: PsbP; DUF4307) 
UT28_C0001G0232  ? hypothetical protein (Pfam: PhdYeFM_antitox; EFG_C) 
UT28_C0001G0231  ? cysteine desulfurase (Pfam: Aminotran_5; Beta_elim_lyase) 
UT28_C0001G0230  ? hypothetical protein (Pfam: NifU_N) 
UT28_C0001G0229  ? hypothetical protein (Pfam: Colicin_V; CAP) 
UT28_C0001G0228  ? FolD bifunctional protein (Pfam: THF_DHG_CYH_C; THF_DHG_CYH) 
UT28_C0001G0227  ? tRNA-specific 2-thiouridylase MnmA [mnmA] (Pfam: tRNA_Me_trans; NAD_synthase; QueC; ThiI; 
DUF3659; Asn_synthase; Arginosuc_synth; LytR_C; ATP_bind_3) 
UT28_C0001G0226  ? carboxy-terminal-processing protease [ctpA] (Pfam: Peptidase_S41; PDZ; PDZ_2; 
GRASP55_65[Golgi]) 
UT28_C0001G0225  ? 50S ribosomal protein L9 [rplI] (Pfam: Ribosomal_L9_N; Ribosomal_L9_C) 
UT28_C0001G0224  ? mucin-2-like protein (Pfam: T2SSG; DctQ) 
UT28_C0001G0223 ʹ LemA (Pfam: LemA; DUF3151; HalX; FtsH_ext) 
UT28_C0001G0222  ? hypothetical protein (Pfam: ARGLU; DUF4889; TRAF_BIRC3_bd) 
UT28_C0001G0221  ? hypothetical protein (Pfam: PsbP; Rad9_Rad53_bind; PsaN; SSP160; ABC2_membrane_3) 




BPLAN_187  ? nucleoside-diphosphate kinase (Pfam: NDK; MaoC_dehydratas)  
BPLAN_188 ʹ LemA (Pfam: LemA; Fez1; DUF1512; DASH_Spc34; EOS1; DivIC; Exonuc_VII_L; ABC2_membrane_3) 
BPLAN_189  ? hypothetical protein (Pfam: TPM_phosphatase) 
13. Bradyrhizobium diazoefficiens USDA 110 
 
bll7267 ʹ LemA (Pfam: LemA; UPF0693) 
bll7266  ? hypothetical protein (Pfam: TPM_phosphatase; MOLO1) 
bll7265  ? hypothetical protein (Pfam: TPM_phosphatase; DUF5130) 
bll7264  ? hypothetical protein 
bll7263  ? hypothetical protein 
14. Brucella abortus bv. 2 86/8/59 
 
DK55_1773  ? signal recognition particle protein [ffh] (Pfam: SRP54; SRP_SPB; SRP54_N; CbiA; AAA_33; AAA_30; 
Zeta_toxin; AAA_19; AAA_31; DnaB_C; AAA_22; APS_kinase; Thymidylate_kin; AAA_16; AAA; 6PF2K; AAA_18; AAA_28; 
AAA_14; AAA_5; ArsA_ATPase) 
DK55_1772  ? chorismate mutase (Pfam: CM_2) 
DK55_1771  ? ribosomal protein S16 [rpsP] (Pfam: Ribosomal_S16; TAF4) 
DK55_1770 ʹ LemA (Pfam: LemA; TPR_15; Dehydratase_SU; zf-piccolo) 
DK55_1769  ? uncharacterized protein (Pfam: TPM_phosphatase; DUF5130; MOLO1; DUF987; DUF1840) 
DK55_1768  ? putative membrane protein (Pfam: TPM_phosphatase; TM140; DUF2207) 
DK55_1767  ? bacterial NAD-glutamate dehydrogenase family protein (Pfam: Bac_GDH; ELFV_dehydrog) 
DK55_1766  ? major Facilitator Superfamily protein (Pfam: ATG22; MFS_1; MFS_1_like) 
15. Brucella melitensis ATCC 23457 
 
BMEA_A1876  ? signal recognition particle protein [ffh] (Pfam: SRP54; SRP_SPB; SRP54_N; CbiA; AAA_33; AAA_30; 
Zeta_toxin; AAA_19; AAA_31; DnaB_C; AAA_22; APS_kinase; AAA_16; AAA; Thymidylate_kin; 6PF2K; AAA_18; AAA_28; 
AAA_14; ArsA_ATPase; AAA_5) 
BMEA_A1875  ? chorismate mutase (Pfam: CM_2) 
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BMEA_A1874  ? ribosomal protein S16 [rpsP] (Pfam: Ribosomal_S16) 
BMEA_A1873  ? hypothetical protein 
BMEA_A1872 ʹ LemA (Pfam: LemA; TPR_15; Dehydratase_SU; zf-piccolo) 
BMEA_A1871 ? uncharacterized protein (Pfam: TPM_phosphatase; DUF5130; MOLO1; DUF987; DUF1840) 
BMEA_A1870  ? putative membrane protein (Pfam: TPM_phosphatase; TM140; DUF2207) 
BMEA_A1869  ? NAD-glutamate dehydrogenase (Pfam: Bac_GDH; ELFV_dehydrog) 
16. Clostridium kluyveri DSM 555 
 
CKL_2442  ? hydroxylamine reductase [hcp] (Pfam: Prismane) 
CKL_2443  ? conserved hypothetical protein (Pfam: DUF3137) 
CKL_2444 ʹ LemA (Pfam: LemA; Halogen_Hydrol; Baculo_11_kDa) 
17. Desulfarculus baarsii 
 
Deba_0170  ? chaperone protein DnaK (Pfam: HSP70; MreB_Mbl; FtsA; DMRL_synthase) 
Deba_0169  ? Phosphoribosylaminoimidazolecarboxamideformyltransferase (Pfam: MGS; AICARFT_IMPCHas) 
Deba_0168  ? phosphoribosylamine/glycine ligase (Pfam: GARS_A; AIRC; GARS_N; GARS_C; ATPgrasp_Ter; 
CPSase_L_D2; ATP-grasp; ATP-grasp_5; ATP-grasp_4; ATP-grasp_2; Dala_Dala_lig_C; RimK; ATP-grasp_3; DAGK_cat) 
Deba_0167  ? Sua5/YciO/YrdC/YwlC family protein (Pfam: Sua5_yciO_yrdC) 
Deba_0166  ? hypothetical protein 
Deba_0165  ? metal dependent phosphohydrolase (Pfam: HDOD; HD) 
Deba_0164  ? methyl-accepting chemotaxis sensory transducer (Pfam: MCPsignal; dCache_1; Laminin_II; KASH_CCD; 
DUF1395; DUF1664) 
Deba_0163  ? chaperone DnaJ domain protein (Pfam: DnaJ_C; DnaJ; NIR_SIR_ferr; RRM_3) 
Deba_0162  ? protein of unknown function DUF477 (Pfam: TPM_phosphatase) 
Deba_0161  ? putative cytoplasmic protein (Pfam: NTP_transf_2) 
Deba_0160 ʹ LemA (Pfam: LemA; DUF4131; DivIC) 
Deba_0159  ? MgtC/SapB transporter (Pfam: MgtC; TctB) 
Deba_0158  ? cation diffusion facilitator family transporter (Pfam: Cation_efflux; ZT_dimer) 
Deba_0157  ? putative cache sensor protein (Pfam: dCache_2; sCache_2; Cache_3-Cache_2; Prim-Pol) 




18. Francisella cf. novicida Fx1 
 
FNFX1_0384  ? hypothetical protein (Pfam: LysR_substrate; HTH_1; PBP_like; PBP_like_2; Phosphonate-bd; 
Orthopox_F14) 
FNFX1_0383 ʹ LemA (Pfam: LemA; DUF4330; DUF4083; Inhibitor_I53; UPF0118; Peptidase_M57; Wzy_C) 
FNFX1_0382  ? heat shock protein HtpX (Pfam: Peptidase_M48; Peptidase_M56 [Signaling antibiotic resistance in 
staphylococci]; zf-DHHC; DUF2268; DUF2569; DUF4157; DUF996) 
FNFX1_0381  ? hypothetical protein (Pfam: N_methyl_2; N_methyl) 
FNFX1_0380  ? hypothetical protein (Pfam: DUF3287; HrpE; DUF1043; 7TMR-HDED; Spc97_Spc98; DUF4140; ZnuA; 
DUF4446; Prefoldin_2; DUF342; Lectin_N; Med4; IncA) 
19. Lactobacillus johnsonii NCC 533 
 
LJ0078  ? hypothetical protein (Pfam: CitMHS) 
LJ0077 ʹ LemA (Pfam: LemA; DUF2408; FtsH_ext; IncA; DUF342; GAT; DUF3139) 
LJ0076  ? heat shock protein HtpX (Pfam: Peptidase_M48; Peptidase_M56 [Signaling antibiotic resistance in 
staphylococci]; Herpes_US9; Cytochrom_B_N_2)  
20. Lactobacillus rhamnosus Lc 705 
 
LC705_02622  ? conserved protein 
LC705_02621  ? ABC transporter, permease protein (Pfam: OpuAC; BPD_transp_1) 
LC705_02620  ? ABC transporter, ATPase component [proV] (Pfam: ABC_tran; AAA_21; AAA_30; AAA_22; AAA_29; 
AAA_16; SMC_N; AAA_19; mRNA_decap_C; G-alpha; Zeta_toxin; AAA_24; T2SSE; AAA_18; AAA_28; SbcCD_C; AAA_15; 
CENP-M; DUF258; AAA_23; AAA_33; AAA)[Osmoprotectant transporter] 
LC705_02619  ? Glutathione reductase [gshR] (Pfam: Pyr_redox_2; Pyr_redox; Pyr_redox_3; Pyr_redox_dim; 




LC705_02618  ? Transporter, major facilitator superfamily MFS_1 (Pfam: MFS_1) 
LC705_02617  ? Tryptophanyl-tRNA synthetase [trpS] (Pfam: tRNA-synt_1b) 
LC705_02616 ʹ LemA (Pfam: LemA; DUF327; TPR_21; DUF2613; IncA; DivIC; DUF4363; STT3; UPF0118) 
LC705_02615  ? Conserved protein (Pfam: TPM_phosphatase; L-fibroin; 60KD_IMP) 
LC705_02614  ? Na-driven multidrug efflux pump [dinF] (Pfam: MatE; MVIN; Polysacc_synt_C; Glycoprotein_B) 
21. Lactobacillus acetotolerans 
 
LBAT_0120  ? cation transport protein (Pfam: CitMHS) 
LBAT_0119 ʹ LemA (Pfam: LemA; DUF3139; ABC2_membrane_3) 
LBAT_0118  ? heat shock protein HtpX (Pfam: Peptidase_M48; Peptidase_M56 [Signaling antibiotic resistance in 
staphylococci]; DUF4191; GPI2; Bax1-I) 
LBAT_0117  ? hypothetical protein (Pfam: SAM35) 
LBAT_0116  ? hypothetical protein 
22. Leptospira biflexa serovar Patoc Patoc 1 
 
LEPBI_I2404  ? putative alpha/beta hydrolase (Pfam: Abhydrolase_6; Hydrolase_4; Abhydrolase_1; Malt_amylase_C; 
Acyl_transf_2; Ribosomal_S2) 
LEPBI_I2403  ? putative transcriptional regulator (Pfam: WHG; TetR_N) 
LEPBI_I2402  ? threonyl-tRNA synthetase (Pfam: tRNA-synt_2b; HGTP_anticodon; tRNA_SAD; TGS) 
LEPBI_I2401  ? hypothetical protein 
LEPBI_I2400  ? translation initiation factor IF-3 (Pfam: IF3_C; IF3_N; mIF3) 
LEPBI_I2399  ? 50S ribosomal protein L35 [rpmI] (Pfam: Ribosomal_L35p) 
LEPBI_I2398  ? 50S ribosomal protein L20 [rplT] (Pfam: Ribosomal_L20) 
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LEPBI_I2397  ? hypothetical protein 
LEPBI_I2396  ? hypothetical protein (Pfam: TolA_bind_tri; Mod_r) 
LEPBI_I2395  ? cell division protein ZapA (Pfam: ZapA) 
LEPBI_I2394  ? putative 5-formyltetrahydrofolate cyclo-ligase (Pfam: 5-FTHF_cyc-lig) 
LEPBI_I2393  ? putative chemotaxis protein CheW-like protein (Pfam: CheW) 
LEPBI_I2392  ? chemotaxis protein CheA [cheA3] (Pfam: CheW; Hpt; H-kinase_dim; HATPase_c; P2; CheC; CheX) 
LEPBI_I2391  ? chemotaxis response regulator protein-glutamate methylesterase [cheB3] (Pfam: CheB_methylest; 
Response_reg) 
LEPBI_I2390  ? chemotaxis protein CheY [cheY3] (Pfam: Response_reg) 
LEPBI_I2389  ? chromosome segregation and condensation protein ScpA [scpA] (Pfam: SMC_ScpA) 
LEPBI_I2388  ? chromosome segregation and condensation protein ScpB [scpB] (Pfam: SMC_ScpB; MarR; HRDC; 
HTH_IclR) 
LEPBI_I2387  ? P-protein [pheA] (Pfam: PDT; CM_2; ACT) 
LEPBI_I2386  ? prephenate dehydrogenase [tyrA] (Pfam: PDH; Semialdhyde_dh) 
LEPBI_I2385  ? putative signal peptide (Pfam: DUF1343) 
LEPBI_I2384 ʹ LemA (Pfam: LemA) 
23. Marinobacter salaries 
 
AU15_01365  ? pseudogene 
AU15_01360 ʹ LemA (Pfam: LemA; DASH_Spc34; Col_cuticle_N; IncA; P12) 
AU15_01355  ? pseudogene [two ORFs] (peptidase_M48)(heat shock protein HtpX) 
24. Methylophaga nitratireducenticrescens 
 
Q7A_1995 ʹ LemA (Pfam: LemA; Pro-rich_19) 
Q7A_1994  ? Zn-dependent protease with chaperone function (Pfam: Peptidase_M48; DUF3357; FtsX; Peptidase_M56 
[Signaling antibiotic resistance in staphylococci]; SprT-like; Peptidase_A24; Sigma_reg_N) 
25. Mycobacterium smegmatis MC2 155 
 
MSMEI_2984  ? YjeF-like protein (Pfam: YhhN; MTTB) 
MSMEI_2985  ? primosomal protein N priA [priA] 
MSMEI_2986  ? hypothetical protein (Pfam: DUF2207) 
MSMEI_2987 ʹ LemA (Pfam: LemA) 
MSMEI_2988  ? methionyl-tRNA formyltransferase [fmt] (Pfam: Formyl_trans_N; Formyl_trans_C) 
MSMEI_2989  ? hypothetical protein (Pfam: Methyltr_RsmB-F; NusB; Methyltransf_25; Methyltransf_11; 
Methyltransf_15) 




MSMEI_2991  ? diaminohydroxyphosphoribosylaminopyrimidine deaminase [ribD] (Pfam: RibD_C; dCMP_cyt_deam_1; 
MafB19-deam; Ldh_2) 
26. Nitrosomonas sp. AL212: NAL212_2014 (Produces similar membranous structures) 
 
NAL212_2014 ʹ LemA (Pfam: LemA; DUF576; DUF1869) 
NAL212_2015  ? uncharacterized protein (Pfam: TPM_phosphatase; FUSC_2; MOLO1; Equine_IAV_S2; QLQ) 
NAL212_2016  ? protein of unknown function DUF477 (Pfam: TPM_phosphatase; DUF3386) 
27. Nitrosomonas sp. Is79A3 (Produces similar membranous structures) 
 
Nit79A3_2186 ʹ LemA (Pfam: LemA; LPAM_2; DUF576; DUF1869) 
Nit79A3_2187  ? hypothetical protein (Pfam: TPM_phosphatase; DUF4191; MOLO1) 
Nit79A3_2188  ? hypothetical protein (Pfam: TPM_phosphatase) 
Nit79A3_2189  ? hydrogenase maturation protease 
Nit79A3_2190  ? HupE/UreJ protein (Pfam: HupE_UreJ) 
Nit79A3_2191  ? hydrogenase nickel incorporation protein hypA (Pfam: HypA; DZR; DUF2039; zinc_ribbon_6; zinc-
ribbons_6; zf-ribbon_3; DUF4776; tRNA_anti_2; PSD4; zf-ISL3; Ribosomal_L32p; Zn-ribbon_8) 
Nit79A3_2192  ? hydrogenase accessory protein HypB (Pfam: cobW; MobB; AAA_19; DUF3281; NTPase_1) 
Nit79A3_2193  ? pseudogene 
Nit79A3_2194  ? heat shock protein 33 (Pfam: HSP33) 
Nit79A3_2195  ? hypothetical protein (Pfam: Ctr) 
Nit79A3_2196  ? response regulator receiver protein (Pfam: Response_reg) 
Nit79A3_2197  ? integral membrane sensor signal transduction histidine kinase (Pfam: HATPase_c; HATPase_c_2; 
HATPase_c_3; HisKA) 
 
Nit79A3_2971 ʹ LemA (Pfam: LemA; HalX) 
Nit79A3_2970  ? E3 ubiquitin ligase (Pfam: GIDE; EF-hand_5; EF-hand_1; EF-hand_6; Ribosomal_S4Pg; EF_assoc_2 EF-
hand_8; AbiEi_3_N) 




28. Owenweeksia hongkongensis 
 
Oweho_1874  ? metalloendopeptidase-like membrane protein (Pfam: Peptidase_M23; Amidase_5; Biotin_lipoyl_2) 
Oweho_1873  ? putative transcriptional regulator (Pfam: MerR_1; MerR; HTH_17; Acetyltransf_11) 
Oweho_1872 ʹ LemA (Pfam: LemA; CcmE) 
Oweho_1871  ? putative membrane protein (Pfam: TPM_phosphatase) 
Oweho_1870  ? uncharacterized protein (Pfam: TPM_phosphatase) 
Oweho_1869  ? 6-pyruvoyl-tetrahydropterin synthase (Pfam: PTPS) 
Oweho_1868  ? S23 ribosomal protein (Pfam: 23S_rRNA_IVP) 
Oweho_1867  ? malonyl CoA-acyl carrier protein transacylase (Pfam: Acyl_transf_1) 
Oweho_1866  ? diphosphomevalonate decarboxylase (Pfam: GHMP_kinases_N) 
Oweho_1865  ? mevalonate kinase (Pfam: GHMP_kinases_C; GHMP_kinases_N) 
Oweho_1864  ? 4-hydroxybenzoate polyprenyltransferase-like prenyltransferase (Pfam: UbiA; Methyltransf_15) 
Oweho_1863  ? hypothetical protein 
29. Parachlamydia acanthamoebae 
 
PUV_13780  ? hypothetical protein (Pfam: Methyltransf_2; Methyltransf_23) 
PUV_13770  ? hypothetical protein (Pfam: Glyco_transf_92; Glyco_tranf_2_4) 
PUV_13760  ? hypothetical protein (Pfam: Glyco_transf_11) 
PUV_13750  ? hypothetical protein (Pfam: CitMHS) 
PUV_13740 ʹ LemA (Pfam: LemA) 
PUV_13730  ? protease HtpX-like protein [htpX] (Pfam: Peptidase_M48; Yip1[Golgi protein]; Peptidase_M56[Signaling 
antibiotic resistance in staphylococci]) 
 
30. Pasteurella multocida ATCC 43137 
 
DR93_1622  ? OmpA-OmpF porin [ompA] (Pfam: OmpA_membrane; OMP_b-brl; OmpA; BBP2; OprF; Autotransporter) 
DR93_1621 ʹ LemA (Pfam: LemA; DUF87; Syntaxin_2; DUF4330; Spore_III_AB; DUF2986) 
DR93_1620  ? uncharacterized protein (Pfam: TPM_phosphatase; DUF5130) 
DR93_1619  ? uncharacterized protein (Pfam: TPM_phosphatase; MOLO1) 




31. Pectobacterium wasabiae 
 
Pecwa_2703 ʹ LemA (Pfam: LemA) 
Pecwa_2702  ? Protein of unknown function DUF2207 (Pfam: DUF2207) 
Pecwa_2701  ? conserved hypothetical protein 
Pecwa_2700  ? D-isomer specific 2-hydroxyacid dehydrogenase NAD-binding protein (Pfam: 2-Hacid_dh_C; Pyr_redox; 
Pyr_redox_2; IlvN; ThiF; Shikimate_DH; Oxidored_nitro; FAD_binding_3) 
32. Pelosinus fermentans 
 
JBW_00777  ? UvrABC system protein C (Pfam: UvrC_HhH_N; UVR; GIY-YIG; HHH_2; HHH_5; CUTL) 
JBW_00778 ʹ LemA (Pfam: LemA; DivIVA) 
JBW_00779  ? uncharacterized protein (Pfam: TPM_phosphatase) 
JBW_00880  ? Rubredoxin domain containing protein (Pfam: Rubredoxin; Vps36-NZF-N; zf-Sec23_Sec24; 
zinc_ribbon_10; zf-RanBP; PHD_4; ADK_lid) 
33. Providencia stuartii MRSN 2154 
 
S70_16200  ? ATP-binding protein involved in chromosome partitioning (Pfam: ParA; CbiA; AAA_31; Fer4_NifH; MipZ; 
ArsA_ATPase; AAA_26; CLP1_P; VirC1; CBP_BcsQ; AAA_25; ArgK; SRP54) 
S70_16205 ʹ LemA (Pfam: LemA; Anillin_N; DUF4083) 
S70_16210  ? heat shock protein HtpX (Pfam: Peptidase_M48; DUF4184; Peptidase_M56 [Signaling antibiotic resistance 
in staphylococci]; HisKA_7TM; DUF955; MENTAL) 




PA1S_23740 ʹ LemA (Pfam: LemA) 
PA1S_23735  ? hypothetical protein (Pfam: GIDE; EF-hand_1; DUF1771) 
35. Rhodococcus aetherivorans 
 
AAT18_15280  ? peptidase A8 (Pfam: Peptidase_A8 
AAT18_15275  ? pseudouridine synthase (Pfam: PseudoU_synth_2; S4) 
AAT18_15270  ? hypothetical protein 
AAT18_15265  ? membrane protein precursor (Pfam: DUF2207) 
AAT18_15260 ʹ LemA (Pfam: LemA; SP_C-Propep) 
AAT18_15255  ? protein rarD (Pfam: EamA) 
AAT18_15250  ? DNA polymerase III subunit alpha (Pfam: DNA_pol3_alpha; PHP; HHH_6; tRNA_anti-codon; DUF655) 
36. Rickettsiales bacterium Ac37b 
 
NOVO_01815 ʹ LemA (Pfam: LemA; Yuri_gagarin; HAP1_N) 
NOVO_01815  ? Transposase 
NOVO_01815  ? hypothetical protein (Pfam: DDE_3; rve; DDE_1) 
37. Rufibacter sp. DG31D 
 
TH63_18270 ʹ LemA (Pfam: LemA) 
TH63_18275  ? membrane protein (Pfam: TPM_phosphatase; N-glycanase_N) 




38. Shewanella baltica OS185 
 
Shew185_4246 ʹ LemA (Pfam: LemA; DUF86; TPR_15; ALIX_LYPXL_bnd; DUF1825) 
Shew185_4245  ? conserved hypothetical protein (Pfam: DUF3137) 
Shew185_4244  ? Lytic transglycosylase catalytic (Pfam: SLT; SLT_2; DUF4124; DUF2530) 
39. Sorangium cellulosum So0157-2 
 
SCE1572_02850 ʹ LemA (Pfam: LemA; BBP1_N) 
SCE1572_02855  ? hypothetical protein (Pfam: TPM_phosphatase; DUF5130; NHS; RskA) 
SCE1572_02860  ? hypothetical protein 
SCE1572_02865  ? acetyl-CoA acetyltransferase (Pfam: Thiolase_N; Thiolase_C; ketoacyl-synt) 
SCE1572_02870  ? cyclophilin (Pfam: Pro_isomerase) 
40. Spirosoma radiotolerans 
 
SD10_25035 ʹ LemA (Pfam: LemA; Ribosomal_L36e; Laminin_II) 
SD10_25030  ? hypothetical protein (Pfam: TPM_phosphatase; Catalase-rel) 
SD10_25025  ? beta-propeller domains of methanol dehydrogenase (TPM_phosphatase; Cytomega_TRL10; 
Rifin_STEVOR) 
SD10_25020  ? hypothetical protein (Pfam: CBM9_1) 
41. Sphaerochaeta coccoides 
 
Spico_0205 ʹ LemA (Pfam: LemA; DUF1320; IncA; NusG_II; Complex1_51K) 
Spico_0206  ? hypothetical protein (Pfam: DUF2207; Acyl_transf_3) 
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Spico_0207  ? hypothetical protein 
Spico_0208  ? hypothetical protein (Pfam: DUF2804) 
42. Sphingomonas sp. MM-1 
 
G432_02365  ? TetR family transcriptional regulator (Pfam: TetR_N; POTRA_2; HTH_AraC; LacI) 
G432_02360 ʹ LemA (Pfam: LemA; EcoEI_R_C; DUF87; EzrA; Laminin_II; DUF1525) 
G432_02355  ? hypothetical protein (Pfam: TPM_phosphatase) 
G432_02350  ? hypothetical protein (Pfam: TPM_phosphatase) 
G432_02345  ? gluconate 2-dehydrogenase (Pfam: Cytochrome_CBB3; Cytochrom_C; Cytochrom_C550; 
GSu_C4xC__C2xCH) 
G432_02340  ? putative dehydrogenase subunit ( Pfam: Fer2_2; Fer2; Fer2_3; Fer2_4; DHODB_Fe-S_bind) 
G432_02335  ? aldehyde oxidase and xanthine dehydrogenase molybdopterin binding protein (Pfam: Ald_Xan_dh_C2) 
G432_02330  ? epocide hydrolase domain-containing protein (Pfam: EHN; Abhydrolase_1) 
G432_02325  ? hypothetical protein (Pfam: Ribonuc_L-PSP) 
43. Streptococcus parauberis 
 
STP_1383 ʹ LemA (Pfam: LemA; Yuri_gagarin; DUF342; Ribosomal_L36e; RuBisCO_large_N; DUF1049; T4SS; 
Fib_alpha) 
STP_1382  ? putative protease HtpX-like protein (Pfam: Peptidase_M48; Peptidase_M56 [Signaling antibiotic resistance 
in staphylococci]; Yip1; DUF799; DUF2162; DUF2964) 
STP_1381  ? hypothetical protein (Pfam: DUF177) 
STP_1380  ? response regulator protein (Pfam: Response_reg; Trans_reg_C; QRPTase_C) 
STP_1379  ? sensor histidine kinase (Pfam: HATPase_c; HisKA; HAMP; HATPase_c_3; HATPase_c_5; DUF3013) 
44. Streptococcus pneumoniae INV104 
 
  
INV104_11060 ʹ LemA (Pfam: LemA; FtsH_ext; P12) 
INV104_11050  ? putative protease HtpX homolog [htpX] (Pfam: Peptidase_M48; Peptidase_M56 [Signaling antibiotic 




45. Streptococcus agalactiae CNCTC 
 
W903_1622 ʹ LemA (Pfam: LemA; RINT1_TIP1; FtsH_ext; pRN1_helical; Ribosomal_L36e; IncA) 
W903_1621  ? heat shock protein HtpX (Pfam: Peptidase_M48; Peptidase_M56 [Signaling antibiotic resistance in 
staphylococci]; DUF4191; DUF1218) 
W903_1620  ? hypothetical protein (Pfam: DUF177) 
W903_1619  ? putative transcriptional activator CadC (Pfam: Trans_reg_C; Response_reg) 
W903_1618  ? HAMP domain protein (Pfam: HATPase_c; HisKA; HAMP; HATPase_c_3; HATPase_c_5; bPH_3; YrvL) 
46. Sulfuricella denitrificans 
 
SCD_n01605  ? hypothetical protein (Pfam: Apolipoprotein; ApoLp-III; DUF883) 
SCD_n01604  ? ubiquinone biosynthesis protein (Pfam: ABC1; APH) 
SCD_n01603  ? hydrogen dehydrogenase (Pfam: Complex1_51K; 2Fe-2S_thioredx; NADH_4Fe-4S; SLBB) 
SCD_n01602  ? hydrogen dehydrogenase (Pfam: Fer2_4; Fer4_15; NADH-G_4Fe-4S_3; Fer2; Fer4_13; Fer4; Fer4_7; 
Fer2_3) 
SCD_n01601  ? hydrogen dehydrogenase (Pfam: Oxidored_q6) 
SCD_n01600  ? nickel-dependent hydrogenase (Pfam: NiFeSe_Hases; Complex1_49kDa) 
SCD_n01599  ? hydrogenase maturation protease 
SCD_n01598  ? helicase c2 (Pfam: Helicase_C_2; DEAD; ResIII; DEAD_2; Helicase_C; RhoGAP-FF1; PhoH) 
SCD_n01597  ? hypothetical protein (Pfam: HIRAN) 
SCD_n01596  ? eptidase M22, glycoprotease (Pfam: Peptidase_M22) 
SCD_n01595  ? SSU ribosomal protein S18P alanine acetyltransferase (Pfam: Acetyltransf_1; Acetyltransf_10; 
Acetyltransf_7; FR47; Acetyltransf_4; Acetyltransf_3; Acetyltransf_9) 
SCD_n01594  ? phage DNA polymerase (Pfam: UDG) 
SCD_n01593 ʹ LemA (Pfam: LemA; DUF576; DUF1869; Alanine_zipper; Lipase_bact_N; LPAM_2) 
SCD_n01592  ? hypothetical protein (Pfam: TPM_phosphatase) 
SCD_n01591  ? hypothetical protein (Pfam: TPM_phosphatase) 
47. Syntrophus aciditrophicus 
 
SYN_00539  ? phosphohydrolase (Pfam: NUDIX) 
SYN_00538  ? Fe-S oxidoreductase (Pfam: Radical_SAM; B12-binding) 
SYN_00537  ? uncharacterized protein (Pfam: TPM_phosphatase) 
SYN_00536  ? hypothetical cytosolic protein (Pfam: NTP_transf_2) 
SYN_00535 ʹ LemA (Pfam: LemA) 
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SYN_00534  ? phosphoesterase (Pfam: Metallophos; Metallophos_2; AmoA; Metallophos_3) 
SYN_00533  ? tRNA nucleotidyltransferase (Pfam: PolyA_pol; CBS; PolyA_pol_RNAbd; DHH; DHHA1) 
48. Tannerella forsythia 
 
BFO_0223  ? hypothetical protein 
BFO_0224 ʹ LemA (Pfam: LemA; DUF4083; ABC2_membrane_3; PBC; Vps5; Erp_C; IncA; Wzy_C; DASH_Spc34; 
Leu_Phe_trans; S1FA; Tmemb_9; DUF4303; DUF4446) 
BFO_0225  ? heat shock protein HtpX (Pfam: Peptidase_M48; Peptidase_M56 [Signaling antibiotic resistance in 
staphylococci]; MadM; SprT-like; DUF962) 
BFO_0226  ? threonine/alanine tRNA ligase (Pfam: tRNA_SAD) 
BFO_0227  ? phosphoglycerate kinase [pgk] (Pfam: PGK; GST_C) 
BFO_0228  ? MATE efflux family protein (Pfam: MatE; Polysacc_synt_C; MVIN; Polysacc_synt; UPF0259) 
49. Thermoanaerobacter wiegelii 
 
Thewi_0414  ? MoxR-like ATPase (Pfam: AAA_3; AAA_5; MCM; AAA; RuvB_N; Sigma54_activat; Mg_chelatase; AAA_18; 
SKI; AAA_2; Thymidylate_kin; AAA_16; AAA_19) 
Thewi_0415  ? protein of unknown function (Pfam: DUF58; CstA) 
Thewi_0416  ? hypothetical protein (Pfam: DUF4129; OAD_gamma; SUR7) 
Thewi_0417 ʹ LemA (Pfam: LemA; DUF4837; OmpH; DUF1043; DUF1628; ABC2_membrane_3; Ribosomal_L36e) 
50. Vulgatibacter incomptus 
 
AKJ08_3292 ʹ LemA (Pfam: LemA; DUF1869; Lipase_bact_N; LPAM_2; LptE) 
AKJ08_3293  ? uncharacterized protein (Pfam: TPM_phosphatase; HigB-like_toxin) 
AKJ08_3294  ? hypothetical protein (Pfam: Peptidase_S46; Trypsin_2; Trypsin; Peptidase_S7; DUF31) 
AKJ08_3295  ? Fatty acid hydroxylase-like protein (Pfam: FA_hydroxylase; Papilloma_E5A) 
51. Yersinia pestis 91001 (biovar Microtus) 
 
YP_2432 ʹ LemA (Pfam: LemA) 
YP_2433  ? pseudogene 
YP_2434  ? Uncharacterized Zn-ribbon-containing protein involved in phosphonate metabolism [phnA] (Pfam: PhnA; 
205 
 
PhnA_Zn_Ribbon; zinc-ribbons_6; DNA_RNApol_7kD; UPF0547; TF_Zn_Ribbon; HypA; DUF2318; zinc_ribbon_4; zf-trcl; 
OrfB_Zn_ribbon; Zn-ribbon_8; zf-ribbon_3; Zn_Tnp_IS1595) 
52. Zunongwangia profunda 
 
ZPR_0786  ? M23 family peptidase (Pfam: Peptidase_M23; Amidase_5; Biotin_lipoyl_2; PTS_EIIA_1) 
ZPR_0785  ? MerR family transcriptional regulator (Pfam: MerR_1; MerR; Acetyltransf_11) 
ZPR_0784 ʹ LemA ( Pfam: LemA; NTNH_C) 
ZPR_0783  ? conserved hypothetical protein (Pfam: TPM_phosphatase; DUF5130; CinA) 
ZPR_0782  ? uncharacterized protein (Pfam: TPM_phosphatase; DUF4105) 
 
